Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 19p13.3(chr19:233565-4699472)x3	LOC130063041|LOC130063042|LOC130063043|LOC130063044|LOC130063045|LOC130063046|LOC130063047|LOC130063048|LOC130063049|LOC130063050|LOC130063051|LOC130063052|LOC130063053|LOC130063054|LOC130063055|LOC130063056|LOC130063057|LOC130063058|LOC130063059|LOC130063060|LOC130063061|LOC130063062|LOC130063063|LOC130063064|LOC130063065|LOC130063066|LOC130063067|LOC130063068|LOC130063069|LOC130063070|LOC130063071|LOC130063072|LOC130063073|LOC130063074|LOC130063075|LOC130063076|LOC130063077|LOC130063078|LOC130063079|LOC130063080|LOC130063081|LOC130063082|LOC130063083|LOC130063084|LOC130063085|LOC130063086|LOC130063087|LOC130063088|LOC130063089|LOC130063090|LOC130063091|LOC130063092|LOC130063093|LOC130063094|LOC130063095|LOC130063096|LOC130063097|LOC130063098|LOC130063099|LOC130063100|LOC130063101|LOC130063102|LOC130063103|LOC130063104|LOC130063105|LOC130063106|LOC130063107|LOC130063108|LOC130063109|LOC130063110|LOC130063111|LOC130063112|LOC130063113|LOC130063114|LOC130063115|LOC130063116|LOC130063117|LOC130063118|LOC130063119|LOC130063120|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC132090902|LRG1|LSM7|MADCAM1|MADCAM1-AS1|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MIDN|MIER2|MIR1227|MIR1909|MIR3187|MIR4321|MIR4745|MIR4746|MIR637|MIR6789|MIR7108|MIR7850|MISP|MKNK2|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFS7|NFIC|NMRK2|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|POLR2E|POLRMT|PRSS57|PRTN3|PTBP1|PWWP3A|R3HDM4|RAX2|REEP6|REXO1|RNF126|RNU6-2|RNU6-9|RPS15|S1PR4|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH3GL1|SHC2|SHD|SIRT6|SLC39A3|SMIM24|SMIM44|SNORD37|SPMAP2|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TNFAIP8L1|TPGS1|TRF-GAA1-6|TRN-GTT2-6|UBXN6|UQCR11|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF57|ZNF77|ABCA7|ABHD17A|ADAMTSL5|ADAT3|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ATCAY|ATP5F1D|ATP8B3|AZU1|BSG|BSG-AS1|BTBD2|C19orf25|C2CD4C|CACTIN|CACTIN-AS1|CBARP|CBARP-DT|CDC34|CELF5|CFD|CHAF1A|CIMAP1D|CIRBP|CIRBP-AS1|CNN2|CREB3L3|CSNK1G2|CSNK1G2-AS1|DAPK3|DAZAP1|DIRAS1|DOHH|DOT1L|DPP9|DPP9-AS1|EBI3|EEF2|EFNA2|ELANE|FAM174C|FGF22|FSD1|FSTL3|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNA15-DT|GNG7|GPX4|GRIN3B|GZMM|HCN2|HDGFL2|HMG20B|IZUMO4|JSRP1|KISS1R|KLF16|LINC01775|LINGO3|LMNB2|LOC100288123|LOC101928450|LOC105372244|LOC106804547|LOC108254692|LOC108281123|LOC108348031|LOC108783649|LOC110006317|LOC110006318|LOC111413035|LOC111556134|LOC111721712|LOC111828491|LOC112543439|LOC112543440|LOC112543441|LOC112543443|LOC112543475|LOC112543476|LOC112543477|LOC112543480|LOC112543481|LOC112543482|LOC112543490|LOC113939966|LOC113939970|LOC116276493|LOC116276494|LOC116276495|LOC116276496|LOC116276497|LOC116276498|LOC121627842|LOC121627843|LOC121627844|LOC121627845|LOC121627846|LOC121627847|LOC121627848|LOC121627849|LOC121627850|LOC121627851|LOC121852971|LOC121852972|LOC121852973|LOC121852974|LOC125371444|LOC125371446|LOC125371447|LOC125371448|LOC125371449|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC125371457|LOC126862835|LOC126862836|LOC126862837|LOC126862838|LOC126862839|LOC126862840|LOC128772422|LOC128772423|LOC128772424|LOC128900001|LOC129391009|LOC129391010|LOC129391011|LOC129391012|LOC129391013|LOC129391014|LOC129391015|LOC129391016|LOC129391017|LOC129391018|LOC129391019|LOC129391020|LOC129391021|LOC129391022|LOC129391023|LOC129391024|LOC129391025|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129929036|LOC130062811|LOC130062812|LOC130062813|LOC130062814|LOC130062815|LOC130062816|LOC130062817|LOC130062818|LOC130062819|LOC130062820|LOC130062821|LOC130062822|LOC130062823|LOC130062824|LOC130062825|LOC130062826|LOC130062827|LOC130062828|LOC130062829|LOC130062830|LOC130062831|LOC130062832|LOC130062833|LOC130062834|LOC130062835|LOC130062836|LOC130062837|LOC130062838|LOC130062839|LOC130062840|LOC130062841|LOC130062842|LOC130062843|LOC130062844|LOC130062845|LOC130062846|LOC130062847|LOC130062848|LOC130062849|LOC130062850|LOC130062851|LOC130062852|LOC130062853|LOC130062854|LOC130062855|LOC130062856|LOC130062857|LOC130062858|LOC130062859|LOC130062860|LOC130062861|LOC130062862|LOC130062863|LOC130062864|LOC130062865|LOC130062866|LOC130062867|LOC130062868|LOC130062869|LOC130062870|LOC130062871|LOC130062872|LOC130062873|LOC130062874|LOC130062875|LOC130062876|LOC130062877|LOC130062878|LOC130062879|LOC130062880|LOC130062881|LOC130062882|LOC130062883|LOC130062884|LOC130062885|LOC130062886|LOC130062887|LOC130062888|LOC130062889|LOC130062890|LOC130062891|LOC130062892|LOC130062893|LOC130062894|LOC130062895|LOC130062896|LOC130062897|LOC130062898|LOC130062899|LOC130062900|LOC130062901|LOC130062902|LOC130062903|LOC130062904|LOC130062905|LOC130062906|LOC130062907|LOC130062908|LOC130062909|LOC130062910|LOC130062911|LOC130062912|LOC130062913|LOC130062914|LOC130062915|LOC130062916|LOC130062917|LOC130062918|LOC130062919|LOC130062920|LOC130062921|LOC130062922|LOC130062923|LOC130062924|LOC130062925|LOC130062926|LOC130062927|LOC130062928|LOC130062929|LOC130062930|LOC130062931|LOC130062932|LOC130062933|LOC130062934|LOC130062935|LOC130062936|LOC130062937|LOC130062938|LOC130062939|LOC130062940|LOC130062941|LOC130062942|LOC130062943|LOC130062944|LOC130062945|LOC130062946|LOC130062947|LOC130062948|LOC130062949|LOC130062950|LOC130062951|LOC130062952|LOC130062953|LOC130062954|LOC130062955|LOC130062956|LOC130062957|LOC130062958|LOC130062959|LOC130062960|LOC130062961|LOC130062962|LOC130062963|LOC130062964|LOC130062965|LOC130062966|LOC130062967|LOC130062968|LOC130062969|LOC130062970|LOC130062971|LOC130062972|LOC130062973|LOC130062974|LOC130062975|LOC130062976|LOC130062977|LOC130062978|LOC130062979|LOC130062980|LOC130062981|LOC130062982|LOC130062983|LOC130062984|LOC130062985|LOC130062986|LOC130062987|LOC130062988|LOC130062989|LOC130062990|LOC130062991|LOC130062992|LOC130062993|LOC130062994|LOC130062995|LOC130062996|LOC130062997|LOC130062998|LOC130062999|LOC130063000|LOC130063001|LOC130063002|LOC130063003|LOC130063004|LOC130063005|LOC130063006|LOC130063007|LOC130063008|LOC130063009|LOC130063010|LOC130063011|LOC130063012|LOC130063013|LOC130063014|LOC130063015|LOC130063016|LOC130063017|LOC130063018|LOC130063019|LOC130063020|LOC130063021|LOC130063022|LOC130063023|LOC130063024|LOC130063025|LOC130063026|LOC130063027|LOC130063028|LOC130063029|LOC130063030|LOC130063031|LOC130063032|LOC130063033|LOC130063034|LOC130063035|LOC130063036|LOC130063037|LOC130063038|LOC130063039|LOC130063040		See cases	VCV000058787	19	233565 - 4699484	19	233565 - 4699472	58787	73382			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 19p13.3(chr19:259395-6795611)x3	LOC130062978|LOC130062979|LOC130062980|LOC130062981|LOC130062982|LOC130062983|LOC130062984|LOC130062985|LOC130062986|LOC130062987|LOC130062988|LOC130062989|LOC130062990|LOC130062991|LOC130062992|LOC130062993|LOC130062994|LOC130062995|LOC130062996|LOC130062997|LOC130062998|LOC130062999|LOC130063000|LOC130063001|LOC130063002|LOC130063003|LOC130063004|LOC130063005|LOC130063006|LOC130063007|LOC130063008|LOC130063009|LOC130063010|LOC130063011|LOC130063012|LOC130063013|LOC130063014|LOC130063015|LOC130063016|LOC130063017|LOC130063018|LOC130063019|LOC130063020|LOC130063021|LOC130063022|LOC130063023|LOC130063024|LOC130063025|LOC130063026|LOC130063027|LOC130063028|LOC130063029|LOC130063030|LOC130063031|LOC130063032|LOC130063033|LOC130063034|LOC130063035|LOC130063036|LOC130063037|LOC130063038|LOC130063039|LOC130063040|LOC130063041|LOC130063042|LOC130063043|LOC130063044|LOC130063045|LOC130063046|LOC130063047|LOC130063048|LOC130063049|LOC130063050|LOC130063051|LOC130063052|LOC130063053|LOC130063054|LOC130063055|LOC130063056|LOC130063057|LOC130063058|LOC130063059|LOC130063060|LOC130063061|LOC130063062|LOC130063063|LOC130063064|LOC130063065|LOC130063066|LOC130063067|LOC130063068|LOC130063069|LOC130063070|LOC130063071|LOC130063072|LOC130063073|LOC130063074|LOC130063075|LOC130063076|LOC130063077|LOC130063078|LOC130063079|LOC130063080|LOC130063081|LOC130063082|LOC130063083|LOC130063084|LOC130063085|LOC130063086|LOC130063087|LOC130063088|LOC130063089|LOC130063090|LOC130063091|LOC130063092|LOC130063093|LOC130063094|LOC130063095|LOC130063096|LOC130063097|LOC130063098|LOC130063099|LOC130063100|LOC130063101|LOC130063102|LOC130063103|LOC130063104|LOC130063105|LOC130063106|LOC130063107|LOC130063108|LOC130063109|LOC130063110|LOC130063111|LOC130063112|LOC130063113|LOC130063114|LOC130063115|LOC130063116|LOC130063117|LOC130063118|LOC130063119|LOC130063120|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LOC130063231|LOC130063232|LOC130063233|LOC130063234|LOC130063235|LOC130063236|LOC130063237|LOC130063238|LOC130063239|LOC130063240|LOC130063241|LOC130063242|LOC130063243|LOC130063244|LOC130063245|LOC130063246|LOC130063247|LOC130063248|LOC130063249|LOC130063250|LOC130063251|LOC130063252|LOC130063253|LOC130063254|LOC130063255|LOC130063256|LOC130063257|LOC130063258|LOC130063259|LOC130063260|LOC130063261|LOC130063262|LOC130063263|LOC130063264|LOC130063265|LOC130063266|LOC130063267|LOC130063268|LOC130063269|LOC130063270|LOC130063271|LOC130063272|LOC130063273|LOC130063274|LOC130063275|LOC130063276|LOC130063277|LOC130063278|LOC130063279|LOC130063280|LOC130063281|LOC130063282|LOC130063283|LOC130063284|LOC130063285|LOC130063286|LOC130063287|LOC130063288|LOC130063289|LOC130063290|LOC130063291|LOC130063292|LOC130063293|LOC130063294|LOC130063295|LOC130063296|LOC130063297|LOC130063298|LOC130063299|LOC130063300|LOC130063301|LOC130063302|LOC130063303|LOC130063304|LOC130063305|LOC130063306|LOC130063307|LOC130063308|LOC130063309|LOC130063310|LOC130063311|LOC130063312|LOC130063313|LOC130063314|LOC130063315|LOC130063316|LOC130063317|LOC130063318|LOC130063319|LOC130063320|LOC130063321|LOC130063322|LOC130063323|LOC130063324|LOC130063325|LOC130063326|LOC130063327|LOC130063328|LOC130063329|LOC130063330|LOC130063331|LOC130063332|LOC130063333|LOC130063334|LOC130063335|LOC130063336|LOC130063337|LOC130063338|LOC130063339|LOC130063340|LOC130063341|LOC132090552|LOC132090553|LOC132090555|LOC132090556|LOC132090902|LOC132090903|LOC390877|LONP1|LRG1|LSM7|MADCAM1|MADCAM1-AS1|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MICOS13|MIDN|MIER2|MIR1227|MIR1909|MIR3187|MIR3940|MIR4321|MIR4745|MIR4746|MIR4747|MIR637|MIR6789|MIR6790|MIR6791|MIR6885|MIR7-3|MIR7-3HG|MIR7108|MIR7850|MISP|MKNK2|MLLT1|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFA11|NDUFS7|NFIC|NMRK2|NRTN|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|POLR2E|POLRMT|PRR22|PRSS57|PRTN3|PSPN|PTBP1|PTPRS|PTPRS-AS1|PWWP3A|R3HDM4|RANBP3|RANBP3-DT|RAX2|REEP6|REXO1|RFX2|RNF126|RNU6-2|RNU6-9|RPL36|RPS15|S1PR4|SAFB|SAFB2|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH2D3A|SH3GL1|SHC2|SHD|SIRT6|SLC25A23|SLC25A41|SLC39A3|SMIM24|SMIM44|SNORD37|SPMAP2|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TICAM1|TIMM13|TINCR|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TPGS1|TRF-GAA1-6|TRG-TCC1-1|TRIP10|TRN-GTT2-6|TRV-CAC3-1|TUBB4A|UBXN6|UHRF1|UQCR11|VAV1|VMAC|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF57|ZNF77|ZNRF4|ABCA7|ABHD17A|ACER1|ACSBG2|ADAMTSL5|ADAT3|ALKBH7|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ARRDC5|ATCAY|ATP5F1D|ATP8B3|AZU1|BSG|BSG-AS1|BTBD2|C19orf25|C2CD4C|C3|CACTIN|CACTIN-AS1|CAPS|CATSPERD|CBARP|CBARP-DT|CD70|CDC34|CELF5|CFD|CHAF1A|CIMAP1D|CIRBP|CIRBP-AS1|CLPP|CNN2|CRB3|CREB3L3|CSNK1G2|CSNK1G2-AS1|DAPK3|DAZAP1|DENND1C|DIRAS1|DOHH|DOT1L|DPP9|DPP9-AS1|DUS3L|EBI3|EEF2|EFNA2|ELANE|FAM174C|FEM1A|FGF22|FSD1|FSTL3|FUT3|FUT5|FUT6|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNA15-DT|GNG7|GPR108|GPX4|GRIN3B|GTF2F1|GZMM|HCN2|HDGFL2|HMG20B|HSD11B1L|IZUMO4|JSRP1|KDM4B|KHSRP|KISS1R|KLF16|LINC01775|LINGO3|LMNB2|LOC100288123|LOC101928450|LOC101928844|LOC105372244|LOC105372253|LOC105372255|LOC106804547|LOC108254692|LOC108281123|LOC108348031|LOC108783649|LOC110006317|LOC110006318|LOC111413035|LOC111556134|LOC111721712|LOC111828491|LOC111828495|LOC112543439|LOC112543440|LOC112543441|LOC112543443|LOC112543475|LOC112543476|LOC112543477|LOC112543480|LOC112543481|LOC112543482|LOC112543490|LOC112552148|LOC112552174|LOC112552175|LOC112552176|LOC113939966|LOC113939970|LOC113939971|LOC113939974|LOC116276493|LOC116276494|LOC116276495|LOC116276496|LOC116276497|LOC116276498|LOC116276499|LOC116276500|LOC121627842|LOC121627843|LOC121627844|LOC121627845|LOC121627846|LOC121627847|LOC121627848|LOC121627849|LOC121627850|LOC121627851|LOC121627852|LOC121627853|LOC121852971|LOC121852972|LOC121852973|LOC121852974|LOC121852975|LOC121852976|LOC125371444|LOC125371446|LOC125371447|LOC125371448|LOC125371449|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC125371457|LOC125371459|LOC125371460|LOC125371461|LOC125371462|LOC125371463|LOC125371464|LOC125371465|LOC126862835|LOC126862836|LOC126862837|LOC126862838|LOC126862839|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC126862844|LOC126862845|LOC126862846|LOC126862847|LOC128772422|LOC128772423|LOC128772424|LOC128900001|LOC129391009|LOC129391010|LOC129391011|LOC129391012|LOC129391013|LOC129391014|LOC129391015|LOC129391016|LOC129391017|LOC129391018|LOC129391019|LOC129391020|LOC129391021|LOC129391022|LOC129391023|LOC129391024|LOC129391025|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC129391040|LOC129391041|LOC129391042|LOC129929036|LOC130062811|LOC130062812|LOC130062813|LOC130062814|LOC130062815|LOC130062816|LOC130062817|LOC130062818|LOC130062819|LOC130062820|LOC130062821|LOC130062822|LOC130062823|LOC130062824|LOC130062825|LOC130062826|LOC130062827|LOC130062828|LOC130062829|LOC130062830|LOC130062831|LOC130062832|LOC130062833|LOC130062834|LOC130062835|LOC130062836|LOC130062837|LOC130062838|LOC130062839|LOC130062840|LOC130062841|LOC130062842|LOC130062843|LOC130062844|LOC130062845|LOC130062846|LOC130062847|LOC130062848|LOC130062849|LOC130062850|LOC130062851|LOC130062852|LOC130062853|LOC130062854|LOC130062855|LOC130062856|LOC130062857|LOC130062858|LOC130062859|LOC130062860|LOC130062861|LOC130062862|LOC130062863|LOC130062864|LOC130062865|LOC130062866|LOC130062867|LOC130062868|LOC130062869|LOC130062870|LOC130062871|LOC130062872|LOC130062873|LOC130062874|LOC130062875|LOC130062876|LOC130062877|LOC130062878|LOC130062879|LOC130062880|LOC130062881|LOC130062882|LOC130062883|LOC130062884|LOC130062885|LOC130062886|LOC130062887|LOC130062888|LOC130062889|LOC130062890|LOC130062891|LOC130062892|LOC130062893|LOC130062894|LOC130062895|LOC130062896|LOC130062897|LOC130062898|LOC130062899|LOC130062900|LOC130062901|LOC130062902|LOC130062903|LOC130062904|LOC130062905|LOC130062906|LOC130062907|LOC130062908|LOC130062909|LOC130062910|LOC130062911|LOC130062912|LOC130062913|LOC130062914|LOC130062915|LOC130062916|LOC130062917|LOC130062918|LOC130062919|LOC130062920|LOC130062921|LOC130062922|LOC130062923|LOC130062924|LOC130062925|LOC130062926|LOC130062927|LOC130062928|LOC130062929|LOC130062930|LOC130062931|LOC130062932|LOC130062933|LOC130062934|LOC130062935|LOC130062936|LOC130062937|LOC130062938|LOC130062939|LOC130062940|LOC130062941|LOC130062942|LOC130062943|LOC130062944|LOC130062945|LOC130062946|LOC130062947|LOC130062948|LOC130062949|LOC130062950|LOC130062951|LOC130062952|LOC130062953|LOC130062954|LOC130062955|LOC130062956|LOC130062957|LOC130062958|LOC130062959|LOC130062960|LOC130062961|LOC130062962|LOC130062963|LOC130062964|LOC130062965|LOC130062966|LOC130062967|LOC130062968|LOC130062969|LOC130062970|LOC130062971|LOC130062972|LOC130062973|LOC130062974|LOC130062975|LOC130062976|LOC130062977		See cases	VCV000154560	19	259395 - 6795622	19	259395 - 6795611	154560	164314			copy number gain		Pathogenic	Feb 11, 2011	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:1549144-4288720)x1	ABHD17A|ADAT3|AMH|ANKRD24|AP3D1|APBA3|ATCAY|ATP8B3|BTBD2|CACTIN|CACTIN-AS1|CELF5|CREB3L3|CSNK1G2|CSNK1G2-AS1|DAPK3|DIRAS1|DOHH|DOT1L|EBI3|EEF2|FZR1|GADD45B|GIPC3|GNA11|GNA15|GNA15-DT|GNG7|HMG20B|IZUMO4|JSRP1|KLF16|LINC01775|LINGO3|LMNB2|LOC100288123|LOC105372244|LOC106804547|LOC108348031|LOC108783649|LOC111556134|LOC111721712|LOC112543440|LOC112543441|LOC112543443|LOC112543475|LOC112543476|LOC112543477|LOC112543480|LOC112543481|LOC112543482|LOC112543490|LOC113939970|LOC116276497|LOC116276498|LOC121627845|LOC121627846|LOC121627847|LOC121627848|LOC121627849|LOC121852972|LOC121852973|LOC125371448|LOC125371449|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC126862838|LOC126862839|LOC128772422|LOC128772423|LOC128772424|LOC128900001|LOC129391019|LOC129391020|LOC129391021|LOC129391022|LOC129391023|LOC129391024|LOC129391025|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129929036|LOC130062966|LOC130062967|LOC130062968|LOC130062969|LOC130062970|LOC130062971|LOC130062972|LOC130062973|LOC130062974|LOC130062975|LOC130062976|LOC130062977|LOC130062978|LOC130062979|LOC130062980|LOC130062981|LOC130062982|LOC130062983|LOC130062984|LOC130062985|LOC130062986|LOC130062987|LOC130062988|LOC130062989|LOC130062990|LOC130062991|LOC130062992|LOC130062993|LOC130062994|LOC130062995|LOC130062996|LOC130062997|LOC130062998|LOC130062999|LOC130063000|LOC130063001|LOC130063002|LOC130063003|LOC130063004|LOC130063005|LOC130063006|LOC130063007|LOC130063008|LOC130063009|LOC130063010|LOC130063011|LOC130063012|LOC130063013|LOC130063014|LOC130063015|LOC130063016|LOC130063017|LOC130063018|LOC130063019|LOC130063020|LOC130063021|LOC130063022|LOC130063023|LOC130063024|LOC130063025|LOC130063026|LOC130063027|LOC130063028|LOC130063029|LOC130063030|LOC130063031|LOC130063032|LOC130063033|LOC130063034|LOC130063035|LOC130063036|LOC130063037|LOC130063038|LOC130063039|LOC130063040|LOC130063041|LOC130063042|LOC130063043|LOC130063044|LOC130063045|LOC130063046|LOC130063047|LOC130063048|LOC130063049|LOC130063050|LOC130063051|LOC130063052|LOC130063053|LOC130063054|LOC130063055|LOC130063056|LOC130063057|LOC130063058|LOC130063059|LOC130063060|LOC130063061|LOC130063062|LOC130063063|LOC130063064|LOC130063065|LOC130063066|LOC130063067|LOC130063068|LOC130063069|LOC130063070|LOC130063071|LOC130063072|LOC130063073|LOC130063074|LOC130063075|LOC130063076|LOC130063077|LOC130063078|LOC130063079|LOC130063080|LOC130063081|LOC130063082|LOC130063083|LOC130063084|LOC130063085|LOC130063086|LOC130063087|LOC130063088|LOC130063089|LOC130063090|LOC130063091|LOC130063092|LOC130063093|LOC130063094|LOC130063095|LOC130063096|LOC130063097|LOC130063098|LOC130063099|LOC130063100|LOC130063101|LOC130063102|LOC130063103|LOC130063104|LOC130063105|LOC130063106|LOC130063107|LOC130063108|LOC130063109|LOC130063110|LOC130063111|LOC130063112|LOC130063113|LOC130063114|LOC130063115|LOC130063116|LOC130063117|LOC130063118|LOC130063119|LOC130063120|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LSM7|MAP2K2|MATK|MBD3|MEX3D|MFSD12|MIR1227|MIR1909|MIR4321|MIR637|MIR6789|MIR7108|MIR7850|MKNK2|MOB3A|MRPL54|NCLN|NFIC|NMRK2|OAZ1|ONECUT3|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|RAX2|REXO1|S1PR4|SCAMP4|SF3A2|SGTA|SHD|SIRT6|SLC39A3|SMIM24|SMIM44|SNORD37|SPPL2B|TBXA2R|TCF3|TEKTIP1|THOP1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMPRSS9|UQCR11|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF57|ZNF77		See cases	VCV000145414	19	1549143 - 4288717	19	1549144 - 4288720	145414	155165			copy number loss		Pathogenic	Aug 30, 2010	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:1565575-4108128)x3	ABHD17A|ADAT3|AMH|AP3D1|APBA3|ATCAY|ATP8B3|BTBD2|CACTIN|CACTIN-AS1|CELF5|CSNK1G2|CSNK1G2-AS1|DAPK3|DIRAS1|DOHH|DOT1L|EEF2|FZR1|GADD45B|GIPC3|GNA11|GNA15|GNA15-DT|GNG7|HMG20B|IZUMO4|JSRP1|KLF16|LINC01775|LINGO3|LMNB2|LOC100288123|LOC105372244|LOC106804547|LOC108348031|LOC108783649|LOC111556134|LOC111721712|LOC112543440|LOC112543441|LOC112543443|LOC112543475|LOC112543476|LOC112543477|LOC112543480|LOC112543481|LOC112543482|LOC113939970|LOC116276497|LOC116276498|LOC121627845|LOC121627846|LOC121627847|LOC121627848|LOC121852972|LOC121852973|LOC125371449|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC126862838|LOC126862839|LOC128772422|LOC128772423|LOC128772424|LOC128900001|LOC129391019|LOC129391020|LOC129391021|LOC129391022|LOC129391023|LOC129391024|LOC129391025|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129929036|LOC130062966|LOC130062967|LOC130062968|LOC130062969|LOC130062970|LOC130062971|LOC130062972|LOC130062973|LOC130062974|LOC130062975|LOC130062976|LOC130062977|LOC130062978|LOC130062979|LOC130062980|LOC130062981|LOC130062982|LOC130062983|LOC130062984|LOC130062985|LOC130062986|LOC130062987|LOC130062988|LOC130062989|LOC130062990|LOC130062991|LOC130062992|LOC130062993|LOC130062994|LOC130062995|LOC130062996|LOC130062997|LOC130062998|LOC130062999|LOC130063000|LOC130063001|LOC130063002|LOC130063003|LOC130063004|LOC130063005|LOC130063006|LOC130063007|LOC130063008|LOC130063009|LOC130063010|LOC130063011|LOC130063012|LOC130063013|LOC130063014|LOC130063015|LOC130063016|LOC130063017|LOC130063018|LOC130063019|LOC130063020|LOC130063021|LOC130063022|LOC130063023|LOC130063024|LOC130063025|LOC130063026|LOC130063027|LOC130063028|LOC130063029|LOC130063030|LOC130063031|LOC130063032|LOC130063033|LOC130063034|LOC130063035|LOC130063036|LOC130063037|LOC130063038|LOC130063039|LOC130063040|LOC130063041|LOC130063042|LOC130063043|LOC130063044|LOC130063045|LOC130063046|LOC130063047|LOC130063048|LOC130063049|LOC130063050|LOC130063051|LOC130063052|LOC130063053|LOC130063054|LOC130063055|LOC130063056|LOC130063057|LOC130063058|LOC130063059|LOC130063060|LOC130063061|LOC130063062|LOC130063063|LOC130063064|LOC130063065|LOC130063066|LOC130063067|LOC130063068|LOC130063069|LOC130063070|LOC130063071|LOC130063072|LOC130063073|LOC130063074|LOC130063075|LOC130063076|LOC130063077|LOC130063078|LOC130063079|LOC130063080|LOC130063081|LOC130063082|LOC130063083|LOC130063084|LOC130063085|LOC130063086|LOC130063087|LOC130063088|LOC130063089|LOC130063090|LOC130063091|LOC130063092|LOC130063093|LOC130063094|LOC130063095|LOC130063096|LOC130063097|LOC130063098|LOC130063099|LOC130063100|LOC130063101|LOC130063102|LOC130063103|LOC130063104|LOC130063105|LOC130063106|LOC130063107|LOC130063108|LOC130063109|LOC130063110|LOC130063111|LOC130063112|LOC130063113|LOC130063114|LOC130063115|LOC130063116|LOC130063117|LOC130063118|LOC130063119|LOC130063120|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LSM7|MAP2K2|MATK|MBD3|MEX3D|MFSD12|MIR1227|MIR1909|MIR4321|MIR637|MIR6789|MIR7108|MIR7850|MKNK2|MOB3A|MRPL54|NCLN|NFIC|NMRK2|OAZ1|ONECUT3|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|RAX2|REXO1|S1PR4|SCAMP4|SF3A2|SGTA|SLC39A3|SMIM24|SMIM44|SNORD37|SPPL2B|TBXA2R|TCF3|TEKTIP1|THOP1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMPRSS9|UQCR11|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF57|ZNF77		See cases	VCV000059081	19	1565574 - 4108126	19	1565575 - 4108128	59081	73676			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 19p13.3-13.2(chr19:1972245-9648879)x3	LOC130063254|LOC130063255|LOC130063256|LOC130063257|LOC130063258|LOC130063259|LOC130063260|LOC130063261|LOC130063262|LOC130063263|LOC130063264|LOC130063265|LOC130063266|LOC130063267|LOC130063268|LOC130063269|LOC130063270|LOC130063271|LOC130063272|LOC130063273|LOC130063274|LOC130063275|LOC130063276|LOC130063277|LOC130063278|LOC130063279|LOC130063280|LOC130063281|LOC130063282|LOC130063283|LOC130063284|LOC130063285|LOC130063286|LOC130063287|LOC130063288|LOC130063289|LOC130063290|LOC130063291|LOC130063292|LOC130063293|LOC130063294|LOC130063295|LOC130063296|LOC130063297|LOC130063298|LOC130063299|LOC130063300|LOC130063301|LOC130063302|LOC130063303|LOC130063304|LOC130063305|LOC130063306|LOC130063307|LOC130063308|LOC130063309|LOC130063310|LOC130063311|LOC130063312|LOC130063313|LOC130063314|LOC130063315|LOC130063316|LOC130063317|LOC130063318|LOC130063319|LOC130063320|LOC130063321|LOC130063322|LOC130063323|LOC130063324|LOC130063325|LOC130063326|LOC130063327|LOC130063328|LOC130063329|LOC130063330|LOC130063331|LOC130063332|LOC130063333|LOC130063334|LOC130063335|LOC130063336|LOC130063337|LOC130063338|LOC130063339|LOC130063340|LOC130063341|LOC130063342|LOC130063343|LOC130063344|LOC130063345|LOC130063346|LOC130063347|LOC130063348|LOC130063349|LOC130063350|LOC130063351|LOC130063352|LOC130063353|LOC130063354|LOC130063355|LOC130063356|LOC130063357|LOC130063358|LOC130063359|LOC130063360|LOC130063361|LOC130063362|LOC130063363|LOC130063364|LOC130063365|LOC130063366|LOC130063367|LOC130063368|LOC130063369|LOC130063370|LOC130063371|LOC130063372|LOC130063373|LOC130063374|LOC130063375|LOC130063376|LOC130063377|LOC130063378|LOC130063379|LOC130063380|LOC130063381|LOC130063382|LOC130063383|LOC130063384|LOC130063385|LOC130063386|LOC130063387|LOC130063388|LOC130063389|LOC130063390|LOC130063391|LOC130063392|LOC130063393|LOC130063394|LOC130063395|LOC130063396|LOC130063397|LOC130063398|LOC130063399|LOC130063400|LOC130063401|LOC130063402|LOC130063403|LOC130063404|LOC130063405|LOC130063406|LOC130063407|LOC130063408|LOC130063409|LOC130063410|LOC130063411|LOC130063412|LOC130063413|LOC130063414|LOC130063415|LOC130063416|LOC130063417|LOC130063418|LOC130063419|LOC130063420|LOC130063421|LOC130063422|LOC130063423|LOC130063424|LOC130063425|LOC130063426|LOC130063427|LOC130063428|LOC130063429|LOC130063430|LOC130063431|LOC130063432|LOC130063433|LOC130063434|LOC130063435|LOC130063436|LOC130063437|LOC130063438|LOC130063439|LOC130063440|LOC130063441|LOC130063442|LOC130063443|LOC130063444|LOC130063445|LOC130063446|LOC130063447|LOC130063448|LOC130063449|LOC130063450|LOC130063451|LOC130063452|LOC130063453|LOC130063454|LOC132090552|LOC132090553|LOC132090555|LOC132090556|LOC132090903|LOC390877|LONP1|LRG1|LRRC8E|LSM7|MAP2K2|MAP2K7|MARCHF2|MATK|MBD3L1|MBD3L2|MBD3L2B|MBD3L3|MBD3L4|MBD3L5|MCEMP1|MCOLN1|MFSD12|MICOS13|MIR1227|MIR3940|MIR4321|MIR4746|MIR4747|MIR4999|MIR637|MIR6789|MIR6790|MIR6791|MIR6792|MIR6885|MIR7-3|MIR7-3HG|MIR7108|MIR7850|MKNK2|MLLT1|MOB3A|MPND|MRPL54|MUC16|MYDGF|MYO1F|NCLN|NDUFA11|NDUFA7|NFIC|NFILZ|NMRK2|NRTN|OAZ1|OR1M1|OR2Z1|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|PCP2|PEAK3|PET100|PEX11G|PIAS4|PIP5K1C|PLEKHJ1|PLIN3|PLIN4|PLIN5|PNPLA6|PRAM1|PRR22|PRR36|PSPN|PTPRS|PTPRS-AS1|RAB11B|RAB11B-AS1|RANBP3|RANBP3-DT|RAX2|RETN|RFX2|RPL36|RPS28|S1PR4|SAFB|SAFB2|SAXO5|SEMA6B|SF3A2|SGTA|SH2D3A|SH3GL1|SHD|SIRT6|SLC25A23|SLC25A41|SLC39A3|SMIM24|SMIM44|SNAPC2|SNORD37|SPPL2B|STAP2|STXBP2|TBXA2R|TEKTIP1|TGFBR3L|THOP1|TICAM1|TIMM13|TIMM44|TINCR|TJP3|TLE2|TLE5|TLE6|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TRAPPC5|TRG-TCC1-1|TRIP10|TRV-CAC3-1|TUBB4A|UBXN6|UHRF1|VAV1|VMAC|XAB2|YJU2|ZBTB7A|ZFR2|ZNF121|ZNF177|ZNF266|ZNF317|ZNF358|ZNF414|ZNF426|ZNF426-DT|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF561-AS1|ZNF562|ZNF57|ZNF699|ZNF77|ZNRF4|ACER1|ACSBG2|ACTL9|ADAMTS10|ADGRE1|ALKBH7|AMH|ANGPTL4|ANKRD24|AP3D1|APBA3|ARHGEF18|ARHGEF18-AS1|ARRDC5|ATCAY|BTBD2|C3|CACTIN|CACTIN-AS1|CAMSAP3|CAPS|CATSPERD|CCL25|CD209|CD320|CD70|CELF5|CERS4|CHAF1A|CLEC4G|CLEC4M|CLPP|CRB3|CREB3L3|CSNK1G2|CTXN1|DAPK3|DENND1C|DIRAS1|DOHH|DOT1L|DPP9|DPP9-AS1|DUS3L|EBI3|EEF2|ELAVL1|EVI5L|FBN3|FCER2|FEM1A|FSD1|FUT3|FUT5|FUT6|FZR1|GADD45B|GIPC3|GNA11|GNA15|GNA15-DT|GNG7|GPR108|GTF2F1|HDGFL2|HMG20B|HNRNPM|HSD11B1L|INSR|IZUMO4|JSRP1|KANK3|KDM4B|KHSRP|LINC01775|LINGO3|LMNB2|LOC101928844|LOC105372244|LOC105372253|LOC105372255|LOC106804547|LOC108348031|LOC108783649|LOC111413022|LOC111556134|LOC111721712|LOC111828491|LOC111828495|LOC112543475|LOC112543476|LOC112543477|LOC112543480|LOC112543481|LOC112543482|LOC112543490|LOC112552148|LOC112552174|LOC112552175|LOC112552176|LOC112577455|LOC112577456|LOC112577457|LOC112577458|LOC113939970|LOC113939971|LOC113939974|LOC116276497|LOC116276498|LOC116276499|LOC116276500|LOC117282006|LOC117307477|LOC117307478|LOC121627846|LOC121627847|LOC121627848|LOC121627849|LOC121627850|LOC121627851|LOC121627852|LOC121627853|LOC121627854|LOC121627855|LOC121852972|LOC121852973|LOC121852974|LOC121852975|LOC121852976|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC125371457|LOC125371459|LOC125371460|LOC125371461|LOC125371462|LOC125371463|LOC125371464|LOC125371465|LOC125371466|LOC125371467|LOC125371468|LOC125371469|LOC125371470|LOC125371471|LOC125371472|LOC125371473|LOC126862839|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC126862844|LOC126862845|LOC126862846|LOC126862847|LOC126862848|LOC126862849|LOC126862850|LOC128772422|LOC128772423|LOC128772424|LOC129391022|LOC129391023|LOC129391024|LOC129391025|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC129391040|LOC129391041|LOC129391042|LOC129391043|LOC129391044|LOC129391045|LOC129391046|LOC129391047|LOC129391048|LOC129391049|LOC129391050|LOC129391051|LOC129391052|LOC129391053|LOC129391054|LOC129391055|LOC129391056|LOC129391057|LOC129929036|LOC130063009|LOC130063010|LOC130063011|LOC130063012|LOC130063013|LOC130063014|LOC130063015|LOC130063016|LOC130063017|LOC130063018|LOC130063019|LOC130063020|LOC130063021|LOC130063022|LOC130063023|LOC130063024|LOC130063025|LOC130063026|LOC130063027|LOC130063028|LOC130063029|LOC130063030|LOC130063031|LOC130063032|LOC130063033|LOC130063034|LOC130063035|LOC130063036|LOC130063037|LOC130063038|LOC130063039|LOC130063040|LOC130063041|LOC130063042|LOC130063043|LOC130063044|LOC130063045|LOC130063046|LOC130063047|LOC130063048|LOC130063049|LOC130063050|LOC130063051|LOC130063052|LOC130063053|LOC130063054|LOC130063055|LOC130063056|LOC130063057|LOC130063058|LOC130063059|LOC130063060|LOC130063061|LOC130063062|LOC130063063|LOC130063064|LOC130063065|LOC130063066|LOC130063067|LOC130063068|LOC130063069|LOC130063070|LOC130063071|LOC130063072|LOC130063073|LOC130063074|LOC130063075|LOC130063076|LOC130063077|LOC130063078|LOC130063079|LOC130063080|LOC130063081|LOC130063082|LOC130063083|LOC130063084|LOC130063085|LOC130063086|LOC130063087|LOC130063088|LOC130063089|LOC130063090|LOC130063091|LOC130063092|LOC130063093|LOC130063094|LOC130063095|LOC130063096|LOC130063097|LOC130063098|LOC130063099|LOC130063100|LOC130063101|LOC130063102|LOC130063103|LOC130063104|LOC130063105|LOC130063106|LOC130063107|LOC130063108|LOC130063109|LOC130063110|LOC130063111|LOC130063112|LOC130063113|LOC130063114|LOC130063115|LOC130063116|LOC130063117|LOC130063118|LOC130063119|LOC130063120|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LOC130063231|LOC130063232|LOC130063233|LOC130063234|LOC130063235|LOC130063236|LOC130063237|LOC130063238|LOC130063239|LOC130063240|LOC130063241|LOC130063242|LOC130063243|LOC130063244|LOC130063245|LOC130063246|LOC130063247|LOC130063248|LOC130063249|LOC130063250|LOC130063251|LOC130063252|LOC130063253		See cases	VCV000059082	19	1972244 - 9759555	19	1972245 - 9648879	59082	73677			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 19p13.3(chr19:3080621-4912622)x3	ANKRD24|APBA3|ARRDC5|ATCAY|CACTIN|CACTIN-AS1|CELF5|CHAF1A|CREB3L3|DAPK3|DOHH|DPP9|DPP9-AS1|EBI3|EEF2|FEM1A|FSD1|FZR1|GIPC3|GNA11|GNA15|GNA15-DT|HDGFL2|HMG20B|LOC105372244|LOC111721712|LOC111828491|LOC112543480|LOC112543481|LOC112543482|LOC112543490|LOC112552148|LOC113939970|LOC113939971|LOC116276499|LOC121627849|LOC121627850|LOC121627851|LOC121852972|LOC121852973|LOC121852974|LOC125371450|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC125371457|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC128772422|LOC128772423|LOC128772424|LOC129391026|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC130063121|LOC130063122|LOC130063123|LOC130063124|LOC130063125|LOC130063126|LOC130063127|LOC130063128|LOC130063129|LOC130063130|LOC130063131|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LOC130063231|LOC130063232|LOC130063233|LOC130063234|LOC130063235|LRG1|MAP2K2|MATK|MFSD12|MIR4746|MIR637|MIR7-3|MIR7-3HG|MPND|MRPL54|MYDGF|NCLN|NFIC|NMRK2|PIAS4|PIP5K1C|PLIN3|PLIN4|PLIN5|RAX2|S1PR4|SEMA6B|SH3GL1|SHD|SIRT6|SMIM24|SMIM44|SNORD37|STAP2|TBXA2R|TEKTIP1|TICAM1|TJP3|TMIGD2|TNFAIP8L1|TRG-TCC1-1|TRV-CAC3-1|UBXN6|UHRF1|YJU2|ZBTB7A|ZFR2		See cases	VCV000148645	19	3080619 - 4912634	19	3080621 - 4912622	148645	158396			copy number gain		Likely pathogenic	Dec 16, 2011	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:3338024-4833139)x1	LOC121852974|LOC125371451|LOC125371452|LOC125371453|LOC125371455|LOC125371457|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC128772422|LOC128772423|LOC128772424|LOC129391027|LOC129391028|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC130063132|LOC130063133|LOC130063134|LOC130063135|LOC130063136|LOC130063137|LOC130063138|LOC130063139|LOC130063140|LOC130063141|LOC130063142|LOC130063143|LOC130063144|LOC130063145|LOC130063146|LOC130063147|LOC130063148|LOC130063149|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LRG1|MAP2K2|MATK|MFSD12|MIR4746|MIR637|MIR7-3|MIR7-3HG|MPND|MRPL54|MYDGF|NFIC|NMRK2|PIAS4|PIP5K1C|PLIN4|PLIN5|RAX2|SEMA6B|SH3GL1|SHD|SIRT6|SMIM24|SMIM44|SNORD37|STAP2|TBXA2R|TEKTIP1|TICAM1|TJP3|TMIGD2|TNFAIP8L1|TRG-TCC1-1|TRV-CAC3-1|UBXN6|YJU2|ZBTB7A|ZFR2|ANKRD24|APBA3|ATCAY|CACTIN|CACTIN-AS1|CHAF1A|CREB3L3|DAPK3|DOHH|DPP9|DPP9-AS1|EBI3|EEF2|FEM1A|FSD1|FZR1|GIPC3|HDGFL2|HMG20B|LOC111721712|LOC111828491|LOC112543481|LOC112543482|LOC112543490|LOC112552148|LOC113939970|LOC113939971|LOC121627849|LOC121627850|LOC121627851|LOC121852972|LOC121852973		See cases	VCV000145080	19	3338022 - 4833151	19	3338024 - 4833139	145080	154831			copy number loss		Pathogenic	Nov 30, 2010	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:3554635-4690965)x1	PIP5K1C|PLIN4|PLIN5|RAX2|SEMA6B|SH3GL1|SHD|SIRT6|SNORD37|STAP2|TBXA2R|TJP3|TMIGD2|TNFAIP8L1|UBXN6|YJU2|ZBTB7A|ZFR2|ANKRD24|APBA3|ATCAY|CACTIN|CACTIN-AS1|CHAF1A|CREB3L3|DAPK3|DPP9|DPP9-AS1|EBI3|EEF2|FSD1|GIPC3|HDGFL2|HMG20B|LOC111828491|LOC112543481|LOC112543482|LOC112543490|LOC113939970|LOC121627849|LOC121627850|LOC121627851|LOC121852972|LOC121852973|LOC121852974|LOC125371453|LOC125371455|LOC125371457|LOC129391029|LOC129391030|LOC129391031|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC130063150|LOC130063151|LOC130063152|LOC130063153|LOC130063154|LOC130063155|LOC130063156|LOC130063157|LOC130063158|LOC130063159|LOC130063160|LOC130063161|LOC130063162|LOC130063163|LOC130063164|LOC130063165|LOC130063166|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LRG1|MAP2K2|MATK|MFSD12|MIR4746|MIR637|MPND|MRPL54|MYDGF|NMRK2|PIAS4		See cases	VCV000060071	19	3554633 - 4690977	19	3554635 - 4690965	60071	74666			copy number loss		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 19p13.3(chr19:3788727-5147354)x1	ANKRD24|ARRDC5|ATCAY|CHAF1A|CREB3L3|DAPK3|DPP9|DPP9-AS1|EBI3|EEF2|FEM1A|FSD1|HDGFL2|KDM4B|LOC111828491|LOC112543490|LOC112552148|LOC113939970|LOC113939971|LOC116276499|LOC121627849|LOC121627850|LOC121627851|LOC121627852|LOC121852974|LOC125371453|LOC125371455|LOC125371457|LOC125371459|LOC125371460|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC129391032|LOC129391033|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC130063167|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LOC130063231|LOC130063232|LOC130063233|LOC130063234|LOC130063235|LOC130063236|LOC130063237|LOC130063238|LOC130063239|LOC130063240|LOC130063241|LOC130063242|LOC130063243|LOC130063244|LOC130063245|LRG1|MAP2K2|MATK|MIR4746|MIR4747|MIR637|MIR7-3|MIR7-3HG|MPND|MYDGF|NMRK2|PIAS4|PLIN3|PLIN4|PLIN5|SEMA6B|SH3GL1|SHD|SIRT6|SNORD37|STAP2|TICAM1|TMIGD2|TNFAIP8L1|TRG-TCC1-1|TRV-CAC3-1|UBXN6|UHRF1|YJU2|ZBTB7A|ZFR2		See cases	VCV000155547	19	3788725 - 5147365	19	3788727 - 5147354	155547	165301			copy number loss		Likely pathogenic	Sep 23, 2013	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:3947934-5196676)x3	ANKRD24|ARRDC5|CHAF1A|CREB3L3|DAPK3|DPP9|DPP9-AS1|EBI3|EEF2|FEM1A|FSD1|HDGFL2|KDM4B|LOC111828491|LOC112543490|LOC112552148|LOC113939971|LOC116276499|LOC121627849|LOC121627850|LOC121627851|LOC121627852|LOC121852974|LOC125371455|LOC125371457|LOC125371459|LOC125371460|LOC126862840|LOC126862841|LOC126862842|LOC126862843|LOC126862844|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC129391039|LOC130063168|LOC130063169|LOC130063170|LOC130063171|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LOC130063228|LOC130063229|LOC130063230|LOC130063231|LOC130063232|LOC130063233|LOC130063234|LOC130063235|LOC130063236|LOC130063237|LOC130063238|LOC130063239|LOC130063240|LOC130063241|LOC130063242|LOC130063243|LOC130063244|LOC130063245|LOC130063246|LOC130063247|LRG1|MAP2K2|MIR4746|MIR4747|MIR637|MIR7-3|MIR7-3HG|MPND|MYDGF|PIAS4|PLIN3|PLIN4|PLIN5|PTPRS-AS1|SEMA6B|SH3GL1|SHD|SIRT6|SNORD37|STAP2|TICAM1|TMIGD2|TNFAIP8L1|TRG-TCC1-1|TRV-CAC3-1|UBXN6|UHRF1|YJU2|ZBTB7A		See cases	VCV000144751	19	3947932 - 5196687	19	3947934 - 5196676	144751	154502			copy number gain		Uncertain significance	Aug 19, 2010	no assertion criteria provided							
GRCh38/hg38 19p13.3(chr19:4008560-4763159)x3	ANKRD24|CHAF1A|CREB3L3|DPP9|DPP9-AS1|EBI3|FSD1|HDGFL2|LOC111828491|LOC112543490|LOC112552148|LOC121627849|LOC121627850|LOC121627851|LOC121852974|LOC125371455|LOC125371457|LOC126862840|LOC126862841|LOC126862842|LOC129391034|LOC129391035|LOC129391036|LOC129391037|LOC129391038|LOC130063172|LOC130063173|LOC130063174|LOC130063175|LOC130063176|LOC130063177|LOC130063178|LOC130063179|LOC130063180|LOC130063181|LOC130063182|LOC130063183|LOC130063184|LOC130063185|LOC130063186|LOC130063187|LOC130063188|LOC130063189|LOC130063190|LOC130063191|LOC130063192|LOC130063193|LOC130063194|LOC130063195|LOC130063196|LOC130063197|LOC130063198|LOC130063199|LOC130063200|LOC130063201|LOC130063202|LOC130063203|LOC130063204|LOC130063205|LOC130063206|LOC130063207|LOC130063208|LOC130063209|LOC130063210|LOC130063211|LOC130063212|LOC130063213|LOC130063214|LOC130063215|LOC130063216|LOC130063217|LOC130063218|LOC130063219|LOC130063220|LOC130063221|LOC130063222|LOC130063223|LOC130063224|LOC130063225|LOC130063226|LOC130063227|LRG1|MAP2K2|MIR4746|MPND|MYDGF|PIAS4|PLIN4|PLIN5|SEMA6B|SH3GL1|SHD|SIRT6|STAP2|TMIGD2|TNFAIP8L1|TRG-TCC1-1|TRV-CAC3-1|UBXN6|YJU2|ZBTB7A		See cases	VCV000059083	19	4008558 - 4763171	19	4008560 - 4763159	59083	73678			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.*174C>A	MAP2K2		not provided	VCV001220587	19	4090422	19	4090424	1220587	49319	rs6630	NC_000019.10:4090423:G:T	single nucleotide variant	3 prime UTR variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.*24C>G	MAP2K2		not provided	VCV001227853	19	4090572	19	4090574	1227853	1215245	rs6629	NC_000019.10:4090573:G:C	single nucleotide variant	3 prime UTR variant	Benign	Mar 6, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.*24C>T	MAP2K2		not provided|not specified	VCV000040848	19	4090572	19	4090574	40848	49318	rs6629	NC_000019.10:4090573:G:A	single nucleotide variant	3 prime UTR variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.*20G>A	MAP2K2		not provided|not specified	VCV000388412	19	4090576	19	4090578	388412	379588	rs377441764	NC_000019.10:4090577:C:T	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jul 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.3(MAP2K2):c.*19C>T	MAP2K2		not specified|not provided	VCV000138164	19	4090577	19	4090579	138164	141867	rs145743390	NC_000019.10:4090578:G:A	single nucleotide variant	3 prime UTR variant	Benign	Nov 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.*14C>T	MAP2K2		not specified	VCV000382115	19	4090582	19	4090584	382115	379589	rs374728969	NC_000019.10:4090583:G:A	single nucleotide variant	3 prime UTR variant	Likely benign	Apr 10, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.*9G>A	MAP2K2		not specified	VCV000046224	19	4090587	19	4090589	46224	55389	rs397517410	NC_000019.10:4090588:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jul 13, 2012	criteria provided, single submitter							
NM_030662.3(MAP2K2):c.*8C>T	MAP2K2		RASopathy	VCV000046223	19	4090588	19	4090590	46223	55387	rs377675706	NC_000019.10:4090589:G:A	single nucleotide variant	3 prime UTR variant	Likely benign	Sep 17, 2024	reviewed by expert panel							
NM_030662.4(MAP2K2):c.*2A>T	MAP2K2		not specified	VCV000383208	19	4090594	19	4090596	383208	376554	rs1057521556	NC_000019.10:4090595:T:A	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 28, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1198G>T (p.Val400Leu)	MAP2K2	V400L	Cardiofaciocutaneous syndrome 4|Cardiovascular phenotype	VCV002548628	19	4090601	19	4090603	2548628	2707049		NC_000019.10:4090602:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 20, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.1198G>A (p.Val400Met)	MAP2K2	V400M	Noonan syndrome and Noonan-related syndrome|RASopathy|not provided|not specified	VCV000040847	19	4090601	19	4090603	40847	49317	rs533247725	NC_000019.10:4090602:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1197C>G (p.Ala399=)	MAP2K2		RASopathy|not provided	VCV002979927	19	4090602	19	4090604	2979927	3134691		NC_000019.10:4090603:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1197C>T (p.Ala399=)	MAP2K2		Cardiovascular phenotype|RASopathy|not specified	VCV000496470	19	4090602	19	4090604	496470	488049	rs987393686	NC_000019.10:4090603:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1196C>T (p.Ala399Val)	MAP2K2	A399V	RASopathy	VCV002081253	19	4090603	19	4090605	2081253	2143052		NC_000019.10:4090604:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1195G>A (p.Ala399Thr)	MAP2K2	A399T	not specified|RASopathy	VCV001027629	19	4090604	19	4090606	1027629	1015383	rs1382101858	NC_000019.10:4090605:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1194C>T (p.Thr398=)	MAP2K2		RASopathy	VCV000040846	19	4090605	19	4090607	40846	49316	rs144850779	NC_000019.10:4090606:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1193C>G (p.Thr398Ser)	MAP2K2	T398S	RASopathy	VCV002968748	19	4090606	19	4090608	2968748	3139057		NC_000019.10:4090607:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1192A>C (p.Thr398Pro)	MAP2K2	T398P	not provided	VCV001710619	19	4090607	19	4090609	1710619	1709030		NC_000019.10:4090608:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1191C>A (p.Arg397=)	MAP2K2		MAP2K2-related disorder	VCV003348051	19	4090608	19	4090610	3348051	3507281		NC_000019.10:4090609:G:T	single nucleotide variant	synonymous variant	Likely benign	May 8, 2024	no assertion criteria provided							
NM_030662.4(MAP2K2):c.1191C>T (p.Arg397=)	MAP2K2		Cardiovascular phenotype|RASopathy|not provided|not specified	VCV000697209	19	4090608	19	4090610	697209	684819	rs148592592	NC_000019.10:4090609:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1190G>T (p.Arg397Leu)	MAP2K2	R397L	RASopathy	VCV002870053	19	4090609	19	4090611	2870053	3021062		NC_000019.10:4090610:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1190G>A (p.Arg397His)	MAP2K2	R397H	Cardiofaciocutaneous syndrome 4|RASopathy|Cardiovascular phenotype	VCV000040844	19	4090609	19	4090611	40844	49314	rs751040819	NC_000019.10:4090610:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1189C>T (p.Arg397Cys)	MAP2K2	R397C	RASopathy|not provided	VCV000180910	19	4090610	19	4090612	180910	179818	rs730880516	NC_000019.10:4090611:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.1188G>A (p.Thr396=)	MAP2K2		RASopathy	VCV002054532	19	4090611	19	4090613	2054532	2112414		NC_000019.10:4090612:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1187C>T (p.Thr396Met)	MAP2K2	T396M	RASopathy	VCV000279960	19	4090612	19	4090614	279960	265075	rs117945277	NC_000019.10:4090613:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2019	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1185del (p.Thr396fs)	MAP2K2	T396fs	RASopathy	VCV001037390	19	4090614	19	4090616	1037390	1034319	rs2040845949	NC_000019.10:4090615:GGG:GG	Deletion	frameshift variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1184C>G (p.Pro395Arg)	MAP2K2	P395R	RASopathy	VCV001002402	19	4090615	19	4090617	1002402	998614	rs2040845976	NC_000019.10:4090616:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1182A>G (p.Thr394=)	MAP2K2		RASopathy|not specified|Cardiovascular phenotype|not provided	VCV000996277	19	4090617	19	4090619	996277	984000	rs375253105	NC_000019.10:4090618:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1181C>T (p.Thr394Ile)	MAP2K2	T394I	RASopathy	VCV002912384	19	4090618	19	4090620	2912384	3073541		NC_000019.10:4090619:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1180A>T (p.Thr394Ser)	MAP2K2	T394S	not provided|RASopathy	VCV000180909	19	4090619	19	4090621	180909	179819	rs730880515	NC_000019.10:4090620:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1178G>T (p.Gly393Val)	MAP2K2	G393V	RASopathy	VCV002882490	19	4090621	19	4090623	2882490	3043091		NC_000019.10:4090622:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1177G>A (p.Gly393Ser)	MAP2K2	G393S	not specified|RASopathy	VCV000837895	19	4090622	19	4090624	837895	847718	rs755887476	NC_000019.10:4090623:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1176C>T (p.Pro392=)	MAP2K2		Noonan syndrome and Noonan-related syndrome|not provided|not specified|Cardiovascular phenotype|RASopathy	VCV000496472	19	4090623	19	4090625	496472	488001	rs529064753	NC_000019.10:4090624:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 1, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.1170C>G (p.Asn390Lys)	MAP2K2	N390K	RASopathy|Cardiovascular phenotype	VCV002158666	19	4090629	19	4090631	2158666	1883648		NC_000019.10:4090630:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1167G>A (p.Leu389=)	MAP2K2		Cardiovascular phenotype|not specified	VCV000513229	19	4090632	19	4090634	513229	506826	rs1473228474	NC_000019.10:4090633:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1165C>T (p.Leu389=)	MAP2K2		RASopathy	VCV001987944	19	4090634	19	4090636	1987944	2036792		NC_000019.10:4090635:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1164G>A (p.Arg388=)	MAP2K2		Cardiovascular phenotype	VCV003542702	19	4090635	19	4090637	3542702	3699984		NC_000019.10:4090636:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1163G>A (p.Arg388Gln)	MAP2K2	R388Q	not provided|Cardiofaciocutaneous syndrome 4|RASopathy	VCV001005324	19	4090636	19	4090638	1005324	998615	rs749615795	NC_000019.10:4090637:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1162C>A (p.Arg388=)	MAP2K2		Cardiovascular phenotype	VCV001737151	19	4090637	19	4090639	1737151	1790350		NC_000019.10:4090638:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1162C>T (p.Arg388Trp)	MAP2K2	R388W	RASopathy	VCV000040843	19	4090637	19	4090639	40843	49313	rs144383241	NC_000019.10:4090638:G:A	single nucleotide variant	missense variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1159C>T (p.Leu387=)	MAP2K2		RASopathy	VCV001635966	19	4090640	19	4090642	1635966	1643991	rs1172594212	NC_000019.10:4090641:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1158C>T (p.Thr386=)	MAP2K2		RASopathy	VCV002727134	19	4090641	19	4090643	2727134	2882452		NC_000019.10:4090642:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1157C>A (p.Thr386Asn)	MAP2K2	T386N	RASopathy	VCV002898766	19	4090642	19	4090644	2898766	3060401		NC_000019.10:4090643:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1157C>T (p.Thr386Ile)	MAP2K2	T386I	RASopathy	VCV001506401	19	4090642	19	4090644	1506401	1430326	rs2145036510	NC_000019.10:4090643:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1151G>A (p.Cys384Tyr)	MAP2K2	C384Y	not provided|RASopathy	VCV001308219	19	4090648	19	4090650	1308219	1296840	rs2040846395	NC_000019.10:4090649:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1150T>C (p.Cys384Arg)	MAP2K2	C384R	RASopathy|Cardiovascular phenotype	VCV002843440	19	4090649	19	4090651	2843440	3004095		NC_000019.10:4090650:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1141G>A (p.Gly381Ser)	MAP2K2	G381S	RASopathy|not provided	VCV001525536	19	4090658	19	4090660	1525536	1359994	rs565860695	NC_000019.10:4090659:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1140C>T (p.Ala380=)	MAP2K2		RASopathy	VCV000050938	19	4090659	19	4090661	50938	65599	rs146618055	NC_000019.10:4090660:G:A	single nucleotide variant	synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1138G>A (p.Ala380Thr)	MAP2K2	A380T	RASopathy	VCV001438169	19	4090661	19	4090663	1438169	1355022	rs867823488	NC_000019.10:4090662:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1130T>C (p.Val377Ala)	MAP2K2	V377A	RASopathy	VCV002697388	19	4090669	19	4090671	2697388	2864785		NC_000019.10:4090670:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1123G>T (p.Glu375Ter)	MAP2K2	E375*	RASopathy	VCV002770949	19	4090676	19	4090678	2770949	2923923		NC_000019.10:4090677:C:A	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1120G>A (p.Val374Met)	MAP2K2	V374M	Cardiovascular phenotype	VCV002622926	19	4090679	19	4090681	2622926	2793334		NC_000019.10:4090680:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1117G>C (p.Glu373Gln)	MAP2K2	E373Q	RASopathy	VCV001973996	19	4090682	19	4090684	1973996	2026693		NC_000019.10:4090683:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1117G>A (p.Glu373Lys)	MAP2K2	E373K	Cardiovascular phenotype|RASopathy|not specified	VCV001796590	19	4090682	19	4090684	1796590	1855165		NC_000019.10:4090683:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1116C>G (p.Ser372=)	MAP2K2		Cardiovascular phenotype	VCV001796280	19	4090683	19	4090685	1796280	1852715		NC_000019.10:4090684:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 10, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1116C>T (p.Ser372=)	MAP2K2		RASopathy	VCV001635039	19	4090683	19	4090685	1635039	1610765	rs772111297	NC_000019.10:4090684:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 19, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1112G>T (p.Arg371Leu)	MAP2K2	R371L	RASopathy	VCV002199936	19	4090687	19	4090689	2199936	1933848		NC_000019.10:4090688:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1112G>A (p.Arg371Gln)	MAP2K2	R371Q	RASopathy	VCV000040842	19	4090687	19	4090689	40842	49312	rs730880514	NC_000019.10:4090688:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2019	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1111C>T (p.Arg371Trp)	MAP2K2	R371W	not provided|RASopathy|Cardiofaciocutaneous syndrome 4|Cardiovascular phenotype	VCV000572410	19	4090688	19	4090690	572410	574978	rs1003521922	NC_000019.10:4090689:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1109A>T (p.Lys370Met)	MAP2K2	K370M	RASopathy	VCV001398919	19	4090690	19	4090692	1398919	1450215	rs1599278009	NC_000019.10:4090691:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1109A>G (p.Lys370Arg)	MAP2K2	K370R	Noonan syndrome	VCV000666426	19	4090690	19	4090692	666426	653982	rs1599278009	NC_000019.10:4090691:T:C	single nucleotide variant	missense variant	Uncertain significance		no assertion criteria provided							
NM_030662.4(MAP2K2):c.1106T>C (p.Ile369Thr)	MAP2K2	I369T	not provided|Noonan syndrome and Noonan-related syndrome	VCV001334256	19	4090693	19	4090695	1334256	1325115	rs2145036656	NC_000019.10:4090694:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1105A>C (p.Ile369Leu)	MAP2K2	I369L	RASopathy	VCV002816445	19	4090694	19	4090696	2816445	2983948		NC_000019.10:4090695:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1101C>G (p.Thr367=)	MAP2K2		RASopathy	VCV001655927	19	4090698	19	4090700	1655927	1529174	rs1483599413	NC_000019.10:4090699:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1100C>A (p.Thr367Asn)	MAP2K2	T367N	RASopathy	VCV001504208	19	4090699	19	4090701	1504208	1337084	rs2145036668	NC_000019.10:4090700:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1093-6T>C	MAP2K2		RASopathy	VCV000046228	19	4090712	19	4090714	46228	55393	rs369681843	NC_000019.10:4090713:A:G	single nucleotide variant	intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1093-14_1093-11del	MAP2K2		RASopathy	VCV002026998	19	4090717 - 4090720	19	4090719 - 4090722	2026998	2084918		NC_000019.10:4090718:AGGG:	Deletion	intron variant	Likely benign	Aug 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1093-16T>C	MAP2K2		RASopathy	VCV002026999	19	4090722	19	4090724	2026999	2084919		NC_000019.10:4090723:A:G	single nucleotide variant	intron variant	Likely benign	Aug 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1093-19G>T	MAP2K2		RASopathy	VCV001529198	19	4090725	19	4090727	1529198	1634967	rs571595941	NC_000019.10:4090726:C:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1093-19G>A	MAP2K2		RASopathy	VCV001428897	19	4090725	19	4090727	1428897	1457861	rs571595941	NC_000019.10:4090726:C:T	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1093-128G>A	MAP2K2		not provided	VCV001194792	19	4090834	19	4090836	1194792	1185486	rs188271658	NC_000019.10:4090835:C:T	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1093-273C>T	MAP2K2		not provided	VCV000561942	19	4090979	19	4090981	561942	553025	rs140520358	NC_000019.10:4090980:G:A	single nucleotide variant	intron variant	Likely benign	Jun 19, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+341C>A	MAP2K2		RASopathy	VCV001670957	19	4094110	19	4094112	1670957	1605264	rs2289859	NC_000019.10:4094111:G:T	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+127G>A	MAP2K2		not provided	VCV001196051	19	4094324	19	4094326	1196051	1188777	rs116693958	NC_000019.10:4094325:C:T	single nucleotide variant	intron variant	Likely benign	Aug 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+16G>A	MAP2K2		RASopathy	VCV001653127	19	4094435	19	4094437	1653127	1579626	rs755758122	NC_000019.10:4094436:C:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+15C>T	MAP2K2		RASopathy	VCV001394958	19	4094436	19	4094438	1394958	1415847	rs777596226	NC_000019.10:4094437:G:A	single nucleotide variant	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+14G>T	MAP2K2		RASopathy	VCV001632290	19	4094437	19	4094439	1632290	1650621	rs371297574	NC_000019.10:4094438:C:A	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092+7G>A	MAP2K2		RASopathy	VCV002709680	19	4094444	19	4094446	2709680	2878425		NC_000019.10:4094445:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1092A>C (p.Thr364=)	MAP2K2		not specified|Cardiofaciocutaneous syndrome 4|RASopathy|Noonan syndrome and Noonan-related syndrome	VCV000632883	19	4094451	19	4094453	632883	621633	rs779378237	NC_000019.10:4094452:T:G	single nucleotide variant	synonymous variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1092A>G (p.Thr364=)	MAP2K2		not specified	VCV000514650	19	4094451	19	4094453	514650	507820	rs779378237	NC_000019.10:4094452:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1090A>G (p.Thr364Ala)	MAP2K2	T364A	RASopathy	VCV003021502	19	4094453	19	4094455	3021502	3172707		NC_000019.10:4094454:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1089C>G (p.Leu363=)	MAP2K2		Cardiovascular phenotype	VCV001788423	19	4094454	19	4094456	1788423	1844484		NC_000019.10:4094455:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1087C>T (p.Leu363Phe)	MAP2K2	L363F	RASopathy	VCV001434578	19	4094456	19	4094458	1434578	1494394	rs2145041802	NC_000019.10:4094457:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1086G>A (p.Met362Ile)	MAP2K2	M362I	Cardiofaciocutaneous syndrome 4	VCV003583899	19	4094457	19	4094459	3583899	3709748		NC_000019.10:4094458:C:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1085T>G (p.Met362Arg)	MAP2K2	M362R	RASopathy	VCV002957235	19	4094458	19	4094460	2957235	3122333		NC_000019.10:4094459:A:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1085T>C (p.Met362Thr)	MAP2K2	M362T	not provided|RASopathy	VCV000180908	19	4094458	19	4094460	180908	179820	rs730880513	NC_000019.10:4094459:A:G	single nucleotide variant	missense variant	Likely benign	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1080G>A (p.Leu360=)	MAP2K2		not specified	VCV000928896	19	4094463	19	4094465	928896	917294	rs2040885847	NC_000019.10:4094464:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1074G>C (p.Ala358=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001395596	19	4094469	19	4094471	1395596	1424995	rs140896887	NC_000019.10:4094470:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1074G>A (p.Ala358=)	MAP2K2		RASopathy	VCV000261928	19	4094469	19	4094471	261928	257127	rs140896887	NC_000019.10:4094470:C:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1073C>T (p.Ala358Val)	MAP2K2	A358V	RASopathy	VCV001963524	19	4094470	19	4094472	1963524	2017195		NC_000019.10:4094471:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1065G>A (p.Ala355=)	MAP2K2		not provided|not specified|Cardiovascular phenotype|RASopathy	VCV000046227	19	4094478	19	4094480	46227	55392	rs374807671	NC_000019.10:4094479:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1064C>T (p.Ala355Val)	MAP2K2	A355V	not provided|Cardiovascular phenotype|RASopathy|not specified	VCV000285437	19	4094479	19	4094481	285437	269674	rs768826287	NC_000019.10:4094480:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1063G>C (p.Ala355Pro)	MAP2K2	A355P	Cardiovascular phenotype	VCV002585789	19	4094480	19	4094482	2585789	2753349		NC_000019.10:4094481:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1061C>T (p.Pro354Leu)	MAP2K2	P354L	not specified|not provided|Cardiovascular phenotype	VCV000505055	19	4094482	19	4094484	505055	497519	rs879819202	NC_000019.10:4094483:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1053C>T (p.Ile351=)	MAP2K2		RASopathy	VCV001625736	19	4094490	19	4094492	1625736	1607296	rs2145041881	NC_000019.10:4094491:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1051A>C (p.Ile351Leu)	MAP2K2	I351L	RASopathy	VCV002077104	19	4094492	19	4094494	2077104	2134925		NC_000019.10:4094493:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1050C>T (p.Leu350=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV002885705	19	4094493	19	4094495	2885705	3043710		NC_000019.10:4094494:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1047-2dup	MAP2K2		not provided	VCV000422278	19	4094497 - 4094498	19	4094499 - 4094500	422278	410612	rs1555696233	NC_000019.10:4094499:T:TT	Duplication	splice acceptor variant	Likely benign	Aug 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-3C>T	MAP2K2		not specified	VCV000373028	19	4094499	19	4094501	373028	360422	rs1002166872	NC_000019.10:4094500:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 27, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-6C>A	MAP2K2		not specified	VCV000987817	19	4094502	19	4094504	987817	975839	rs774258077	NC_000019.10:4094503:G:T	single nucleotide variant	intron variant	Uncertain significance	Nov 9, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-20C>T	MAP2K2		RASopathy	VCV003011003	19	4094516	19	4094518	3011003	3170037		NC_000019.10:4094517:G:A	single nucleotide variant	intron variant	Likely benign	Mar 19, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-31G>A	MAP2K2		not provided	VCV001209378	19	4094527	19	4094529	1209378	1199129	rs181512820	NC_000019.10:4094528:C:T	single nucleotide variant	intron variant	Likely benign	Jul 11, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-140_1047-139insG	MAP2K2		not provided	VCV000561451	19	4094635 - 4094636	19	4094637 - 4094638	561451	553026	rs151175043	NC_000019.10:4094637::C	Insertion	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-212G>A	MAP2K2		not provided	VCV000561446	19	4094708	19	4094710	561446	553027	rs559885829	NC_000019.10:4094709:C:T	single nucleotide variant	intron variant	Likely benign	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1047-279C>T	MAP2K2		not provided	VCV000561820	19	4094775	19	4094777	561820	553028	rs350916	NC_000019.10:4094776:G:A	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1047-366G>T	MAP2K2		not provided	VCV002649027	19	4094862	19	4094864	2649027	2815194		NC_000019.10:4094863:C:A	single nucleotide variant	intron variant	Benign	Jul 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1047-391C>T	MAP2K2		not provided	VCV001711459	19	4094887	19	4094889	1711459	1709875		NC_000019.10:4094888:G:A	single nucleotide variant	intron variant	Likely benign	Jun 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+303del	MAP2K2		not provided	VCV000561918	19	4095083	19	4095085	561918	553029	rs574248280	NC_000019.10:4095084:A:	Deletion	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+200C>T	MAP2K2		not provided	VCV000561457	19	4095186	19	4095188	561457	553030	rs116476767	NC_000019.10:4095187:G:A	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+91_1046+92del	MAP2K2		not provided	VCV000561436	19	4095294 - 4095295	19	4095296 - 4095297	561436	553031	rs559885397	NC_000019.10:4095295:GGG:G	Deletion	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+16C>A	MAP2K2		not specified|RASopathy	VCV000506906	19	4095370	19	4095372	506906	507825	rs906888337	NC_000019.10:4095371:G:T	single nucleotide variant	intron variant	Likely benign	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1046+13G>A	MAP2K2		RASopathy|not specified	VCV000138163	19	4095373	19	4095375	138163	141866	rs587781029	NC_000019.10:4095374:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1046+12C>T	MAP2K2		RASopathy	VCV002886225	19	4095374	19	4095376	2886225	3053939		NC_000019.10:4095375:G:A	single nucleotide variant	intron variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+7G>A	MAP2K2		RASopathy	VCV001583192	19	4095379	19	4095381	1583192	1535430	rs1005472404	NC_000019.10:4095380:C:T	single nucleotide variant	intron variant	Likely benign	Aug 28, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1046+4G>A	MAP2K2		not specified	VCV000505191	19	4095382	19	4095384	505191	497520	rs1011864039	NC_000019.10:4095383:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 24, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1043_1046del (p.Lys348fs)	MAP2K2	K348fs	RASopathy	VCV002123037	19	4095386 - 4095389	19	4095388 - 4095391	2123037	2180931		NC_000019.10:4095387:CATT:	Deletion	frameshift variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1043A>G (p.Lys348Arg)	MAP2K2	K348R	MAP2K2-related disorder|RASopathy	VCV002631794	19	4095389	19	4095391	2631794	2801325		NC_000019.10:4095390:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1042A>G (p.Lys348Glu)	MAP2K2	K348E	Cardiofaciocutaneous syndrome 4|RASopathy	VCV001032231	19	4095390	19	4095392	1032231	1021895	rs1460336485	NC_000019.10:4095391:T:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1041T>C (p.Asn347=)	MAP2K2		RASopathy	VCV002908595	19	4095391	19	4095393	2908595	3066103		NC_000019.10:4095392:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1039A>G (p.Asn347Asp)	MAP2K2	N347D	not specified|Cardiovascular phenotype	VCV000372940	19	4095393	19	4095395	372940	360399	rs1057518088	NC_000019.10:4095394:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1036G>A (p.Val346Ile)	MAP2K2	V346I	not specified|Cardiovascular phenotype|RASopathy|Cardiofaciocutaneous syndrome 4|not provided	VCV000372640	19	4095396	19	4095398	372640	360552	rs1015139062	NC_000019.10:4095397:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1031A>G (p.Glu344Gly)	MAP2K2	E344G	RASopathy	VCV002905801	19	4095401	19	4095403	2905801	3062249		NC_000019.10:4095402:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1026C>A (p.Phe342Leu)	MAP2K2	F342L	RASopathy	VCV001718457	19	4095406	19	4095408	1718457	1778817		NC_000019.10:4095407:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1022A>C (p.Asp341Ala)	MAP2K2	D341A	Cardiovascular phenotype|RASopathy	VCV001416918	19	4095410	19	4095412	1416918	1487658	rs2040903643	NC_000019.10:4095411:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1021G>A (p.Asp341Asn)	MAP2K2	D341N	RASopathy|Cardiovascular phenotype	VCV001407871	19	4095411	19	4095413	1407871	1506749	rs564067943	NC_000019.10:4095412:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1020C>T (p.Pro340=)	MAP2K2		RASopathy	VCV000046226	19	4095412	19	4095414	46226	55391	rs192389729	NC_000019.10:4095413:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.1019C>G (p.Pro340Arg)	MAP2K2	P340R	RASopathy	VCV001421670	19	4095413	19	4095415	1421670	1423086	rs1277686711	NC_000019.10:4095414:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1019C>T (p.Pro340Leu)	MAP2K2	P340L	not specified	VCV000997863	19	4095413	19	4095415	997863	985654	rs1277686711	NC_000019.10:4095414:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1017C>T (p.Thr339=)	MAP2K2		Cardiofaciocutaneous syndrome 4|Cardiovascular phenotype	VCV001747506	19	4095415	19	4095417	1747506	1799804		NC_000019.10:4095416:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 12, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.1011G>A (p.Val337=)	MAP2K2		Cardiovascular phenotype	VCV001731241	19	4095421	19	4095423	1731241	1795614		NC_000019.10:4095422:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1010T>G (p.Val337Gly)	MAP2K2	V337G	Cardiovascular phenotype|RASopathy	VCV001518801	19	4095422	19	4095424	1518801	1342995	rs1232245814	NC_000019.10:4095423:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1007G>A (p.Gly336Asp)	MAP2K2	G336D	RASopathy	VCV001920530	19	4095425	19	4095427	1920530	1975558		NC_000019.10:4095426:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.1006G>A (p.Gly336Ser)	MAP2K2	G336S	Cardiofaciocutaneous syndrome 4|RASopathy	VCV000649050	19	4095426	19	4095428	649050	648136	rs1599282416	NC_000019.10:4095427:C:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.1005C>T (p.Asn335=)	MAP2K2		not specified|RASopathy|Cardiovascular phenotype|Noonan syndrome and Noonan-related syndrome	VCV000138162	19	4095427	19	4095429	138162	141865	rs587781028	NC_000019.10:4095428:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 6, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.1001C>G (p.Pro334Arg)	MAP2K2	P334R	not provided	VCV003364423	19	4095431	19	4095433	3364423	3523630		NC_000019.10:4095432:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.999G>T (p.Leu333=)	MAP2K2		RASopathy	VCV002866893	19	4095433	19	4095435	2866893	3030385		NC_000019.10:4095434:C:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.999G>A (p.Leu333=)	MAP2K2		RASopathy	VCV002077594	19	4095433	19	4095435	2077594	2141978		NC_000019.10:4095434:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.996G>A (p.Lys332=)	MAP2K2		RASopathy	VCV002956034	19	4095436	19	4095438	2956034	3118542		NC_000019.10:4095437:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.991C>T (p.Pro331Ser)	MAP2K2	P331S	not provided	VCV001677495	19	4095441	19	4095443	1677495	1669185	rs1427321403	NC_000019.10:4095442:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.990T>C (p.Pro330=)	MAP2K2		RASopathy	VCV002864989	19	4095442	19	4095444	2864989	3019887		NC_000019.10:4095443:A:G	single nucleotide variant	synonymous variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.990T>A (p.Pro330=)	MAP2K2		not specified	VCV000928897	19	4095442	19	4095444	928897	917295	rs1454910757	NC_000019.10:4095443:A:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.987A>G (p.Pro329=)	MAP2K2		not specified	VCV000928895	19	4095445	19	4095447	928895	917296	rs1173273857	NC_000019.10:4095446:T:C	single nucleotide variant	synonymous variant	Uncertain significance	Jun 24, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.986C>T (p.Pro329Leu)	MAP2K2	P329L	Cardiovascular phenotype|RASopathy	VCV000955821	19	4095446	19	4095448	955821	950799	rs2040904724	NC_000019.10:4095447:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.985C>T (p.Pro329Ser)	MAP2K2	P329S	not specified|Cardiovascular phenotype	VCV000177843	19	4095447	19	4095449	177843	176169	rs727504353	NC_000019.10:4095448:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.985-3C>T	MAP2K2		RASopathy	VCV003623354	19	4095450	19	4095452	3623354	3754609		NC_000019.10:4095451:G:A	single nucleotide variant	intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-5C>G	MAP2K2		RASopathy	VCV002042300	19	4095452	19	4095454	2042300	2098893		NC_000019.10:4095453:G:C	single nucleotide variant	intron variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-7_985-5del	MAP2K2		not specified|RASopathy	VCV000704380	19	4095452 - 4095454	19	4095454 - 4095456	704380	695823	rs753469223	NC_000019.10:4095453:GGAGGAG:GGAG	Microsatellite	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.985-14G>C	MAP2K2		not specified|RASopathy	VCV002682589	19	4095461	19	4095463	2682589	2843619		NC_000019.10:4095462:C:G	single nucleotide variant	intron variant	Likely benign	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.985-14G>A	MAP2K2		RASopathy	VCV001591786	19	4095461	19	4095463	1591786	1577902	rs953403341	NC_000019.10:4095462:C:T	single nucleotide variant	intron variant	Likely benign	Oct 17, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-15T>C	MAP2K2		RASopathy	VCV002771388	19	4095462	19	4095464	2771388	2933404		NC_000019.10:4095463:A:G	single nucleotide variant	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-16C>A	MAP2K2		RASopathy	VCV002709681	19	4095463	19	4095465	2709681	2878426		NC_000019.10:4095464:G:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-18C>T	MAP2K2		RASopathy	VCV003014587	19	4095465	19	4095467	3014587	3181377		NC_000019.10:4095466:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-19C>T	MAP2K2		RASopathy	VCV002167765	19	4095466	19	4095468	2167765	1903008		NC_000019.10:4095467:G:A	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.985-19C>A	MAP2K2		RASopathy|not specified|Cardiofaciocutaneous syndrome 4	VCV001627676	19	4095466	19	4095468	1627676	1530894	rs987549297	NC_000019.10:4095467:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.985-150C>G	MAP2K2		not provided	VCV000561450	19	4095597	19	4095599	561450	553032	rs16992199	NC_000019.10:4095598:G:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+307C>T	MAP2K2		not provided	VCV001274940	19	4096970	19	4096972	1274940	1265476	rs8111064	NC_000019.10:4096971:G:A	single nucleotide variant	intron variant	Benign	Jun 13, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+235dup	MAP2K2		not provided	VCV001269111	19	4097025 - 4097026	19	4097027 - 4097028	1269111	1260254	rs11353017	NC_000019.10:4097027:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 16, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+251del	MAP2K2		not provided	VCV001245142	19	4097026	19	4097028	1245142	1235095	rs11353017	NC_000019.10:4097027:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAA	Deletion	intron variant	Benign	Aug 19, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+250_984+251del	MAP2K2		not provided	VCV001236940	19	4097026 - 4097027	19	4097028 - 4097029	1236940	1227354	rs11353017	NC_000019.10:4097027:AAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAA	Deletion	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+33C>T	MAP2K2		not provided	VCV001257426	19	4097244	19	4097246	1257426	1246922	rs766781110	NC_000019.10:4097245:G:A	single nucleotide variant	intron variant	Benign	Dec 29, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+15C>A	MAP2K2		RASopathy	VCV002743793	19	4097262	19	4097264	2743793	2907146		NC_000019.10:4097263:G:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+12A>T	MAP2K2		RASopathy	VCV002918956	19	4097265	19	4097267	2918956	3077703		NC_000019.10:4097266:T:A	single nucleotide variant	intron variant	Likely benign	Dec 1, 2022	criteria provided, single submitter							
NC_000019.10:g.(?_4097269)_(4097353_?)del	MAP2K2		RASopathy	VCV000650706	19	4097267 - 4097351	19	4097269 - 4097353	650706	653578			Deletion		Uncertain significance	Nov 1, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.984+8C>T	MAP2K2		RASopathy	VCV001139268	19	4097269	19	4097271	1139268	1127904	rs970652962	NC_000019.10:4097270:G:A	single nucleotide variant	intron variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.981C>T (p.Asn327=)	MAP2K2		not provided|Cardiovascular phenotype|not specified|RASopathy	VCV000040840	19	4097280	19	4097282	40840	49310	rs143275018	NC_000019.10:4097281:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.976G>T (p.Val326Leu)	MAP2K2	V326L	RASopathy	VCV001722188	19	4097285	19	4097287	1722188	1777050		NC_000019.10:4097286:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.973_974del (p.Ile325fs)	MAP2K2	I325fs	RASopathy|Cardiofaciocutaneous syndrome 4	VCV001433527	19	4097287 - 4097288	19	4097289 - 4097290	1433527	1419200	rs770978109	NC_000019.10:4097288:ATATA:ATA	Microsatellite	frameshift variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.974T>C (p.Ile325Thr)	MAP2K2	I325T	not provided	VCV001188050	19	4097287	19	4097289	1188050	1178385	rs2145046473	NC_000019.10:4097288:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.971A>G (p.Tyr324Cys)	MAP2K2	Y324C	RASopathy|Cardiofaciocutaneous syndrome 4|not provided	VCV000180907	19	4097290	19	4097292	180907	179821	rs730880512	NC_000019.10:4097291:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.969C>G (p.Asp323Glu)	MAP2K2	D323E	Cardiovascular phenotype|Cardiofaciocutaneous syndrome 4|Noonan syndrome and Noonan-related syndrome	VCV001334257	19	4097292	19	4097294	1334257	1325116	rs768656734	NC_000019.10:4097293:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.963C>A (p.Leu321=)	MAP2K2		RASopathy	VCV002040273	19	4097298	19	4097300	2040273	2102044		NC_000019.10:4097299:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.956T>C (p.Phe319Ser)	MAP2K2	F319S	RASopathy	VCV002807965	19	4097305	19	4097307	2807965	2971606		NC_000019.10:4097306:A:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.952A>G (p.Ile318Val)	MAP2K2	I318V	RASopathy|not provided|Cardiovascular phenotype	VCV000424604	19	4097309	19	4097311	424604	410613	rs1064797064	NC_000019.10:4097310:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.951C>T (p.Ala317=)	MAP2K2		Cardiovascular phenotype|Noonan syndrome and Noonan-related syndrome|RASopathy	VCV001334258	19	4097310	19	4097312	1334258	1325117	rs1041035741	NC_000019.10:4097311:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 6, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.946A>G (p.Met316Val)	MAP2K2	M316V	RASopathy|Cardiofaciocutaneous syndrome 4	VCV002964957	19	4097315	19	4097317	2964957	3117524		NC_000019.10:4097316:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.940C>A (p.Pro314Thr)	MAP2K2	P314T	RASopathy	VCV001374944	19	4097321	19	4097323	1374944	1466231	rs775940718	NC_000019.10:4097322:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.939G>T (p.Arg313=)	MAP2K2		not specified|RASopathy|Cardiovascular phenotype	VCV000046243	19	4097322	19	4097324	46243	55408	rs397517417	NC_000019.10:4097323:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.938G>A (p.Arg313Gln)	MAP2K2	R313Q	not specified|not provided|Cardiofaciocutaneous syndrome 4|Noonan syndrome|Cardiovascular phenotype|Noonan syndrome and Noonan-related syndrome|RASopathy	VCV000040839	19	4097323	19	4097325	40839	49309	rs151133017	NC_000019.10:4097324:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.937C>A (p.Arg313=)	MAP2K2		Cardiovascular phenotype	VCV001766732	19	4097324	19	4097326	1766732	1824975		NC_000019.10:4097325:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.937C>T (p.Arg313Trp)	MAP2K2	R313W	RASopathy|Cardiofaciocutaneous syndrome 4|not provided|Cardiovascular phenotype	VCV000280685	19	4097324	19	4097326	280685	264952	rs772831628	NC_000019.10:4097325:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.932A>G (p.Asp311Gly)	MAP2K2	D311G	Cardiovascular phenotype	VCV002611447	19	4097329	19	4097331	2611447	2773439		NC_000019.10:4097330:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.928A>G (p.Met310Val)	MAP2K2	M310V	not provided|RASopathy	VCV001254454	19	4097333	19	4097335	1254454	1244388	rs766715536	NC_000019.10:4097334:T:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.927G>A (p.Gly309=)	MAP2K2		Cardiovascular phenotype	VCV002450618	19	4097334	19	4097336	2450618	2423104		NC_000019.10:4097335:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.925G>A (p.Gly309Arg)	MAP2K2	G309R	Cardiofaciocutaneous syndrome 4|RASopathy	VCV001989641	19	4097336	19	4097338	1989641	2037187		NC_000019.10:4097337:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.924C>G (p.His308Gln)	MAP2K2	H308Q	RASopathy	VCV002754421	19	4097337	19	4097339	2754421	2913863		NC_000019.10:4097338:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.924C>T (p.His308=)	MAP2K2		RASopathy|not provided	VCV001198721	19	4097337	19	4097339	1198721	1188778	rs768099163	NC_000019.10:4097338:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.920-6G>A	MAP2K2		RASopathy	VCV001579399	19	4097347	19	4097349	1579399	1533357	rs1258620869	NC_000019.10:4097348:C:T	single nucleotide variant	intron variant	Likely benign	Dec 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-8C>G	MAP2K2		RASopathy	VCV002706811	19	4097349	19	4097351	2706811	2870384		NC_000019.10:4097350:G:C	single nucleotide variant	intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-17TC[3]	MAP2K2		RASopathy	VCV002730586	19	4097351 - 4097352	19	4097353 - 4097354	2730586	2883322		NC_000019.10:4097352:GAGAGAGA:GAGAGA	Microsatellite	intron variant	Likely benign	May 4, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-12C>T	MAP2K2		RASopathy	VCV002955756	19	4097353	19	4097355	2955756	3122152		NC_000019.10:4097354:G:A	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-14C>T	MAP2K2		RASopathy	VCV001987651	19	4097355	19	4097357	1987651	2040298		NC_000019.10:4097356:G:A	single nucleotide variant	intron variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-16C>G	MAP2K2		RASopathy	VCV003624576	19	4097357	19	4097359	3624576	3757715		NC_000019.10:4097358:G:C	single nucleotide variant	intron variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-17T>A	MAP2K2		not provided|RASopathy	VCV000391577	19	4097358	19	4097360	391577	377684	rs1057524145	NC_000019.10:4097359:A:T	single nucleotide variant	intron variant	Likely benign	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.920-18A>G	MAP2K2		RASopathy	VCV002955375	19	4097359	19	4097361	2955375	3125278		NC_000019.10:4097360:T:C	single nucleotide variant	intron variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-19C>T	MAP2K2		RASopathy	VCV001989786	19	4097360	19	4097362	1989786	2037332		NC_000019.10:4097361:G:A	single nucleotide variant	intron variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.920-24A>G	MAP2K2		not provided	VCV001291241	19	4097365	19	4097367	1291241	49308	rs146376140	NC_000019.10:4097366:T:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.919+252C>T	MAP2K2		not provided	VCV000561819	19	4098947	19	4098949	561819	553033	rs1979013	NC_000019.10:4098948:G:A	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+37C>T	MAP2K2		not provided	VCV001221297	19	4099162	19	4099164	1221297	49307	rs770574009	NC_000019.10:4099163:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+33C>T	MAP2K2		not provided	VCV001269985	19	4099166	19	4099168	1269985	1258598	rs376075475	NC_000019.10:4099167:G:A	single nucleotide variant	intron variant	Benign	Dec 18, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+31G>C	MAP2K2		not provided	VCV001279367	19	4099168	19	4099170	1279367	49306	rs1055638166	NC_000019.10:4099169:C:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+20C>T	MAP2K2		RASopathy	VCV002898646	19	4099179	19	4099181	2898646	3060281		NC_000019.10:4099180:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+19A>C	MAP2K2		RASopathy	VCV001650879	19	4099180	19	4099182	1650879	1663661	rs757492030	NC_000019.10:4099181:T:G	single nucleotide variant	intron variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+19A>G	MAP2K2		RASopathy	VCV001383942	19	4099180	19	4099182	1383942	1447538	rs757492030	NC_000019.10:4099181:T:C	single nucleotide variant	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+16G>A	MAP2K2		RASopathy	VCV001987957	19	4099183	19	4099185	1987957	2036805		NC_000019.10:4099184:C:T	single nucleotide variant	intron variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+12A>C	MAP2K2		RASopathy	VCV003017363	19	4099187	19	4099189	3017363	3175030		NC_000019.10:4099188:T:G	single nucleotide variant	intron variant	Likely benign	Oct 30, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+10_919+12delinsAAG	MAP2K2		not specified|not provided	VCV000420458	19	4099187 - 4099189	19	4099189 - 4099191	420458	410614	rs1064794489	NC_000019.10:4099188:TTC:CTT	Indel	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2020	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.919+12A>G	MAP2K2		not provided|RASopathy|not specified|Cardiofaciocutaneous syndrome 4	VCV000040835	19	4099187	19	4099189	40835	49305	rs350911	NC_000019.10:4099188:T:C	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.919+11A>T	MAP2K2		RASopathy	VCV001605726	19	4099188	19	4099190	1605726	1646778	rs572591550	NC_000019.10:4099189:T:A	single nucleotide variant	intron variant	Benign	Dec 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+10G>A	MAP2K2		RASopathy|not specified|not provided	VCV000378903	19	4099189	19	4099191	378903	377526	rs780890887	NC_000019.10:4099190:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.919+9T>G	MAP2K2		RASopathy	VCV002066489	19	4099190	19	4099192	2066489	2125303		NC_000019.10:4099191:A:C	single nucleotide variant	intron variant	Likely benign	Apr 30, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+7C>T	MAP2K2		RASopathy	VCV002743214	19	4099192	19	4099194	2743214	2896671		NC_000019.10:4099193:G:A	single nucleotide variant	intron variant	Likely benign	Jul 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.919+5G>A	MAP2K2		RASopathy|not specified	VCV000928666	19	4099194	19	4099196	928666	917555	rs540315377	NC_000019.10:4099195:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.919+4C>T	MAP2K2		RASopathy	VCV000040834	19	4099195	19	4099197	40834	49304	rs763424788	NC_000019.10:4099196:G:A	single nucleotide variant	intron variant	Likely benign	Jul 25, 2019	reviewed by expert panel							
NM_030662.4(MAP2K2):c.919G>A (p.Gly307Ser)	MAP2K2	G307S	RASopathy	VCV001494585	19	4099199	19	4099201	1494585	1344727	rs1469141139	NC_000019.10:4099200:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.918C>T (p.Ser306=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV000477729	19	4099200	19	4099202	477729	470250	rs777196833	NC_000019.10:4099201:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.917G>T (p.Ser306Ile)	MAP2K2	S306I	RASopathy	VCV003019195	19	4099201	19	4099203	3019195	3175559		NC_000019.10:4099202:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.913G>A (p.Val305Ile)	MAP2K2	V305I	Cardiofaciocutaneous syndrome 4|RASopathy|not provided	VCV000180903	19	4099205	19	4099207	180903	179822	rs730880509	NC_000019.10:4099206:C:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.912C>T (p.Pro304=)	MAP2K2		Cardiovascular phenotype|not specified|not provided|RASopathy	VCV001329638	19	4099206	19	4099208	1329638	1320322	rs1006127521	NC_000019.10:4099207:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.912C>A (p.Pro304=)	MAP2K2		RASopathy	VCV001081082	19	4099206	19	4099208	1081082	1084741	rs1006127521	NC_000019.10:4099207:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.909C>T (p.Arg303=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV000416255	19	4099209	19	4099211	416255	403254	rs1060504777	NC_000019.10:4099210:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.908G>A (p.Arg303His)	MAP2K2	R303H	RASopathy|Cardiovascular phenotype	VCV001381883	19	4099210	19	4099212	1381883	1341842	rs1251433138	NC_000019.10:4099211:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.908G>T (p.Arg303Leu)	MAP2K2	R303L	not provided	VCV001328854	19	4099210	19	4099212	1328854	1319541	rs1251433138	NC_000019.10:4099211:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.907C>T (p.Arg303Cys)	MAP2K2	R303C	RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 4	VCV001334259	19	4099211	19	4099213	1334259	1325118	rs770521279	NC_000019.10:4099212:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.903dup (p.Gly302fs)	MAP2K2	G302fs	Cardiofaciocutaneous syndrome 4|RASopathy	VCV002663991	19	4099214 - 4099215	19	4099216 - 4099217	2663991	2831461		NC_000019.10:4099216:GGGGGG:GGGGGGG	Duplication	frameshift variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.904G>A (p.Gly302Arg)	MAP2K2	G302R	RASopathy	VCV002197952	19	4099214	19	4099216	2197952	1924113		NC_000019.10:4099215:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.904G>C (p.Gly302Arg)	MAP2K2	G302R	not provided	VCV000283863	19	4099214	19	4099216	283863	268100	rs759148204	NC_000019.10:4099215:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.903del (p.Arg303fs)	MAP2K2	R303fs	RASopathy	VCV002728553	19	4099215	19	4099217	2728553	2886450		NC_000019.10:4099216:GGGGGG:GGGGG	Deletion	frameshift variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.903C>G (p.Pro301=)	MAP2K2		RASopathy	VCV001153985	19	4099215	19	4099217	1153985	1148866	rs560316877	NC_000019.10:4099216:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.903C>T (p.Pro301=)	MAP2K2		Cardiovascular phenotype|RASopathy|not specified|not provided	VCV000040833	19	4099215	19	4099217	40833	49303	rs560316877	NC_000019.10:4099216:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.901C>G (p.Pro301Ala)	MAP2K2	P301A	RASopathy	VCV002416644	19	4099217	19	4099219	2416644	1943867		NC_000019.10:4099218:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.900C>T (p.Pro300=)	MAP2K2		RASopathy	VCV002752458	19	4099218	19	4099220	2752458	2916224		NC_000019.10:4099219:G:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.900C>A (p.Pro300=)	MAP2K2		RASopathy	VCV002133015	19	4099218	19	4099220	2133015	2191854		NC_000019.10:4099219:G:T	single nucleotide variant	synonymous variant	Likely benign	May 2, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.899_900insT (p.Gly302fs)	MAP2K2	G302fs	not provided	VCV000418790	19	4099218 - 4099219	19	4099220 - 4099221	418790	410615	rs1064793436	NC_000019.10:4099220::A	Insertion	frameshift variant	Uncertain significance	Apr 6, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.899C>A (p.Pro300His)	MAP2K2	P300H	RASopathy|Cardiovascular phenotype	VCV001765375	19	4099219	19	4099221	1765375	1821016		NC_000019.10:4099220:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.897G>C (p.Arg299Ser)	MAP2K2	R299S	Cardiovascular phenotype	VCV002231387	19	4099221	19	4099223	2231387	2227314		NC_000019.10:4099222:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.895A>C (p.Arg299=)	MAP2K2		not specified|Cardiovascular phenotype	VCV001338692	19	4099223	19	4099225	1338692	1329698	rs2145049627	NC_000019.10:4099224:T:G	single nucleotide variant	synonymous variant	Likely benign	May 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.894G>A (p.Pro298=)	MAP2K2		RASopathy|not specified|Cardiovascular phenotype	VCV000516421	19	4099224	19	4099226	516421	506828	rs374526051	NC_000019.10:4099225:C:T	single nucleotide variant	synonymous variant	Likely benign	May 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.893C>T (p.Pro298Leu)	MAP2K2	P298L	RASopathy	VCV000040832	19	4099225	19	4099227	40832	49302	rs200371894	NC_000019.10:4099226:G:A	single nucleotide variant	missense variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.890G>A (p.Arg297Gln)	MAP2K2	R297Q	RASopathy|not provided|Cardiofaciocutaneous syndrome 4	VCV000285121	19	4099228	19	4099230	285121	269358	rs140111079	NC_000019.10:4099229:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.889C>A (p.Arg297=)	MAP2K2		RASopathy	VCV002197999	19	4099229	19	4099231	2197999	1924160		NC_000019.10:4099230:G:T	single nucleotide variant	synonymous variant	Likely benign	May 13, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.889C>T (p.Arg297Trp)	MAP2K2	R297W	not provided|RASopathy	VCV000040831	19	4099229	19	4099231	40831	49301	rs562352756	NC_000019.10:4099230:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.888T>G (p.Pro296=)	MAP2K2		Cardiovascular phenotype	VCV001765000	19	4099230	19	4099232	1765000	1824494		NC_000019.10:4099231:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 30, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.886C>T (p.Pro296Ser)	MAP2K2	P296S	RASopathy	VCV002832213	19	4099232	19	4099234	2832213	2994597		NC_000019.10:4099233:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.885G>A (p.Ser295=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001158395	19	4099233	19	4099235	1158395	1148867	rs368405565	NC_000019.10:4099234:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.884C>T (p.Ser295Leu)	MAP2K2	S295L	Cardiofaciocutaneous syndrome 4|RASopathy|not provided	VCV000040830	19	4099234	19	4099236	40830	49300	rs531584619	NC_000019.10:4099235:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 26, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.879C>T (p.Ser293=)	MAP2K2		RASopathy	VCV002189396	19	4099239	19	4099241	2189396	1911739		NC_000019.10:4099240:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.876C>T (p.His292=)	MAP2K2		RASopathy	VCV001550510	19	4099242	19	4099244	1550510	1574199	rs2145049738	NC_000019.10:4099243:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.874C>T (p.His292Tyr)	MAP2K2	H292Y	Cardiofaciocutaneous syndrome 4|RASopathy	VCV002899737	19	4099244	19	4099246	2899737	3067824		NC_000019.10:4099245:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.872C>G (p.Pro291Arg)	MAP2K2	P291R	Cardiovascular phenotype|RASopathy	VCV001718640	19	4099246	19	4099248	1718640	1776144		NC_000019.10:4099247:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.872C>T (p.Pro291Leu)	MAP2K2	P291L	Cardiovascular phenotype|RASopathy	VCV001503846	19	4099246	19	4099248	1503846	1424250	rs752436529	NC_000019.10:4099247:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.871C>G (p.Pro291Ala)	MAP2K2	P291A	RASopathy	VCV002179678	19	4099247	19	4099249	2179678	1916199		NC_000019.10:4099248:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.865G>A (p.Gly289Arg)	MAP2K2	G289R	Cardiovascular phenotype|RASopathy	VCV000543969	19	4099253	19	4099255	543969	533539	rs1555696725	NC_000019.10:4099254:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.860AAG[1] (p.Glu288del)	MAP2K2	E288del	Cardiovascular phenotype|not provided|not specified|RASopathy	VCV000503543	19	4099253 - 4099255	19	4099255 - 4099257	503543	494977	rs763469132	NC_000019.10:4099254:CTTCTTC:CTTC	Microsatellite	inframe_deletion	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.861A>G (p.Glu287=)	MAP2K2		RASopathy	VCV000477728	19	4099257	19	4099259	477728	470924	rs1431720692	NC_000019.10:4099258:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.857G>A (p.Gly286Glu)	MAP2K2	G286E	Cardiovascular phenotype	VCV003292971	19	4099261	19	4099263	3292971	3446442		NC_000019.10:4099262:C:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.856G>A (p.Gly286Arg)	MAP2K2	G286R	Cardiovascular phenotype|not provided|RASopathy	VCV000040829	19	4099262	19	4099264	40829	49299	rs730880523	NC_000019.10:4099263:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.855C>T (p.Asp285=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV002740675	19	4099263	19	4099265	2740675	2902742		NC_000019.10:4099264:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.854A>T (p.Asp285Val)	MAP2K2	D285V	RASopathy	VCV002884735	19	4099264	19	4099266	2884735	3050079		NC_000019.10:4099265:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.853G>A (p.Asp285Asn)	MAP2K2	D285N	not provided|not specified|RASopathy	VCV000040828	19	4099265	19	4099267	40828	49298	rs150369301	NC_000019.10:4099266:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 25, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.852C>T (p.Val284=)	MAP2K2		Cardiovascular phenotype	VCV003542704	19	4099266	19	4099268	3542704	3699986		NC_000019.10:4099267:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.852C>G (p.Val284=)	MAP2K2		RASopathy	VCV001668019	19	4099266	19	4099268	1668019	1569884	rs771633690	NC_000019.10:4099267:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.847G>A (p.Val283Met)	MAP2K2	V283M	RASopathy|Cardiofaciocutaneous syndrome 4|not specified	VCV000496476	19	4099271	19	4099273	496476	488053	rs185999703	NC_000019.10:4099272:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 10, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.847G>T (p.Val283Leu)	MAP2K2	V283L	RASopathy	VCV000448950	19	4099271	19	4099273	448950	442539	rs185999703	NC_000019.10:4099272:C:A	single nucleotide variant	missense variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.846C>T (p.Pro282=)	MAP2K2		RASopathy	VCV000040827	19	4099272	19	4099274	40827	49297	rs11539506	NC_000019.10:4099273:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.844C>T (p.Pro282Ser)	MAP2K2	P282S	RASopathy	VCV000040826	19	4099274	19	4099276	40826	49296	rs142307980	NC_000019.10:4099275:G:A	single nucleotide variant	missense variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.843G>A (p.Arg281=)	MAP2K2		Cardiovascular phenotype	VCV001763394	19	4099275	19	4099277	1763394	1824118		NC_000019.10:4099276:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.842G>C (p.Arg281Pro)	MAP2K2	R281P	RASopathy	VCV001355306	19	4099276	19	4099278	1355306	1512934	rs1332074575	NC_000019.10:4099277:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.842G>A (p.Arg281Gln)	MAP2K2	R281Q	RASopathy	VCV000569590	19	4099276	19	4099278	569590	570803	rs1332074575	NC_000019.10:4099277:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2020	reviewed by expert panel							
NM_030662.4(MAP2K2):c.841C>T (p.Arg281Trp)	MAP2K2	R281W	RASopathy|Cardiovascular phenotype|not specified	VCV000917722	19	4099277	19	4099279	917722	906038	rs759998177	NC_000019.10:4099278:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.836T>G (p.Phe279Cys)	MAP2K2	F279C	Cardiovascular phenotype	VCV003542703	19	4099282	19	4099284	3542703	3699985		NC_000019.10:4099283:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.836T>C (p.Phe279Ser)	MAP2K2	F279S	RASopathy	VCV001471634	19	4099282	19	4099284	1471634	1388662	rs2145049960	NC_000019.10:4099283:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.834C>A (p.Ile278=)	MAP2K2		not specified	VCV000505321	19	4099284	19	4099286	505321	497521	rs766540227	NC_000019.10:4099285:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.834C>G (p.Ile278Met)	MAP2K2	I278M	not specified|RASopathy	VCV000372632	19	4099284	19	4099286	372632	360426	rs766540227	NC_000019.10:4099285:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.833T>C (p.Ile278Thr)	MAP2K2	I278T	not provided	VCV003603126	19	4099285	19	4099287	3603126	3735840		NC_000019.10:4099286:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.829G>A (p.Ala277Thr)	MAP2K2	A277T	not provided	VCV002572251	19	4099289	19	4099291	2572251	2737197		NC_000019.10:4099290:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.826G>C (p.Glu276Gln)	MAP2K2	E276Q	not specified|RASopathy	VCV000372931	19	4099292	19	4099294	372931	360554	rs889422963	NC_000019.10:4099293:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.825G>A (p.Leu275=)	MAP2K2		RASopathy	VCV000138161	19	4099293	19	4099295	138161	141864	rs587781027	NC_000019.10:4099294:C:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.794_824del (p.Tyr265fs)	MAP2K2	Y265fs	RASopathy	VCV002130213	19	4099294 - 4099324	19	4099296 - 4099326	2130213	2178945		NC_000019.10:4099295:AGCTCTTTGGCGTCGGGCGGGGGGATGGGGTA:A	Deletion	frameshift variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.823C>G (p.Leu275Val)	MAP2K2	L275V	RASopathy	VCV003626122	19	4099295	19	4099297	3626122	3761416		NC_000019.10:4099296:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.823C>T (p.Leu275=)	MAP2K2		RASopathy	VCV000040825	19	4099295	19	4099297	40825	49295	rs145934142	NC_000019.10:4099296:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.818A>G (p.Lys273Arg)	MAP2K2	K273R	RASopathy	VCV000040824	19	4099300	19	4099302	40824	49294	rs539555837	NC_000019.10:4099301:T:C	single nucleotide variant	missense variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.814G>A (p.Ala272Thr)	MAP2K2	A272T	Cardiovascular phenotype|RASopathy|Cardiofaciocutaneous syndrome 4|not specified|not provided	VCV000424075	19	4099304	19	4099306	424075	410616	rs757240576	NC_000019.10:4099305:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 29, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.813C>G (p.Asp271Glu)	MAP2K2	D271E	RASopathy|not specified|Cardiovascular phenotype	VCV001092325	19	4099305	19	4099307	1092325	1084742	rs201726622	NC_000019.10:4099306:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.813C>T (p.Asp271=)	MAP2K2		RASopathy	VCV000378108	19	4099305	19	4099307	378108	377687	rs201726622	NC_000019.10:4099306:G:A	single nucleotide variant	synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.811G>A (p.Asp271Asn)	MAP2K2	D271N	not provided|Cardiofaciocutaneous syndrome 4|RASopathy	VCV000666425	19	4099307	19	4099309	666425	653983	rs758031424	NC_000019.10:4099308:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.810C>T (p.Pro270=)	MAP2K2		RASopathy|not provided|Cardiovascular phenotype	VCV001179650	19	4099308	19	4099310	1179650	1169831	rs374119774	NC_000019.10:4099309:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.807G>A (p.Pro269=)	MAP2K2		RASopathy	VCV002040720	19	4099311	19	4099313	2040720	2098613		NC_000019.10:4099312:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.807G>T (p.Pro269=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV001580268	19	4099311	19	4099313	1580268	1653091	rs779598598	NC_000019.10:4099312:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.806C>A (p.Pro269Gln)	MAP2K2	P269Q	RASopathy	VCV002777650	19	4099312	19	4099314	2777650	2936646		NC_000019.10:4099313:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.806C>T (p.Pro269Leu)	MAP2K2	P269L	RASopathy|not provided	VCV000180906	19	4099312	19	4099314	180906	179823	rs368064728	NC_000019.10:4099313:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.806C>G (p.Pro269Arg)	MAP2K2	P269R	RASopathy	VCV000177876	19	4099312	19	4099314	177876	176028	rs368064728	NC_000019.10:4099313:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2020	reviewed by expert panel							
NM_030662.4(MAP2K2):c.804C>T (p.Pro268=)	MAP2K2		RASopathy|not specified	VCV000261933	19	4099314	19	4099316	261933	257128	rs886038700	NC_000019.10:4099315:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.801C>T (p.Ile267=)	MAP2K2		RASopathy	VCV002728244	19	4099317	19	4099319	2728244	2889582		NC_000019.10:4099318:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.798C>T (p.Pro266=)	MAP2K2		Cardiovascular phenotype	VCV003542705	19	4099320	19	4099322	3542705	3699987		NC_000019.10:4099321:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.794A>G (p.Tyr265Cys)	MAP2K2	Y265C	Cardiovascular phenotype|Cardiofaciocutaneous syndrome 4	VCV003228057	19	4099324	19	4099326	3228057	3387826		NC_000019.10:4099325:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.794A>T (p.Tyr265Phe)	MAP2K2	Y265F	RASopathy	VCV001046609	19	4099324	19	4099326	1046609	1034320	rs1377552828	NC_000019.10:4099325:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.792G>T (p.Arg264Ser)	MAP2K2	R264S	not provided	VCV003572456	19	4099326	19	4099328	3572456	3731356		NC_000019.10:4099327:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.792G>A (p.Arg264=)	MAP2K2		RASopathy	VCV002130214	19	4099326	19	4099328	2130214	2178946		NC_000019.10:4099327:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 24, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.791G>A (p.Arg264Lys)	MAP2K2	R264K	RASopathy	VCV002898952	19	4099327	19	4099329	2898952	3060587		NC_000019.10:4099328:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.787G>A (p.Gly263Arg)	MAP2K2	G263R	not provided|not specified|RASopathy	VCV000180914	19	4099331	19	4099333	180914	179824	rs730880522	NC_000019.10:4099332:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.786C>T (p.Val262=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001090336	19	4099332	19	4099334	1090336	1084743	rs748653844	NC_000019.10:4099333:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.784G>A (p.Val262Ile)	MAP2K2	V262I	RASopathy	VCV000046242	19	4099334	19	4099336	46242	55407	rs138873805	NC_000019.10:4099335:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	reviewed by expert panel							
NM_030662.4(MAP2K2):c.783C>T (p.Ala261=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV000416257	19	4099335	19	4099337	416257	403727	rs1060504779	NC_000019.10:4099336:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.778C>T (p.Leu260=)	MAP2K2		not provided	VCV000702500	19	4099340	19	4099342	702500	694425	rs766528759	NC_000019.10:4099341:G:A	single nucleotide variant	synonymous variant	Likely benign	May 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.775G>C (p.Glu259Gln)	MAP2K2	E259Q	RASopathy	VCV001474606	19	4099343	19	4099345	1474606	1503693	rs1038040308	NC_000019.10:4099344:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.768C>G (p.Ser256=)	MAP2K2		not provided|RASopathy	VCV001642847	19	4099350	19	4099352	1642847	1521339	rs774404449	NC_000019.10:4099351:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.767C>G (p.Ser256Cys)	MAP2K2	S256C	RASopathy	VCV002127541	19	4099351	19	4099353	2127541	2175079		NC_000019.10:4099352:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.764T>C (p.Leu255Pro)	MAP2K2	L255P	not provided	VCV001298736	19	4099354	19	4099356	1298736	1288598	rs2145050299	NC_000019.10:4099355:A:G	single nucleotide variant	missense variant	Likely benign	Nov 1, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.763C>T (p.Leu255=)	MAP2K2		not provided	VCV000198595	19	4099355	19	4099357	198595	195756	rs794727877	NC_000019.10:4099356:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Sep 24, 2014	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.760_761del (p.Gly254fs)	MAP2K2	G254fs	RASopathy	VCV002111349	19	4099357 - 4099358	19	4099359 - 4099360	2111349	2163924		NC_000019.10:4099358:CCC:C	Deletion	frameshift variant	Uncertain significance	Dec 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.758T>C (p.Met253Thr)	MAP2K2	M253T	RASopathy|Cardiofaciocutaneous syndrome 4	VCV002140580	19	4099360	19	4099362	2140580	1878954		NC_000019.10:4099361:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.757A>T (p.Met253Leu)	MAP2K2	M253L	not provided	VCV002571832	19	4099361	19	4099363	2571832	2736779		NC_000019.10:4099362:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.750C>T (p.Ile250=)	MAP2K2		not specified	VCV000996278	19	4099368	19	4099370	996278	984001	rs2040968148	NC_000019.10:4099369:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.745G>T (p.Asp249Tyr)	MAP2K2	D249Y	RASopathy	VCV001997887	19	4099373	19	4099375	1997887	2057107		NC_000019.10:4099374:C:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.744G>A (p.Ser248=)	MAP2K2		RASopathy	VCV001159777	19	4099374	19	4099376	1159777	1148868	rs753640401	NC_000019.10:4099375:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.743C>G (p.Ser248Trp)	MAP2K2	S248W	Cardiovascular phenotype	VCV002450614	19	4099375	19	4099377	2450614	2423100		NC_000019.10:4099376:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.743C>T (p.Ser248Leu)	MAP2K2	S248L	Cardiofaciocutaneous syndrome 4|not provided|RASopathy	VCV001331203	19	4099375	19	4099377	1331203	1321878	rs761669626	NC_000019.10:4099376:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.741G>A (p.Gln247=)	MAP2K2		Cardiovascular phenotype	VCV001758835	19	4099377	19	4099379	1758835	1819546		NC_000019.10:4099378:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.740A>C (p.Gln247Pro)	MAP2K2	Q247P	RASopathy|Cardiovascular phenotype	VCV001007055	19	4099378	19	4099380	1007055	998616	rs1226120513	NC_000019.10:4099379:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.739C>T (p.Gln247Ter)	MAP2K2	Q247*	RASopathy	VCV002998814	19	4099379	19	4099381	2998814	3156583		NC_000019.10:4099380:G:A	single nucleotide variant	nonsense	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.735G>A (p.Ser245=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV001612662	19	4099383	19	4099385	1612662	1601745	rs765121673	NC_000019.10:4099384:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.734C>T (p.Ser245Leu)	MAP2K2	S245L	not provided	VCV003369961	19	4099384	19	4099386	3369961	3529152		NC_000019.10:4099385:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.727C>G (p.His243Asp)	MAP2K2	H243D	RASopathy	VCV002716942	19	4099391	19	4099393	2716942	2876640		NC_000019.10:4099392:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.727C>A (p.His243Asn)	MAP2K2	H243N	Cardiovascular phenotype	VCV002231900	19	4099391	19	4099393	2231900	2220050		NC_000019.10:4099392:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.726A>G (p.Thr242=)	MAP2K2		Cardiovascular phenotype	VCV001757990	19	4099392	19	4099394	1757990	1812871		NC_000019.10:4099393:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.715T>C (p.Leu239=)	MAP2K2		RASopathy	VCV002065782	19	4099403	19	4099405	2065782	2118470		NC_000019.10:4099404:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.713G>A (p.Arg238Gln)	MAP2K2	R238Q	RASopathy	VCV002768026	19	4099405	19	4099407	2768026	2932638		NC_000019.10:4099406:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.712C>T (p.Arg238Trp)	MAP2K2	R238W	Cardiofaciocutaneous syndrome 4|Cardiovascular phenotype	VCV001757301	19	4099406	19	4099408	1757301	1819306		NC_000019.10:4099407:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.708G>A (p.Pro236=)	MAP2K2		RASopathy	VCV002984633	19	4099410	19	4099412	2984633	3146245		NC_000019.10:4099411:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.707C>T (p.Pro236Leu)	MAP2K2	P236L	Cardiovascular phenotype|RASopathy	VCV000591250	19	4099411	19	4099413	591250	582243	rs1309234276	NC_000019.10:4099412:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.706-1_706delinsTT	MAP2K2		Cardiofaciocutaneous syndrome 4|RASopathy|not provided|not specified	VCV000655002	19	4099412 - 4099413	19	4099414 - 4099415	655002	653050	rs1599287155	NC_000019.10:4099413:GC:AA	Indel	splice acceptor variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.706-9C>G	MAP2K2		RASopathy	VCV002715963	19	4099421	19	4099423	2715963	2869201		NC_000019.10:4099422:G:C	single nucleotide variant	intron variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-11C>T	MAP2K2		RASopathy	VCV002724707	19	4099423	19	4099425	2724707	2888635		NC_000019.10:4099424:G:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-15_706-14del	MAP2K2		RASopathy	VCV001587320	19	4099426 - 4099427	19	4099428 - 4099429	1587320	1541836	rs1255196775	NC_000019.10:4099427:AG:	Deletion	intron variant	Likely benign	Jul 29, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-15C>G	MAP2K2		RASopathy	VCV002750286	19	4099427	19	4099429	2750286	2919244		NC_000019.10:4099428:G:C	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-17C>T	MAP2K2		not provided|RASopathy	VCV000386212	19	4099429	19	4099431	386212	379590	rs754737193	NC_000019.10:4099430:G:A	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.706-19C>T	MAP2K2		RASopathy	VCV002183821	19	4099431	19	4099433	2183821	1913820		NC_000019.10:4099432:G:A	single nucleotide variant	intron variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-35C>G	MAP2K2		not provided	VCV001291240	19	4099447	19	4099449	1291240	49292	rs572577745	NC_000019.10:4099448:G:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-38C>T	MAP2K2		not provided	VCV001233834	19	4099450	19	4099452	1233834	49291	rs1371330955	NC_000019.10:4099451:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-72C>T	MAP2K2		not provided	VCV001262041	19	4099484	19	4099486	1262041	49290	rs541608579	NC_000019.10:4099485:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-81G>A	MAP2K2		not provided	VCV001261843	19	4099493	19	4099495	1261843	49289	rs1320229221	NC_000019.10:4099494:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.706-350C>T	MAP2K2		not provided	VCV001879413	19	4099762	19	4099764	1879413	1936251		NC_000019.10:4099763:G:A	single nucleotide variant	intron variant	Likely benign	Jan 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+179T>C	MAP2K2		not provided	VCV000561437	19	4100838	19	4100840	561437	553034	rs115066613	NC_000019.10:4100839:A:G	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.705+128C>T	MAP2K2		not provided	VCV000561389	19	4100889	19	4100891	561389	553035	rs56120956	NC_000019.10:4100890:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.705+20C>G	MAP2K2		RASopathy	VCV001983836	19	4100997	19	4100999	1983836	2042991		NC_000019.10:4100998:G:C	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+19T>C	MAP2K2		RASopathy	VCV002697921	19	4100998	19	4101000	2697921	2861483		NC_000019.10:4100999:A:G	single nucleotide variant	intron variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+18C>G	MAP2K2		RASopathy	VCV002180707	19	4100999	19	4101001	2180707	1909523		NC_000019.10:4101000:G:C	single nucleotide variant	intron variant	Likely benign	Jun 11, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+16C>G	MAP2K2		RASopathy	VCV002901274	19	4101001	19	4101003	2901274	3068065		NC_000019.10:4101002:G:C	single nucleotide variant	intron variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+15G>A	MAP2K2		not specified	VCV000974974	19	4101002	19	4101004	974974	963305	rs1187456546	NC_000019.10:4101003:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 20, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+11G>T	MAP2K2		RASopathy	VCV002969795	19	4101006	19	4101008	2969795	3128886		NC_000019.10:4101007:C:A	single nucleotide variant	intron variant	Likely benign	Apr 8, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+11G>A	MAP2K2		RASopathy|not specified	VCV000227540	19	4101006	19	4101008	227540	231024	rs202086678	NC_000019.10:4101007:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.705+11G>C	MAP2K2		Cardiofaciocutaneous syndrome 4|not specified|RASopathy|not provided	VCV000138160	19	4101006	19	4101008	138160	141863	rs202086678	NC_000019.10:4101007:C:G	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.705+10C>T	MAP2K2		not specified|not provided|RASopathy	VCV000046241	19	4101007	19	4101009	46241	55406	rs372898071	NC_000019.10:4101008:G:A	single nucleotide variant	intron variant	Likely benign	Dec 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.705+8C>G	MAP2K2		RASopathy	VCV001626633	19	4101009	19	4101011	1626633	1583636	rs1022845408	NC_000019.10:4101010:G:C	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.705+2T>C	MAP2K2		RASopathy	VCV001399367	19	4101015	19	4101017	1399367	1365727	rs2145053647	NC_000019.10:4101016:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Aug 7, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.703G>T (p.Ala235Ser)	MAP2K2	A235S	RASopathy	VCV001368592	19	4101019	19	4101021	1368592	1340184	rs1166526430	NC_000019.10:4101020:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.699C>T (p.Tyr233=)	MAP2K2		RASopathy|Cardiovascular phenotype|not specified	VCV000632880	19	4101023	19	4101025	632880	621634	rs1044588100	NC_000019.10:4101024:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.696C>T (p.Ser232=)	MAP2K2		not provided|RASopathy	VCV001116171	19	4101026	19	4101028	1116171	1106527	rs761539527	NC_000019.10:4101027:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.695C>T (p.Ser232Phe)	MAP2K2	S232F	Cardiofaciocutaneous syndrome 4	VCV003583901	19	4101027	19	4101029	3583901	3709751		NC_000019.10:4101028:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.694T>A (p.Ser232Thr)	MAP2K2	S232T	RASopathy	VCV002824273	19	4101028	19	4101030	2824273	2978947		NC_000019.10:4101029:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.692G>A (p.Arg231His)	MAP2K2	R231H	Noonan syndrome and Noonan-related syndrome	VCV000543999	19	4101030	19	4101032	543999	533045	rs730880511	NC_000019.10:4101031:C:T	single nucleotide variant	missense variant	Uncertain significance	May 17, 2019	reviewed by expert panel							
NM_030662.4(MAP2K2):c.692G>T (p.Arg231Leu)	MAP2K2	R231L	Noonan syndrome and Noonan-related syndrome	VCV000040818	19	4101030	19	4101032	40818	49288	rs730880511	NC_000019.10:4101031:C:A	single nucleotide variant	missense variant	Uncertain significance	May 10, 2019	reviewed by expert panel							
NM_030662.4(MAP2K2):c.691C>T (p.Arg231Cys)	MAP2K2	R231C	RASopathy	VCV002176289	19	4101031	19	4101033	2176289	49287	rs375843855	NC_000019.10:4101032:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.690G>A (p.Thr230=)	MAP2K2		RASopathy	VCV000138159	19	4101032	19	4101034	138159	141862	rs201287884	NC_000019.10:4101033:C:T	single nucleotide variant	synonymous variant	Benign	Nov 15, 2018	reviewed by expert panel							
NM_030662.4(MAP2K2):c.689C>T (p.Thr230Met)	MAP2K2	T230M	RASopathy	VCV000859496	19	4101033	19	4101035	859496	847719	rs369714097	NC_000019.10:4101034:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.687C>T (p.Gly229=)	MAP2K2		RASopathy|not provided	VCV002663139	19	4101035	19	4101037	2663139	2830589		NC_000019.10:4101036:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.685G>A (p.Gly229Ser)	MAP2K2	G229S	RASopathy	VCV001975824	19	4101037	19	4101039	1975824	2023472		NC_000019.10:4101038:C:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.684G>A (p.Val228=)	MAP2K2		Cardiovascular phenotype	VCV001755785	19	4101038	19	4101040	1755785	1815280		NC_000019.10:4101039:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.682G>C (p.Val228Leu)	MAP2K2	V228L	RASopathy	VCV000843844	19	4101040	19	4101042	843844	847720	rs999810842	NC_000019.10:4101041:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.682G>A (p.Val228Met)	MAP2K2	V228M	RASopathy|not provided	VCV000425156	19	4101040	19	4101042	425156	413490	rs999810842	NC_000019.10:4101041:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.681C>T (p.Phe227=)	MAP2K2		RASopathy	VCV000699140	19	4101041	19	4101043	699140	689062	rs751129624	NC_000019.10:4101042:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.678C>T (p.Ser226=)	MAP2K2		not specified|not provided|RASopathy|Cardiovascular phenotype	VCV000046240	19	4101044	19	4101046	46240	55405	rs200874968	NC_000019.10:4101045:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.674A>G (p.Asn225Ser)	MAP2K2	N225S	RASopathy|Cardiofaciocutaneous syndrome 4	VCV003583902	19	4101048	19	4101050	3583902	3709752		NC_000019.10:4101049:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.674A>T (p.Asn225Ile)	MAP2K2	N225I	RASopathy	VCV002851168	19	4101048	19	4101050	2851168	3009670		NC_000019.10:4101049:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.674A>C (p.Asn225Thr)	MAP2K2	N225T	Cardiovascular phenotype|not provided	VCV001878795	19	4101048	19	4101050	1878795	1935549		NC_000019.10:4101049:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.661G>A (p.Asp221Asn)	MAP2K2	D221N	RASopathy|Cardiofaciocutaneous syndrome 4	VCV000930860	19	4101061	19	4101063	930860	919868	rs2041001051	NC_000019.10:4101062:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.660C>T (p.Ile220=)	MAP2K2		RASopathy	VCV002913078	19	4101062	19	4101064	2913078	3079118		NC_000019.10:4101063:G:A	single nucleotide variant	synonymous variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.659_660delinsCA (p.Ile220Thr)	MAP2K2	I220T	RASopathy	VCV002796983	19	4101062 - 4101063	19	4101064 - 4101065	2796983	2951637		NC_000019.10:4101063:GA:TG	Indel	missense variant	Uncertain significance	Aug 6, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.660C>A (p.Ile220=)	MAP2K2		RASopathy	VCV000040816	19	4101062	19	4101064	40816	49286	rs10250	NC_000019.10:4101063:G:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.658A>G (p.Ile220Val)	MAP2K2	I220V	not specified	VCV000177860	19	4101064	19	4101066	177860	176170	rs727504363	NC_000019.10:4101065:T:C	single nucleotide variant	missense variant	Likely benign	Mar 18, 2013	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.655C>G (p.Leu219Val)	MAP2K2	L219V	RASopathy	VCV002766074	19	4101067	19	4101069	2766074	2931980		NC_000019.10:4101068:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.653A>T (p.Gln218Leu)	MAP2K2	Q218L	RASopathy|not provided	VCV002502667	19	4101069	19	4101071	2502667	2667773		NC_000019.10:4101070:T:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.651C>G (p.Gly217=)	MAP2K2		RASopathy|Cardiovascular phenotype|not provided	VCV001238442	19	4101071	19	4101073	1238442	49285	rs2145054110	NC_000019.10:4101072:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.650G>C (p.Gly217Ala)	MAP2K2	G217A	Cardiofaciocutaneous syndrome 4	VCV002920917	19	4101072	19	4101074	2920917	3081379		NC_000019.10:4101073:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.649G>A (p.Gly217Ser)	MAP2K2	G217S	Cardiovascular phenotype	VCV001753878	19	4101073	19	4101075	1753878	49284	rs756402608	NC_000019.10:4101074:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.648C>T (p.Ser216=)	MAP2K2		not provided|not specified|RASopathy	VCV000198269	19	4101074	19	4101076	198269	195430	rs147276536	NC_000019.10:4101075:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.646A>G (p.Ser216Gly)	MAP2K2	S216G	Cardiovascular phenotype	VCV003542708	19	4101076	19	4101078	3542708	3699990		NC_000019.10:4101077:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.643G>T (p.Val215Leu)	MAP2K2	V215L	Cardiovascular phenotype|RASopathy	VCV000864097	19	4101079	19	4101081	864097	847721		NC_000019.10:4101080:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.642G>T (p.Gly214=)	MAP2K2		MAP2K2-related disorder	VCV003355101	19	4101080	19	4101082	3355101	3514322		NC_000019.10:4101081:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2024	no assertion criteria provided							
NM_030662.4(MAP2K2):c.642G>A (p.Gly214=)	MAP2K2		RASopathy	VCV001646833	19	4101080	19	4101082	1646833	1599857	rs1474601212	NC_000019.10:4101081:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.640G>A (p.Gly214Arg)	MAP2K2	G214R	RASopathy|not provided|MAP2K2-related disorder	VCV000981555	19	4101082	19	4101084	981555	969695		NC_000019.10:4101083:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.639del (p.Phe213fs)	MAP2K2	F213fs	RASopathy	VCV001384483	19	4101083	19	4101085	1384483	1348760	rs2145054190	NC_000019.10:4101084:G:	Deletion	frameshift variant	Uncertain significance	Oct 4, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.639C>T (p.Phe213=)	MAP2K2		not provided|RASopathy|Cardiovascular phenotype|not specified	VCV000179367	19	4101083	19	4101085	179367	176029	rs727504818	NC_000019.10:4101084:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.630G>A (p.Leu210=)	MAP2K2		RASopathy	VCV002896051	19	4101092	19	4101094	2896051	3066732		NC_000019.10:4101093:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.627G>A (p.Lys209=)	MAP2K2		Noonan syndrome and Noonan-related syndrome	VCV001334260	19	4101095	19	4101097	1334260	1325119	rs1555696933	NC_000019.10:4101096:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Dec 1, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.627G>C (p.Lys209Asn)	MAP2K2	K209N	not provided|RASopathy	VCV000496475	19	4101095	19	4101097	496475	487813	rs1555696933	NC_000019.10:4101096:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.626A>G (p.Lys209Arg)	MAP2K2	K209R	RASopathy	VCV002895554	19	4101096	19	4101098	2895554	3056331		NC_000019.10:4101097:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.621G>A (p.Glu207=)	MAP2K2		not provided|Cardiovascular phenotype|RASopathy|not specified	VCV000050940	19	4101101	19	4101103	50940	65601	rs397517416	NC_000019.10:4101102:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys)	MAP2K2	E207K	Cardio-facio-cutaneous syndrome	VCV000040813	19	4101103	19	4101105	40813	49283	rs727504382	NC_000019.10:4101104:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.611C>G (p.Ser204Cys)	MAP2K2	S204C	RASopathy	VCV001488119	19	4101111	19	4101113	1488119	1504828	rs775668076	NC_000019.10:4101112:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.608dup (p.Asn203fs)	MAP2K2	N203fs	RASopathy	VCV001468153	19	4101113 - 4101114	19	4101115 - 4101116	1468153	1362398	rs2145054379	NC_000019.10:4101115:TT:TTT	Duplication	frameshift variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.605T>G (p.Val202Gly)	MAP2K2	V202G	not provided	VCV000561954	19	4101117	19	4101119	561954	553036	rs1568253689	NC_000019.10:4101118:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.604G>T (p.Val202Leu)	MAP2K2	V202L	RASopathy	VCV001034905	19	4101118	19	4101120	1034905	1034321	rs769471250	NC_000019.10:4101119:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.604G>A (p.Val202Met)	MAP2K2	V202M	Cardiofaciocutaneous syndrome 4|RASopathy|Cardiovascular phenotype|not specified	VCV000040812	19	4101118	19	4101120	40812	49282	rs769471250	NC_000019.10:4101119:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.603C>T (p.Leu201=)	MAP2K2		RASopathy	VCV000040811	19	4101119	19	4101121	40811	49281	rs148291450	NC_000019.10:4101120:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.602T>C (p.Leu201Pro)	MAP2K2	L201P	RASopathy	VCV002016360	19	4101120	19	4101122	2016360	2075566		NC_000019.10:4101121:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.600C>T (p.Ile200=)	MAP2K2		RASopathy	VCV002900667	19	4101122	19	4101124	2900667	3061009		NC_000019.10:4101123:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.597C>T (p.Asn199=)	MAP2K2		RASopathy	VCV001565439	19	4101125	19	4101127	1565439	1621512	rs773947810	NC_000019.10:4101126:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.594C>T (p.Ser198=)	MAP2K2		RASopathy	VCV002863740	19	4101128	19	4101130	2863740	3029815		NC_000019.10:4101129:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.591C>G (p.Pro197=)	MAP2K2		RASopathy	VCV002915393	19	4101131	19	4101133	2915393	3076763		NC_000019.10:4101132:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.591C>T (p.Pro197=)	MAP2K2		not provided	VCV001263414	19	4101131	19	4101133	1263414	49280	rs2145054504	NC_000019.10:4101132:G:A	single nucleotide variant	synonymous variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.590C>T (p.Pro197Leu)	MAP2K2	P197L	Cardiofaciocutaneous syndrome 4	VCV003583903	19	4101132	19	4101134	3583903	3709753		NC_000019.10:4101133:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-2A>G	MAP2K2		RASopathy	VCV002138187	19	4101143	19	4101145	2138187	1868340		NC_000019.10:4101144:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-3C>T	MAP2K2		RASopathy|not provided	VCV001223829	19	4101144	19	4101146	1223829	1214102	rs754233409	NC_000019.10:4101145:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 1, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.581-4C>G	MAP2K2		RASopathy	VCV001966626	19	4101145	19	4101147	1966626	2031792		NC_000019.10:4101146:G:C	single nucleotide variant	intron variant	Likely benign	Jun 15, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-5T>C	MAP2K2		not specified|RASopathy	VCV000633294	19	4101146	19	4101148	633294	621871	rs757662989	NC_000019.10:4101147:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 22, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.581-8G>T	MAP2K2		RASopathy	VCV001981006	19	4101149	19	4101151	1981006	2035076		NC_000019.10:4101150:C:A	single nucleotide variant	intron variant	Likely benign	May 28, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-8G>A	MAP2K2		RASopathy|not specified|Cardiofaciocutaneous syndrome 4|not provided	VCV000227539	19	4101149	19	4101151	227539	231025	rs369262004	NC_000019.10:4101150:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.581-9C>T	MAP2K2		not specified|RASopathy	VCV000507401	19	4101150	19	4101152	507401	507041	rs539611844	NC_000019.10:4101151:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.581-10C>T	MAP2K2		RASopathy	VCV000697009	19	4101151	19	4101153	697009	685459	rs200400944	NC_000019.10:4101152:G:A	single nucleotide variant	intron variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-11G>A	MAP2K2		not specified	VCV000516568	19	4101152	19	4101154	516568	507386	rs758442973	NC_000019.10:4101153:C:T	single nucleotide variant	intron variant	Likely benign	Jun 27, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-13C>T	MAP2K2		RASopathy	VCV001674172	19	4101154	19	4101156	1674172	1617985	rs780175317	NC_000019.10:4101155:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-18G>A	MAP2K2		RASopathy|not specified	VCV000378107	19	4101159	19	4101161	378107	379591	rs372759920	NC_000019.10:4101160:C:T	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.581-19C>T	MAP2K2		not provided|RASopathy	VCV000387949	19	4101160	19	4101162	387949	377528	rs573730409	NC_000019.10:4101161:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.581-20C>T	MAP2K2		not provided	VCV000388631	19	4101161	19	4101163	388631	376555	rs1057523179	NC_000019.10:4101162:G:A	single nucleotide variant	intron variant	Likely benign	Aug 22, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.581-29G>A	MAP2K2		not provided	VCV001241239	19	4101170	19	4101172	1241239	49279	rs377061653	NC_000019.10:4101171:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.580+39G>T	MAP2K2		not provided	VCV001268906	19	4101188	19	4101190	1268906	1261337	rs374098881	NC_000019.10:4101189:C:A	single nucleotide variant	intron variant	Benign	Oct 18, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+31C>T	MAP2K2		not provided	VCV001294178	19	4101196	19	4101198	1294178	1283977	rs376421011	NC_000019.10:4101197:G:A	single nucleotide variant	intron variant	Benign	Feb 13, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+18C>T	MAP2K2		RASopathy	VCV002190970	19	4101209	19	4101211	2190970	1912014		NC_000019.10:4101210:G:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+15G>A	MAP2K2		not specified|not provided|RASopathy	VCV000379104	19	4101212	19	4101214	379104	377530	rs370921720	NC_000019.10:4101213:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.580+14C>T	MAP2K2		not provided|RASopathy	VCV000379086	19	4101213	19	4101215	379086	379592	rs544557960	NC_000019.10:4101214:G:A	single nucleotide variant	intron variant	Likely benign	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.580+12C>T	MAP2K2		RASopathy	VCV001969002	19	4101215	19	4101217	1969002	2025140		NC_000019.10:4101216:G:A	single nucleotide variant	intron variant	Likely benign	Jun 28, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+10A>T	MAP2K2		RASopathy	VCV003626823	19	4101217	19	4101219	3626823	3755464		NC_000019.10:4101218:T:A	single nucleotide variant	intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.578_580+9del	MAP2K2		RASopathy	VCV002051554	19	4101218 - 4101229	19	4101220 - 4101231	2051554	2108145		NC_000019.10:4101219:GGGCCTTACCTCGG:GG	Deletion	splice donor variant	Uncertain significance	Feb 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+8C>T	MAP2K2		RASopathy	VCV001982949	19	4101219	19	4101221	1982949	2035708		NC_000019.10:4101220:G:A	single nucleotide variant	intron variant	Likely benign	May 2, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+6G>A	MAP2K2		RASopathy	VCV000040808	19	4101221	19	4101223	40808	49278	rs201435249	NC_000019.10:4101222:C:T	single nucleotide variant	intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.580+5G>C	MAP2K2		RASopathy	VCV002196119	19	4101222	19	4101224	2196119	1923592		NC_000019.10:4101223:C:G	single nucleotide variant	intron variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+5G>A	MAP2K2		not provided	VCV000280460	19	4101222	19	4101224	280460	265077	rs886041663	NC_000019.10:4101223:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 1, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.580+3A>G	MAP2K2		RASopathy	VCV003619639	19	4101224	19	4101226	3619639	3756661		NC_000019.10:4101225:T:C	single nucleotide variant	intron variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.578G>A (p.Arg193Gln)	MAP2K2	R193Q	not specified|RASopathy|MAP2K2-related disorder|Cardiovascular phenotype	VCV000179899	19	4101229	19	4101231	179899	176171	rs530342723	NC_000019.10:4101230:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.577C>T (p.Arg193Ter)	MAP2K2	R193*	Cardiovascular phenotype|RASopathy	VCV000955822	19	4101230	19	4101232	955822	950800	rs2041005560	NC_000019.10:4101231:G:A	single nucleotide variant	nonsense	Uncertain significance	Dec 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.572T>C (p.Met191Thr)	MAP2K2	M191T	RASopathy	VCV002986623	19	4101235	19	4101237	2986623	3143115		NC_000019.10:4101236:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.570C>A (p.Ile190=)	MAP2K2		RASopathy	VCV002149905	19	4101237	19	4101239	2149905	1881371		NC_000019.10:4101238:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.570C>T (p.Ile190=)	MAP2K2		RASopathy	VCV001079144	19	4101237	19	4101239	1079144	1084744	rs748355174	NC_000019.10:4101238:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.567dup (p.Ile190fs)	MAP2K2	I190fs	RASopathy	VCV002833639	19	4101239 - 4101240	19	4101241 - 4101242	2833639	2998579		NC_000019.10:4101241:C:CC	Duplication	frameshift variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.567G>A (p.Gln189=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV002450617	19	4101240	19	4101242	2450617	2423103		NC_000019.10:4101241:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.565C>G (p.Gln189Glu)	MAP2K2	Q189E	RASopathy	VCV002002328	19	4101242	19	4101244	2002328	2061552		NC_000019.10:4101243:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.564C>T (p.His188=)	MAP2K2		Cardiovascular phenotype|not specified	VCV000163958	19	4101243	19	4101245	163958	176030	rs546749336	NC_000019.10:4101244:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.558G>T (p.Glu186Asp)	MAP2K2	E186D	RASopathy	VCV001353966	19	4101249	19	4101251	1353966	1496085	rs2145055150	NC_000019.10:4101250:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.556G>C (p.Glu186Gln)	MAP2K2	E186Q	not provided|RASopathy	VCV000945704	19	4101251	19	4101253	945704	928974	rs1469284383	NC_000019.10:4101252:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.554G>A (p.Arg185Gln)	MAP2K2	R185Q	RASopathy|not provided	VCV001389303	19	4101253	19	4101255	1389303	1476882	rs772139417	NC_000019.10:4101254:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.553C>T (p.Arg185Ter)	MAP2K2	R185*	Cardiofaciocutaneous syndrome 4|RASopathy	VCV000837134	19	4101254	19	4101256	837134	847722	rs1390219813	NC_000019.10:4101255:G:A	single nucleotide variant	nonsense	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.551T>C (p.Leu184Pro)	MAP2K2	L184P	RASopathy	VCV002086788	19	4101256	19	4101258	2086788	2140829		NC_000019.10:4101257:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.548A>G (p.Tyr183Cys)	MAP2K2	Y183C	RASopathy	VCV002764236	19	4101259	19	4101261	2764236	2931439		NC_000019.10:4101260:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.547T>C (p.Tyr183His)	MAP2K2	Y183H	RASopathy	VCV001716286	19	4101260	19	4101262	1716286	1771583		NC_000019.10:4101261:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.546G>T (p.Ala182=)	MAP2K2		Cardiovascular phenotype	VCV001747733	19	4101261	19	4101263	1747733	1800031		NC_000019.10:4101262:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.546G>C (p.Ala182=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001083103	19	4101261	19	4101263	1083103	1084745	rs141402203	NC_000019.10:4101262:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.546G>A (p.Ala182=)	MAP2K2		RASopathy	VCV000138158	19	4101261	19	4101263	138158	141861	rs141402203	NC_000019.10:4101262:C:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.545C>T (p.Ala182Val)	MAP2K2	A182V	RASopathy	VCV002055057	19	4101262	19	4101264	2055057	49277		NC_000019.10:4101263:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.543G>A (p.Leu181=)	MAP2K2		RASopathy	VCV002908350	19	4101264	19	4101266	2908350	3069948		NC_000019.10:4101265:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.542T>C (p.Leu181Ser)	MAP2K2	L181S	RASopathy|Cardiovascular phenotype	VCV002129638	19	4101265	19	4101267	2129638	2191062		NC_000019.10:4101266:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.541T>A (p.Leu181Met)	MAP2K2	L181M	not specified	VCV000372637	19	4101266	19	4101268	372637	360428	rs1057517898	NC_000019.10:4101267:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.540C>T (p.Gly180=)	MAP2K2		Cardiovascular phenotype	VCV001747357	19	4101267	19	4101269	1747357	1803108		NC_000019.10:4101268:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.539G>A (p.Gly180Asp)	MAP2K2	G180D	RASopathy	VCV002986945	19	4101268	19	4101270	2986945	3143436		NC_000019.10:4101269:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.538G>T (p.Gly180Cys)	MAP2K2	G180C	not provided|RASopathy	VCV001677409	19	4101269	19	4101271	1677409	1669099	rs1336312423	NC_000019.10:4101270:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.536_537delinsTT (p.Arg179Leu)	MAP2K2	R179L	RASopathy	VCV002842098	19	4101270 - 4101271	19	4101272 - 4101273	2842098	3000635		NC_000019.10:4101271:CC:AA	Indel	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.537G>A (p.Arg179=)	MAP2K2		RASopathy	VCV002771423	19	4101270	19	4101272	2771423	2933439		NC_000019.10:4101271:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.536G>A (p.Arg179Gln)	MAP2K2	R179Q	Cardiovascular phenotype|MAP2K2-related disorder|RASopathy|Cardiofaciocutaneous syndrome 4|not provided	VCV000280819	19	4101271	19	4101273	280819	265085	rs776316565	NC_000019.10:4101272:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.535C>T (p.Arg179Trp)	MAP2K2	R179W	RASopathy	VCV000180905	19	4101272	19	4101274	180905	179825	rs370799450	NC_000019.10:4101273:G:A	single nucleotide variant	missense variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.534C>G (p.Leu178=)	MAP2K2		not specified|RASopathy	VCV000703696	19	4101273	19	4101275	703696	694426	rs765573431	NC_000019.10:4101274:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.532C>G (p.Leu178Val)	MAP2K2	L178V	RASopathy	VCV002894153	19	4101275	19	4101277	2894153	3046085		NC_000019.10:4101276:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.531T>C (p.Val177=)	MAP2K2		not specified|Cardiovascular phenotype|RASopathy	VCV000632884	19	4101276	19	4101278	632884	621635	rs528169616	NC_000019.10:4101277:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 10, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.529-2A>C	MAP2K2		RASopathy	VCV001394515	19	4101280	19	4101282	1394515	1338537	rs2145055278	NC_000019.10:4101281:T:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-5T>C	MAP2K2		not specified|RASopathy|not provided	VCV000261932	19	4101283	19	4101285	261932	257129	rs766943752	NC_000019.10:4101284:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.529-7C>G	MAP2K2		RASopathy	VCV002056696	19	4101285	19	4101287	2056696	2109399		NC_000019.10:4101286:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-10T>C	MAP2K2		not specified	VCV000516995	19	4101288	19	4101290	516995	507388	rs551098822	NC_000019.10:4101289:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 5, 2021	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.529-11C>A	MAP2K2		not provided	VCV001261100	19	4101289	19	4101291	1261100	49276	rs373939499	NC_000019.10:4101290:G:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-12G>A	MAP2K2		not specified|RASopathy	VCV000138157	19	4101290	19	4101292	138157	141860	rs375701469	NC_000019.10:4101291:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.529-13C>T	MAP2K2		RASopathy	VCV001593229	19	4101291	19	4101293	1593229	1589301	rs752950899	NC_000019.10:4101292:G:A	single nucleotide variant	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-14G>T	MAP2K2		RASopathy	VCV001581564	19	4101292	19	4101294	1581564	1600123	rs756414078	NC_000019.10:4101293:C:A	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-14G>A	MAP2K2		not provided|RASopathy	VCV000378976	19	4101292	19	4101294	378976	377688	rs756414078	NC_000019.10:4101293:C:T	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.529-15C>T	MAP2K2		RASopathy|not specified	VCV000261931	19	4101293	19	4101295	261931	257130	rs778783152	NC_000019.10:4101294:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.529-18C>G	MAP2K2		RASopathy	VCV001601893	19	4101296	19	4101298	1601893	1633019	rs951927130	NC_000019.10:4101297:G:C	single nucleotide variant	intron variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-26G>A	MAP2K2		not provided	VCV001291239	19	4101304	19	4101306	1291239	49275	rs139730969	NC_000019.10:4101305:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-27C>A	MAP2K2		not provided	VCV001175526	19	4101305	19	4101307	1175526	1165126	rs371369471	NC_000019.10:4101306:G:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-49C>G	MAP2K2		not provided	VCV001282687	19	4101327	19	4101329	1282687	1271256	rs370241745	NC_000019.10:4101328:G:C	single nucleotide variant	intron variant	Benign	Jul 12, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.529-138G>A	MAP2K2		not provided	VCV000561435	19	4101416	19	4101418	561435	553037	rs73536061	NC_000019.10:4101417:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+242T>G	MAP2K2		not provided	VCV000561536	19	4102132	19	4102134	561536	553038	rs12610112	NC_000019.10:4102133:A:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+237T>C	MAP2K2		not provided	VCV000561627	19	4102137	19	4102139	561627	553039	rs8100110	NC_000019.10:4102138:A:G	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+118A>G	MAP2K2		not provided	VCV001226034	19	4102256	19	4102258	1226034	1214716	rs116475330	NC_000019.10:4102257:T:C	single nucleotide variant	intron variant	Benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+46C>T	MAP2K2		not provided|not specified	VCV000261930	19	4102328	19	4102330	261930	257131	rs377101954	NC_000019.10:4102329:G:A	single nucleotide variant	intron variant	Benign	Dec 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+26C>T	MAP2K2		not provided	VCV001198548	19	4102348	19	4102350	1198548	1188779	rs73918027	NC_000019.10:4102349:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+19_528+20inv	MAP2K2		RASopathy	VCV002740447	19	4102354 - 4102355	19	4102356 - 4102357	2740447	2906387		NC_000019.10:4102355:TG:CA	Inversion	intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+20A>G	MAP2K2		RASopathy|not specified|not provided	VCV000040804	19	4102354	19	4102356	40804	49274	rs73918030	NC_000019.10:4102355:T:C	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+19C>T	MAP2K2		RASopathy	VCV001564801	19	4102355	19	4102357	1564801	1567755	rs769390409	NC_000019.10:4102356:G:A	single nucleotide variant	intron variant	Likely benign	Jul 22, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+17C>G	MAP2K2		RASopathy|not specified	VCV001585957	19	4102357	19	4102359	1585957	1593602	rs772831774	NC_000019.10:4102358:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 22, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.528+15G>A	MAP2K2		RASopathy	VCV002984833	19	4102359	19	4102361	2984833	3142619		NC_000019.10:4102360:C:T	single nucleotide variant	intron variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+12G>T	MAP2K2		RASopathy	VCV002708025	19	4102362	19	4102364	2708025	2874190		NC_000019.10:4102363:C:A	single nucleotide variant	intron variant	Likely benign	Jun 10, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+12G>A	MAP2K2		RASopathy	VCV002015069	19	4102362	19	4102364	2015069	2071719		NC_000019.10:4102363:C:T	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+11C>T	MAP2K2		RASopathy|not specified|not provided	VCV000378106	19	4102363	19	4102365	378106	377704	rs369913089	NC_000019.10:4102364:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528+10C>T	MAP2K2		RASopathy	VCV003622526	19	4102364	19	4102366	3622526	3760424		NC_000019.10:4102365:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+7C>G	MAP2K2		RASopathy	VCV003614612	19	4102367	19	4102369	3614612	3742131		NC_000019.10:4102368:G:C	single nucleotide variant	intron variant	Likely benign	May 14, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+7C>T	MAP2K2		RASopathy	VCV001101387	19	4102367	19	4102369	1101387	1106528	rs774589111	NC_000019.10:4102368:G:A	single nucleotide variant	intron variant	Likely benign	Sep 25, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+6T>C	MAP2K2		RASopathy	VCV001389480	19	4102368	19	4102370	1389480	1376960	rs2145057390	NC_000019.10:4102369:A:G	single nucleotide variant	intron variant	Uncertain significance	Oct 26, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+1dup	MAP2K2		not provided	VCV002649028	19	4102372 - 4102373	19	4102374 - 4102375	2649028	2815195		NC_000019.10:4102374:CC:CCC	Duplication	splice donor variant	Uncertain significance	Jul 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528G>C (p.Ala176=)	MAP2K2		not specified|RASopathy	VCV002896001	19	4102374	19	4102376	2896001	3066683		NC_000019.10:4102375:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.528G>A (p.Ala176=)	MAP2K2		Cardiofaciocutaneous syndrome 4|RASopathy	VCV001174505	19	4102374	19	4102376	1174505	1163747	rs767939999	NC_000019.10:4102375:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Jul 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.527C>T (p.Ala176Val)	MAP2K2	A176V	Cardiovascular phenotype|RASopathy	VCV001363165	19	4102375	19	4102377	1363165	1489025	rs775661458	NC_000019.10:4102376:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.526G>A (p.Ala176Thr)	MAP2K2	A176T	RASopathy|Cardiovascular phenotype	VCV001746497	19	4102376	19	4102378	1746497	49273	rs767381558	NC_000019.10:4102377:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.525C>T (p.Ile175=)	MAP2K2		RASopathy	VCV000046239	19	4102377	19	4102379	46239	55404	rs150833333	NC_000019.10:4102378:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.523A>G (p.Ile175Val)	MAP2K2	I175V	Noonan syndrome	VCV000620597	19	4102379	19	4102381	620597	612026	rs373325880	NC_000019.10:4102380:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.521G>C (p.Ser174Thr)	MAP2K2	S174T	RASopathy	VCV001375883	19	4102381	19	4102383	1375883	1470269	rs2145057459	NC_000019.10:4102382:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.520A>G (p.Ser174Gly)	MAP2K2	S174G	not provided	VCV001809665	19	4102382	19	4102384	1809665	1866669		NC_000019.10:4102383:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.518T>C (p.Val173Ala)	MAP2K2	V173A	RASopathy	VCV001972681	19	4102384	19	4102386	1972681	2026240		NC_000019.10:4102385:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.516A>G (p.Lys172=)	MAP2K2		not specified	VCV000261929	19	4102386	19	4102388	261929	257132	rs886038699	NC_000019.10:4102387:T:C	single nucleotide variant	synonymous variant	Likely benign		criteria provided, single submitter							
NM_030662.4(MAP2K2):c.515A>G (p.Lys172Arg)	MAP2K2	K172R	RASopathy	VCV001045343	19	4102387	19	4102389	1045343	1034322	rs1218364046	NC_000019.10:4102388:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.514A>G (p.Lys172Glu)	MAP2K2	K172E	Pain|Migraine|Mitral valve prolapse|Thin skin|High palate|Hypotension|Malar flattening|Abnormal facial shape|Short stature|RASopathy	VCV000523536	19	4102388	19	4102390	523536	514098	rs1413580671	NC_000019.10:4102389:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.513G>A (p.Gly171=)	MAP2K2		RASopathy	VCV002834959	19	4102389	19	4102391	2834959	3002011		NC_000019.10:4102390:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.510G>A (p.Leu170=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001147575	19	4102392	19	4102394	1147575	1148869	rs754109836	NC_000019.10:4102393:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.508C>T (p.Leu170=)	MAP2K2		RASopathy	VCV002024999	19	4102394	19	4102396	2024999	2088040		NC_000019.10:4102395:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.500A>G (p.Glu167Gly)	MAP2K2	E167G	Cardiofaciocutaneous syndrome 4	VCV003583904	19	4102402	19	4102404	3583904	3709754		NC_000019.10:4102403:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.499G>A (p.Glu167Lys)	MAP2K2	E167K	RASopathy	VCV001490428	19	4102403	19	4102405	1490428	1433497	rs1457335620	NC_000019.10:4102404:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.498C>G (p.Pro166=)	MAP2K2		Cardiovascular phenotype	VCV003228055	19	4102404	19	4102406	3228055	3387824		NC_000019.10:4102405:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.498C>T (p.Pro166=)	MAP2K2		RASopathy	VCV000040802	19	4102404	19	4102406	40802	49272	rs139404261	NC_000019.10:4102405:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.491G>A (p.Arg164Lys)	MAP2K2	R164K	Cardiofaciocutaneous syndrome 4	VCV003583905	19	4102411	19	4102413	3583905	3709755		NC_000019.10:4102412:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.491G>T (p.Arg164Met)	MAP2K2	R164M	RASopathy|Cardiofaciocutaneous syndrome 4|not specified	VCV000571542	19	4102411	19	4102413	571542	574979	rs751317148	NC_000019.10:4102412:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.488A>G (p.Lys163Arg)	MAP2K2	K163R	RASopathy	VCV003623365	19	4102414	19	4102416	3623365	3754620		NC_000019.10:4102415:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.485C>T (p.Ala162Val)	MAP2K2	A162V	RASopathy|not provided	VCV001216269	19	4102417	19	4102419	1216269	49271	rs376299424	NC_000019.10:4102418:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.484G>A (p.Ala162Thr)	MAP2K2	A162T	Cardiovascular phenotype	VCV001743562	19	4102418	19	4102420	1743562	1801909		NC_000019.10:4102419:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.479A>G (p.Lys160Arg)	MAP2K2	K160R	not provided	VCV001315090	19	4102423	19	4102425	1315090	1305351	rs2041027193	NC_000019.10:4102424:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.477G>A (p.Leu159=)	MAP2K2		not specified|Cardiovascular phenotype|RASopathy	VCV000544017	19	4102425	19	4102427	544017	533548	rs748135585	NC_000019.10:4102426:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.475C>G (p.Leu159Val)	MAP2K2	L159V	not provided	VCV000392551	19	4102427	19	4102429	392551	376562	rs755613777	NC_000019.10:4102428:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.474G>A (p.Val158=)	MAP2K2		Cardiovascular phenotype|not specified|not provided|RASopathy	VCV000050939	19	4102428	19	4102430	50939	65600	rs370736371	NC_000019.10:4102429:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.464T>C (p.Leu155Pro)	MAP2K2	L155P	Cardiofaciocutaneous syndrome 4	VCV003583906	19	4102438	19	4102440	3583906	3709756		NC_000019.10:4102439:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.463C>T (p.Leu155=)	MAP2K2		RASopathy	VCV002040655	19	4102439	19	4102441	2040655	2098548		NC_000019.10:4102440:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.459C>A (p.Gly153=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV001574549	19	4102443	19	4102445	1574549	1659734	rs746241325	NC_000019.10:4102444:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.457G>A (p.Gly153Ser)	MAP2K2	G153S	Cardiovascular phenotype|Cardiofaciocutaneous syndrome 4|RASopathy	VCV001470832	19	4102445	19	4102447	1470832	1395059	rs772534863	NC_000019.10:4102446:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.456C>T (p.Gly152=)	MAP2K2		not provided|not specified|RASopathy|Cardiovascular phenotype	VCV000512068	19	4102446	19	4102448	512068	506831	rs143106439	NC_000019.10:4102447:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.455G>A (p.Gly152Asp)	MAP2K2	G152D	not provided	VCV002502097	19	4102447	19	4102449	2502097	2534307		NC_000019.10:4102448:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.454G>T (p.Gly152Cys)	MAP2K2	G152C	RASopathy	VCV002132736	19	4102448	19	4102450	2132736	2186737		NC_000019.10:4102449:C:A	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.454G>A (p.Gly152Ser)	MAP2K2	G152S	not provided|RASopathy	VCV000423276	19	4102448	19	4102450	423276	410617	rs910514546	NC_000019.10:4102449:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.453C>G (p.Asp151Glu)	MAP2K2	D151E	not provided|RASopathy	VCV000543996	19	4102449	19	4102451	543996	533550	rs17851657	NC_000019.10:4102450:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.453C>T (p.Asp151=)	MAP2K2		RASopathy	VCV000046237	19	4102449	19	4102451	46237	55402	rs17851657	NC_000019.10:4102450:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.451-4C>T	MAP2K2		RASopathy	VCV002822077	19	4102455	19	4102457	2822077	2981880		NC_000019.10:4102456:G:A	single nucleotide variant	intron variant	Likely benign	Dec 18, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-6C>G	MAP2K2		RASopathy	VCV001900726	19	4102457	19	4102459	1900726	1963556		NC_000019.10:4102458:G:C	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-6C>T	MAP2K2		RASopathy|not provided	VCV001263214	19	4102457	19	4102459	1263214	49270	rs776864612	NC_000019.10:4102458:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.451-7C>T	MAP2K2		not provided|RASopathy|not specified	VCV000700123	19	4102458	19	4102460	700123	690216	rs780396876	NC_000019.10:4102459:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 9, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.451-9G>A	MAP2K2		not specified	VCV000928894	19	4102460	19	4102462	928894	917556	rs765412949	NC_000019.10:4102461:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 26, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-11G>C	MAP2K2		RASopathy	VCV003611412	19	4102462	19	4102464	3611412	3744978		NC_000019.10:4102463:C:G	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-11G>A	MAP2K2		RASopathy	VCV002099717	19	4102462	19	4102464	2099717	2147275		NC_000019.10:4102463:C:T	single nucleotide variant	intron variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-14T>C	MAP2K2		RASopathy	VCV001622743	19	4102465	19	4102467	1622743	1627369	rs2145057945	NC_000019.10:4102466:A:G	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-15T>G	MAP2K2		not provided	VCV001286227	19	4102466	19	4102468	1286227	49269	rs751324814	NC_000019.10:4102467:A:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-20_451-17del	MAP2K2		RASopathy	VCV002999228	19	4102468 - 4102471	19	4102470 - 4102473	2999228	3167278		NC_000019.10:4102469:GAGTGAGTG:GAGTG	Microsatellite	intron variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-19C>A	MAP2K2		RASopathy	VCV001619265	19	4102470	19	4102472	1619265	1614813	rs754710131	NC_000019.10:4102471:G:T	single nucleotide variant	intron variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-44G>A	MAP2K2		not provided	VCV001221737	19	4102495	19	4102497	1221737	49268	rs1286002004	NC_000019.10:4102496:C:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-45G>A	MAP2K2		not provided	VCV001274350	19	4102496	19	4102498	1274350	1262525	rs745572112	NC_000019.10:4102497:C:T	single nucleotide variant	intron variant	Benign	Jan 29, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-69G>C	MAP2K2		not provided	VCV001231335	19	4102520	19	4102522	1231335	49267	rs113143475	NC_000019.10:4102521:C:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-79C>T	MAP2K2		not provided	VCV001233589	19	4102530	19	4102532	1233589	49266	rs113772802	NC_000019.10:4102531:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.451-135C>T	MAP2K2		not provided	VCV001259004	19	4102586	19	4102588	1259004	49265	rs149449675	NC_000019.10:4102587:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.451-172A>G	MAP2K2		not provided	VCV001245216	19	4102623	19	4102625	1245216	1235169	rs2289858	NC_000019.10:4102624:T:C	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+307C>A	MAP2K2		not provided	VCV000561879	19	4110200	19	4110202	561879	553040	rs62132103	NC_000019.10:4110201:G:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+189C>G	MAP2K2		not provided	VCV001249691	19	4110318	19	4110320	1249691	1241316	rs12981086	NC_000019.10:4110319:G:C	single nucleotide variant	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+99A>G	MAP2K2		not provided	VCV000561374	19	4110408	19	4110410	561374	553041	rs12975436	NC_000019.10:4110409:T:C	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+40C>T	MAP2K2		not provided	VCV001202988	19	4110467	19	4110469	1202988	1195415	rs140556662	NC_000019.10:4110468:G:A	single nucleotide variant	intron variant	Likely benign	Jul 9, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+29C>T	MAP2K2		not provided	VCV001234928	19	4110478	19	4110480	1234928	1222758	rs201076824	NC_000019.10:4110479:G:A	single nucleotide variant	intron variant	Benign	Dec 18, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+22G>A	MAP2K2		not provided	VCV001193677	19	4110485	19	4110487	1193677	1185487	rs767239143	NC_000019.10:4110486:C:T	single nucleotide variant	intron variant	Likely benign	Dec 15, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+20G>A	MAP2K2		not specified|RASopathy	VCV000506349	19	4110487	19	4110489	506349	507044	rs374143146	NC_000019.10:4110488:C:T	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+18A>G	MAP2K2		RASopathy	VCV002071684	19	4110489	19	4110491	2071684	2123061		NC_000019.10:4110490:T:C	single nucleotide variant	intron variant	Likely benign	Feb 27, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+17C>T	MAP2K2		RASopathy|Cardiofaciocutaneous syndrome 4|not specified|not provided	VCV000378105	19	4110490	19	4110492	378105	379593	rs199892711	NC_000019.10:4110491:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+15G>T	MAP2K2		not provided|RASopathy|not specified	VCV000040794	19	4110492	19	4110494	40794	49264	rs10424545	NC_000019.10:4110493:C:A	single nucleotide variant	intron variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+14G>A	MAP2K2		not specified|RASopathy	VCV000046236	19	4110493	19	4110495	46236	55401	rs397517414	NC_000019.10:4110494:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 19, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.450+13G>A	MAP2K2		not specified|RASopathy	VCV000178864	19	4110494	19	4110496	178864	176172	rs572847821	NC_000019.10:4110495:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+12C>T	MAP2K2		RASopathy|not provided	VCV000378104	19	4110495	19	4110497	378104	377707	rs750513646	NC_000019.10:4110496:G:A	single nucleotide variant	intron variant	Likely benign	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+9G>T	MAP2K2		RASopathy	VCV001534365	19	4110498	19	4110500	1534365	1647933	rs375368051	NC_000019.10:4110499:C:A	single nucleotide variant	intron variant	Likely benign	Aug 17, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+9G>A	MAP2K2		Noonan syndrome and Noonan-related syndrome|RASopathy	VCV000701979	19	4110498	19	4110500	701979	690217	rs375368051	NC_000019.10:4110499:C:T	single nucleotide variant	intron variant	Likely benign	Mar 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+8C>T	MAP2K2		RASopathy	VCV002810370	19	4110499	19	4110501	2810370	2968898		NC_000019.10:4110500:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.450+5G>A	MAP2K2		RASopathy|Cardiovascular phenotype	VCV002230673	19	4110502	19	4110504	2230673	2216238		NC_000019.10:4110503:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.450+3G>A	MAP2K2		RASopathy	VCV002977294	19	4110504	19	4110506	2977294	3141119		NC_000019.10:4110505:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.449T>C (p.Met150Thr)	MAP2K2	M150T	not specified|RASopathy|not provided	VCV001677627	19	4110508	19	4110510	1677627	1669317	rs1441349097	NC_000019.10:4110509:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.447C>T (p.His149=)	MAP2K2		RASopathy	VCV001079198	19	4110510	19	4110512	1079198	1084746	rs771338833	NC_000019.10:4110511:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.433A>G (p.Ile145Val)	MAP2K2	I145V	Cardiofaciocutaneous syndrome 4|RASopathy	VCV000850397	19	4110524	19	4110526	850397	847723	rs2041140457	NC_000019.10:4110525:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.429C>T (p.Ile143=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV000699612	19	4110528	19	4110530	699612	689063	rs769762171	NC_000019.10:4110529:G:A	single nucleotide variant	synonymous variant	Likely benign	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.423G>A (p.Gly141=)	MAP2K2		Cardiovascular phenotype|RASopathy	VCV001116486	19	4110534	19	4110536	1116486	1106529	rs140136082	NC_000019.10:4110535:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.420C>T (p.Asp140=)	MAP2K2		RASopathy	VCV000046235	19	4110537	19	4110539	46235	55400	rs369925884	NC_000019.10:4110538:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.419A>C (p.Asp140Ala)	MAP2K2	D140A	RASopathy	VCV001721610	19	4110538	19	4110540	1721610	1772944		NC_000019.10:4110539:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.415A>G (p.Ser139Gly)	MAP2K2	S139G	Cardiovascular phenotype	VCV001738318	19	4110542	19	4110544	1738318	1797552		NC_000019.10:4110543:T:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.413A>G (p.Tyr138Cys)	MAP2K2	Y138C	RASopathy	VCV003623293	19	4110544	19	4110546	3623293	3754548		NC_000019.10:4110545:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.405G>A (p.Gly135=)	MAP2K2		Cardiovascular phenotype	VCV003228054	19	4110552	19	4110554	3228054	3387823		NC_000019.10:4110553:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.405G>C (p.Gly135=)	MAP2K2		RASopathy	VCV000040793	19	4110552	19	4110554	40793	49263	rs10424722	NC_000019.10:4110553:C:G	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.404G>T (p.Gly135Val)	MAP2K2	G135V	Cardiofaciocutaneous syndrome 4	VCV003061850	19	4110553	19	4110555	3061850	3222078		NC_000019.10:4110554:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 15, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.403G>A (p.Gly135Arg)	MAP2K2	G135R	not provided|RASopathy	VCV002190492	19	4110554	19	4110556	2190492	1915308		NC_000019.10:4110555:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.402C>T (p.Tyr134=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV000544004	19	4110555	19	4110557	544004	533554	rs753713281	NC_000019.10:4110556:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys)	MAP2K2	Y134C	Cardio-facio-cutaneous syndrome	VCV000177868	19	4110556	19	4110558	177868	176031	rs727504370	NC_000019.10:4110557:T:C	single nucleotide variant	missense variant	Pathogenic	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His)	MAP2K2	Y134H	RASopathy	VCV000008274	19	4110557	19	4110559	8274	23313	rs121434499	NC_000019.10:4110558:A:G	single nucleotide variant	missense variant	Likely pathogenic	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.399C>T (p.Phe133=)	MAP2K2		Cardiovascular phenotype|not specified|RASopathy	VCV000496474	19	4110558	19	4110560	496474	488055	rs145524962	NC_000019.10:4110559:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.395G>T (p.Gly132Val)	MAP2K2	G132V	RASopathy	VCV001495968	19	4110562	19	4110564	1495968	1362883	rs387906800	NC_000019.10:4110563:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 3, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp)	MAP2K2	G132D	not provided|Cardiofaciocutaneous syndrome 4	VCV000030170	19	4110562	19	4110564	30170	39126	rs387906800	NC_000019.10:4110563:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.391G>T (p.Val131Leu)	MAP2K2	V131L	RASopathy|Cardiofaciocutaneous syndrome 4|Cardiovascular phenotype	VCV001736188	19	4110566	19	4110568	1736188	1796722		NC_000019.10:4110567:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.391G>A (p.Val131Met)	MAP2K2	V131M	not specified|RASopathy	VCV000046234	19	4110566	19	4110568	46234	55399	rs397517413	NC_000019.10:4110567:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.390C>T (p.Ile130=)	MAP2K2		not specified|RASopathy|Cardiovascular phenotype	VCV000544018	19	4110567	19	4110569	544018	533110	rs749956316	NC_000019.10:4110568:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.388A>G (p.Ile130Val)	MAP2K2	I130V	RASopathy|Cardiovascular phenotype	VCV001447640	19	4110569	19	4110571	1447640	1403527	rs1263759203	NC_000019.10:4110570:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.386A>G (p.Tyr129Cys)	MAP2K2	Y129C	RASopathy	VCV002763220	19	4110571	19	4110573	2763220	2928281		NC_000019.10:4110572:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.386A>C (p.Tyr129Ser)	MAP2K2	Y129S	RASopathy	VCV002739363	19	4110571	19	4110573	2739363	2899716		NC_000019.10:4110572:T:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.384G>A (p.Pro128=)	MAP2K2		not specified|RASopathy|Cardiovascular phenotype	VCV000163959	19	4110573	19	4110575	163959	176173	rs727503156	NC_000019.10:4110574:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.383C>T (p.Pro128Leu)	MAP2K2	P128L	not provided	VCV000666272	19	4110574	19	4110576	666272	653829	rs267607230	NC_000019.10:4110575:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.383C>G (p.Pro128Arg)	MAP2K2	P128R	not specified	VCV000040792	19	4110574	19	4110576	40792	49262	rs267607230	NC_000019.10:4110575:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2014	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln)	MAP2K2		RASopathy	VCV000008275	19	4110574	19	4110576	8275	23314	rs267607230	NC_000019.10:4110575:G:T	single nucleotide variant	missense variant	Pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_030662.4(MAP2K2):c.381G>A (p.Ser127=)	MAP2K2		RASopathy	VCV001555095	19	4110576	19	4110578	1555095	1564839	rs751309637	NC_000019.10:4110577:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.380C>T (p.Ser127Leu)	MAP2K2	S127L	not provided|RASopathy	VCV000573141	19	4110577	19	4110579	573141	570804	rs1568260052	NC_000019.10:4110578:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.377A>G (p.Asn126Ser)	MAP2K2	N126S	Cardiovascular phenotype	VCV001734825	19	4110580	19	4110582	1734825	1796617		NC_000019.10:4110581:T:C	single nucleotide variant	missense variant	Uncertain significance	May 24, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.376A>C (p.Asn126His)	MAP2K2	N126H	RASopathy	VCV000651646	19	4110581	19	4110583	651646	648137	rs1057519806	NC_000019.10:4110582:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp)	MAP2K2	N126D	RASopathy|Cardiofaciocutaneous syndrome 4	VCV000376176	19	4110581	19	4110583	376176	363055	rs1057519806	NC_000019.10:4110582:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.370G>A (p.Glu124Lys)	MAP2K2	E124K	RASopathy	VCV001392557	19	4110587	19	4110589	1392557	1502460	rs1037950431	NC_000019.10:4110588:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.369C>T (p.His123=)	MAP2K2		not specified|Cardiovascular phenotype	VCV001734036	19	4110588	19	4110590	1734036	1789786		NC_000019.10:4110589:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.368A>C (p.His123Pro)	MAP2K2	H123P	not provided	VCV003364401	19	4110589	19	4110591	3364401	3523608		NC_000019.10:4110590:T:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 18, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.363C>A (p.Val121=)	MAP2K2		RASopathy	VCV002961761	19	4110594	19	4110596	2961761	3116923		NC_000019.10:4110595:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.363C>G (p.Val121=)	MAP2K2		RASopathy	VCV002916460	19	4110594	19	4110596	2916460	3079891		NC_000019.10:4110595:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.363C>T (p.Val121=)	MAP2K2		Cardiovascular phenotype	VCV001733484	19	4110594	19	4110596	1733484	1793105		NC_000019.10:4110595:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.360G>T (p.Gln120His)	MAP2K2	Q120H	not provided	VCV002499908	19	4110597	19	4110599	2499908	2477887		NC_000019.10:4110598:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.358C>G (p.Gln120Glu)	MAP2K2	Q120E	RASopathy	VCV001045401	19	4110599	19	4110601	1045401	1034323	rs2041142085	NC_000019.10:4110600:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.357G>A (p.Leu119=)	MAP2K2		not specified|RASopathy	VCV000632881	19	4110600	19	4110602	632881	621636	rs1377039329	NC_000019.10:4110601:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.356T>C (p.Leu119Pro)	MAP2K2	L119P	MAP2K2-related disorder	VCV002630781	19	4110601	19	4110603	2630781	2796536		NC_000019.10:4110602:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.352G>A (p.Glu118Lys)	MAP2K2	E118K	not specified|MAP2K2-related disorder	VCV000632882	19	4110605	19	4110607	632882	621637	rs756646033	NC_000019.10:4110606:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.351C>T (p.Arg117=)	MAP2K2		RASopathy	VCV001063560	19	4110606	19	4110608	1063560	1051330	rs777670871	NC_000019.10:4110607:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 1, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.351C>G (p.Arg117=)	MAP2K2		not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	VCV000516162	19	4110606	19	4110608	516162	507397	rs777670871	NC_000019.10:4110607:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 21, 2021	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.350G>A (p.Arg117His)	MAP2K2	R117H	RASopathy	VCV001937426	19	4110607	19	4110609	1937426	2000174		NC_000019.10:4110608:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.349C>T (p.Arg117Cys)	MAP2K2	R117C	RASopathy	VCV001524168	19	4110608	19	4110610	1524168	1382730	rs749389113	NC_000019.10:4110609:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.346A>G (p.Ile116Val)	MAP2K2	I116V	Cardiovascular phenotype	VCV003228053	19	4110611	19	4110613	3228053	3387822		NC_000019.10:4110612:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.339C>T (p.Asn113=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV001151854	19	4110618	19	4110620	1151854	1148870	rs2041142483	NC_000019.10:4110619:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.336G>C (p.Arg112=)	MAP2K2		Cardiovascular phenotype	VCV003292970	19	4110621	19	4110623	3292970	3446441		NC_000019.10:4110622:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.335G>A (p.Arg112Gln)	MAP2K2	R112Q	RASopathy|Cardiofaciocutaneous syndrome 4	VCV002055907	19	4110622	19	4110624	2055907	49261		NC_000019.10:4110623:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.335G>T (p.Arg112Leu)	MAP2K2	R112L	RASopathy|Cardiofaciocutaneous syndrome 4	VCV000837201	19	4110622	19	4110624	837201	847724	rs2041142587	NC_000019.10:4110623:C:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.334C>T (p.Arg112Trp)	MAP2K2	R112W	RASopathy	VCV001963465	19	4110623	19	4110625	1963465	2017136		NC_000019.10:4110624:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.333C>G (p.Ile111Met)	MAP2K2	I111M	not provided|RASopathy	VCV000963910	19	4110624	19	4110626	963910	950801	rs2041142671	NC_000019.10:4110625:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.331A>T (p.Ile111Phe)	MAP2K2	I111F	not provided|RASopathy|Cardiofaciocutaneous syndrome 4	VCV000432872	19	4110626	19	4110628	432872	426315	rs1555698031	NC_000019.10:4110627:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.329C>T (p.Ala110Val)	MAP2K2	A110V	not provided	VCV003602396	19	4110628	19	4110630	3602396	3735068		NC_000019.10:4110629:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.327G>A (p.Pro109=)	MAP2K2		not provided|RASopathy|Cardiovascular phenotype	VCV000378103	19	4110630	19	4110632	378103	377533	rs369156025	NC_000019.10:4110631:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.326C>T (p.Pro109Leu)	MAP2K2	P109L	RASopathy|not specified|Cardiofaciocutaneous syndrome 4|not provided	VCV000228849	19	4110631	19	4110633	228849	231026	rs544242665	NC_000019.10:4110632:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.325C>G (p.Pro109Ala)	MAP2K2	P109A	RASopathy	VCV000410630	19	4110632	19	4110634	410630	403729	rs1060502983	NC_000019.10:4110633:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.320T>A (p.Ile107Asn)	MAP2K2	I107N	not specified|not provided|RASopathy	VCV000040790	19	4110637	19	4110639	40790	49260	rs1555698037	NC_000019.10:4110638:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.317A>C (p.Glu106Ala)	MAP2K2	E106A	not provided	VCV002442537	19	4110640	19	4110642	2442537	2416248		NC_000019.10:4110641:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.315T>G (p.Leu105=)	MAP2K2		RASopathy|not provided	VCV000738007	19	4110642	19	4110644	738007	757038	rs761590887	NC_000019.10:4110643:A:C	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.313C>G (p.Leu105Val)	MAP2K2	L105V	not provided	VCV000180913	19	4110644	19	4110646	180913	179826	rs730880521	NC_000019.10:4110645:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.305T>C (p.Leu102Pro)	MAP2K2	L102P	RASopathy	VCV002913560	19	4110652	19	4110654	2913560	3076231		NC_000019.10:4110653:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-3C>G	MAP2K2		Cardiofaciocutaneous syndrome 4	VCV003583908	19	4110656	19	4110658	3583908	3709758		NC_000019.10:4110657:G:C	single nucleotide variant	intron variant	Uncertain significance	May 28, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-4G>A	MAP2K2		RASopathy	VCV002746488	19	4110657	19	4110659	2746488	2911998		NC_000019.10:4110658:C:T	single nucleotide variant	intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-7C>T	MAP2K2		not provided|RASopathy	VCV000386150	19	4110660	19	4110662	386150	379594	rs561127903	NC_000019.10:4110661:G:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.304-10C>A	MAP2K2		RASopathy	VCV002988360	19	4110663	19	4110665	2988360	3143557		NC_000019.10:4110664:G:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-11T>C	MAP2K2		RASopathy	VCV002998780	19	4110664	19	4110666	2998780	3156549		NC_000019.10:4110665:A:G	single nucleotide variant	intron variant	Likely benign	Jan 5, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-15C>G	MAP2K2		RASopathy	VCV001562809	19	4110668	19	4110670	1562809	1643220	rs2145070470	NC_000019.10:4110669:G:C	single nucleotide variant	intron variant	Likely benign	Mar 19, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-18G>A	MAP2K2		not provided|RASopathy	VCV001269898	19	4110671	19	4110673	1269898	1259755	rs766030589	NC_000019.10:4110672:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.304-19C>T	MAP2K2		RASopathy	VCV001645294	19	4110672	19	4110674	1645294	1599192	rs373352091	NC_000019.10:4110673:G:A	single nucleotide variant	intron variant	Likely benign	Dec 24, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-46G>A	MAP2K2		not provided	VCV001200154	19	4110699	19	4110701	1200154	1192169	rs112996316	NC_000019.10:4110700:C:T	single nucleotide variant	intron variant	Likely benign	Dec 7, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.304-127G>A	MAP2K2		not provided	VCV001223113	19	4110780	19	4110782	1223113	1212222	rs138469122	NC_000019.10:4110781:C:T	single nucleotide variant	intron variant	Likely benign	Aug 14, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+92_303+128del	MAP2K2		not provided	VCV001215625	19	4117289 - 4117325	19	4117291 - 4117327	1215625	1205606	rs541009313	NC_000019.10:4117290:GTGGGGATGAGGGACAGAGCCTGGAGCTAATCAGAATG:G	Deletion	intron variant	Likely benign	Jun 29, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+127A>G	MAP2K2		not provided	VCV000561366	19	4117290	19	4117292	561366	553042	rs350891	NC_000019.10:4117291:T:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+118C>G	MAP2K2		not provided	VCV001269659	19	4117299	19	4117301	1269659	1259517	rs74172621	NC_000019.10:4117300:G:C	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+46C>G	MAP2K2		not provided	VCV001270176	19	4117371	19	4117373	1270176	1258788	rs535653930	NC_000019.10:4117372:G:C	single nucleotide variant	intron variant	Benign	Feb 14, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+29G>A	MAP2K2		not provided	VCV001191151	19	4117388	19	4117390	1191151	1181764	rs180919929	NC_000019.10:4117389:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+18G>A	MAP2K2		Cardiofaciocutaneous syndrome 4|not specified|not provided|RASopathy	VCV000040789	19	4117399	19	4117401	40789	49259	rs116988721	NC_000019.10:4117400:C:T	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+17C>T	MAP2K2		RASopathy	VCV001561503	19	4117400	19	4117402	1561503	1554928	rs368897563	NC_000019.10:4117401:G:A	single nucleotide variant	intron variant	Likely benign	Jun 22, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+15G>A	MAP2K2		RASopathy	VCV001625928	19	4117402	19	4117404	1625928	1575143	rs373530124	NC_000019.10:4117403:C:T	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+15G>T	MAP2K2		RASopathy|not specified	VCV001409586	19	4117402	19	4117404	1409586	1340655	rs373530124	NC_000019.10:4117403:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+15del	MAP2K2		not provided|RASopathy	VCV000422217	19	4117402	19	4117404	422217	410618	rs758256765	NC_000019.10:4117403:CCCC:CCC	Deletion	intron variant	Benign/Likely benign	Jul 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+13G>T	MAP2K2		RASopathy	VCV002720061	19	4117404	19	4117406	2720061	2884446		NC_000019.10:4117405:C:A	single nucleotide variant	intron variant	Likely benign	Aug 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.303+12G>A	MAP2K2		RASopathy|not specified	VCV000046233	19	4117405	19	4117407	46233	55398	rs376432107	NC_000019.10:4117406:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+11C>T	MAP2K2		RASopathy|not specified	VCV000138166	19	4117406	19	4117408	138166	141869	rs200405512	NC_000019.10:4117407:G:A	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.303+8C>G	MAP2K2		RASopathy	VCV000177969	19	4117409	19	4117411	177969	176032	rs199612401	NC_000019.10:4117410:G:C	single nucleotide variant	intron variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.303+6C>T	MAP2K2		RASopathy	VCV002733304	19	4117411	19	4117413	2733304	2890764		NC_000019.10:4117412:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.300G>T (p.Arg100Ser)	MAP2K2	R100S	Cardiofaciocutaneous syndrome 4	VCV001032232	19	4117420	19	4117422	1032232	1021896	rs2041236830	NC_000019.10:4117421:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.288CAT[1] (p.Ile97del)	MAP2K2	I97del	RASopathy|Cardiofaciocutaneous syndrome 4	VCV000543989	19	4117427 - 4117429	19	4117429 - 4117431	543989	533115	rs1555698652	NC_000019.10:4117428:ATGATGA:ATGA	Microsatellite	inframe_deletion	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.292A>G (p.Met98Val)	MAP2K2	M98V	Cardiovascular phenotype|RASopathy	VCV001393224	19	4117428	19	4117430	1393224	1402951	rs1484288126	NC_000019.10:4117429:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.291C>T (p.Ile97=)	MAP2K2		RASopathy	VCV001547509	19	4117429	19	4117431	1547509	1624583	rs200918323	NC_000019.10:4117430:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.291C>G (p.Ile97Met)	MAP2K2	I97M	RASopathy|not specified|not provided	VCV000040788	19	4117429	19	4117431	40788	49258	rs200918323	NC_000019.10:4117430:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.291C>A (p.Ile97=)	MAP2K2		RASopathy	VCV000040787	19	4117429	19	4117431	40787	49257	rs200918323	NC_000019.10:4117430:G:T	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.289A>T (p.Ile97Phe)	MAP2K2	I97F	not specified|not provided|RASopathy	VCV000046232	19	4117431	19	4117433	46232	55397	rs373579939	NC_000019.10:4117432:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.288C>T (p.Leu96=)	MAP2K2		not provided	VCV003026736	19	4117432	19	4117434	3026736	3187046		NC_000019.10:4117433:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NC_000019.10:g.4117434_4117435delinsAC	MAP2K2	L96R	not specified|not provided	VCV000046231	19	4117432 - 4117433	19	4117434 - 4117435	46231	55396	rs397517412	NC_000019.10:4117433:GA:AC	Indel		Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.284G>A (p.Gly95Asp)	MAP2K2	G95D	Noonan syndrome and Noonan-related syndrome	VCV001334261	19	4117436	19	4117438	1334261	1325120	rs2145079750	NC_000019.10:4117437:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.282G>A (p.Ser94=)	MAP2K2		RASopathy|Cardiovascular phenotype	VCV001094015	19	4117438	19	4117440	1094015	1084747	rs1180688132	NC_000019.10:4117439:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 10, 2020	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.281C>T (p.Ser94Leu)	MAP2K2	S94L	RASopathy	VCV000040786	19	4117439	19	4117441	40786	49256	rs202220799	NC_000019.10:4117440:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.279C>G (p.Pro93=)	MAP2K2		RASopathy	VCV002202455	19	4117441	19	4117443	2202455	1931577		NC_000019.10:4117442:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.279C>T (p.Pro93=)	MAP2K2		RASopathy	VCV000416256	19	4117441	19	4117443	416256	403261	rs1060504778	NC_000019.10:4117442:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.277C>A (p.Pro93Thr)	MAP2K2	P93T	MAP2K2-related disorder	VCV002633388	19	4117443	19	4117445	2633388	2801605		NC_000019.10:4117444:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.274A>G (p.Arg92Gly)	MAP2K2	R92G	Cardiovascular phenotype|not specified|RASopathy|not provided	VCV000040772	19	4117446	19	4117448	40772	49242	rs759061964	NC_000019.10:4117447:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.270G>T (p.Gln90His)	MAP2K2	Q90H	RASopathy	VCV002877848	19	4117450	19	4117452	2877848	3039020		NC_000019.10:4117451:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.260C>T (p.Thr87Ile)	MAP2K2	T87I	not provided	VCV003252477	19	4117460	19	4117462	3252477	3411272		NC_000019.10:4117461:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.260C>A (p.Thr87Asn)	MAP2K2	T87N	not provided	VCV001298737	19	4117460	19	4117462	1298737	1288599	rs2145079918	NC_000019.10:4117461:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.258C>T (p.Val86=)	MAP2K2		not specified	VCV000512224	19	4117462	19	4117464	512224	507401	rs148437150	NC_000019.10:4117463:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.258C>A (p.Val86=)	MAP2K2		not specified|RASopathy|Cardiofaciocutaneous syndrome 4|not provided|Cardiovascular phenotype	VCV000046230	19	4117462	19	4117464	46230	55395	rs148437150	NC_000019.10:4117463:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.256G>A (p.Val86Ile)	MAP2K2	V86I	RASopathy	VCV002193043	19	4117464	19	4117466	2193043	1932192		NC_000019.10:4117465:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.255G>A (p.Val85=)	MAP2K2		RASopathy	VCV002805558	19	4117465	19	4117467	2805558	2964084		NC_000019.10:4117466:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.253G>T (p.Val85Leu)	MAP2K2	V85L	not provided	VCV000040771	19	4117467	19	4117469	40771	49241	rs142503093	NC_000019.10:4117468:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2012	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.251G>T (p.Gly84Val)	MAP2K2	G84V	Cardiofaciocutaneous syndrome 4	VCV003583909	19	4117469	19	4117471	3583909	3709759		NC_000019.10:4117470:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.250G>A (p.Gly84Arg)	MAP2K2	G84R	not provided	VCV001313314	19	4117470	19	4117472	1313314	1303575	rs1006857816	NC_000019.10:4117471:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.249C>T (p.Gly83=)	MAP2K2		RASopathy	VCV000967817	19	4117471	19	4117473	967817	958644	rs762268865	NC_000019.10:4117472:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 27, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.247G>A (p.Gly83Ser)	MAP2K2	G83S	not provided|not specified|RASopathy|Cardiofaciocutaneous syndrome 4	VCV000372943	19	4117473	19	4117475	372943	360436	rs765755554	NC_000019.10:4117474:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.246C>T (p.Asn82=)	MAP2K2		Cardiovascular phenotype|not specified|RASopathy	VCV000046229	19	4117474	19	4117476	46229	55394	rs150942310	NC_000019.10:4117475:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.245A>G (p.Asn82Ser)	MAP2K2	N82S	RASopathy	VCV001916233	19	4117475	19	4117477	1916233	1977743		NC_000019.10:4117476:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.240G>A (p.Ala80=)	MAP2K2		RASopathy	VCV000378913	19	4117480	19	4117482	378913	377711	rs543217722	NC_000019.10:4117481:C:T	single nucleotide variant	synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.239C>T (p.Ala80Val)	MAP2K2	A80V	RASopathy	VCV000958648	19	4117481	19	4117483	958648	950802	rs142271248	NC_000019.10:4117482:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.238G>T (p.Ala80Ser)	MAP2K2	A80S	RASopathy	VCV001996711	19	4117482	19	4117484	1996711	2053786		NC_000019.10:4117483:C:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.238G>A (p.Ala80Thr)	MAP2K2	A80T	RASopathy|not provided	VCV001496025	19	4117482	19	4117484	1496025	1362940	rs751795549	NC_000019.10:4117483:C:T	single nucleotide variant	missense variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.237C>T (p.Gly79=)	MAP2K2		RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	VCV001334262	19	4117483	19	4117485	1334262	1325121	rs755173195	NC_000019.10:4117484:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.234G>A (p.Leu78=)	MAP2K2		RASopathy	VCV002841520	19	4117486	19	4117488	2841520	2993673		NC_000019.10:4117487:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.232C>T (p.Leu78=)	MAP2K2		Cardiovascular phenotype	VCV002565285	19	4117488	19	4117490	2565285	2732259		NC_000019.10:4117489:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 17, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.228A>C (p.Ser76=)	MAP2K2		not provided	VCV000746650	19	4117492	19	4117494	746650	757039	rs1599307213	NC_000019.10:4117493:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.225C>T (p.Ile75=)	MAP2K2		RASopathy	VCV000448952	19	4117495	19	4117497	448952	442540	rs561400866	NC_000019.10:4117496:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.217G>A (p.Glu73Lys)	MAP2K2	E73K	Cardiovascular phenotype|Cardiofaciocutaneous syndrome 4|RASopathy	VCV000543971	19	4117503	19	4117505	543971	533051	rs187018595	NC_000019.10:4117504:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.216C>T (p.Phe72=)	MAP2K2		RASopathy	VCV001622831	19	4117504	19	4117506	1622831	1627457	rs1057517929	NC_000019.10:4117505:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.216C>G (p.Phe72Leu)	MAP2K2	F72L	not specified	VCV000372695	19	4117504	19	4117506	372695	360427	rs1057517929	NC_000019.10:4117505:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.214T>G (p.Phe72Val)	MAP2K2	F72V	RASopathy	VCV001422797	19	4117506	19	4117508	1422797	1412690	rs2145080238	NC_000019.10:4117507:A:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.210_212del (p.Asp71del)	MAP2K2	D71del	Smith-Magenis Syndrome-like	VCV000254207	19	4117508 - 4117510	19	4117510 - 4117512	254207	248722	rs1114167351	NC_000019.10:4117509:TCATC:TC	Deletion	inframe_deletion	Pathogenic	Aug 15, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.211G>A (p.Asp71Asn)	MAP2K2	D71N	MAP2K2-related disorder	VCV003344297	19	4117509	19	4117511	3344297	3505283		NC_000019.10:4117510:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	no assertion criteria provided							
NM_030662.4(MAP2K2):c.209A>T (p.Asp70Val)	MAP2K2	D70V	not provided	VCV003371174	19	4117511	19	4117513	3371174	3530364		NC_000019.10:4117512:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.209A>G (p.Asp70Gly)	MAP2K2	D70G	RASopathy	VCV002101382	19	4117511	19	4117513	2101382	2147640		NC_000019.10:4117512:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.208G>A (p.Asp70Asn)	MAP2K2	D70N	RASopathy|not specified	VCV002503830	19	4117512	19	4117514	2503830	2668740		NC_000019.10:4117513:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.207C>T (p.Asp69=)	MAP2K2		not provided|Cardiovascular phenotype|RASopathy|not specified	VCV000477727	19	4117513	19	4117515	477727	468821	rs199850535	NC_000019.10:4117514:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.206del (p.Asp69fs)	MAP2K2	D69fs	not provided	VCV001313319	19	4117514	19	4117516	1313319	1303580	rs2145080289	NC_000019.10:4117515:T:	Deletion	frameshift variant	Uncertain significance	Oct 19, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.205G>C (p.Asp69His)	MAP2K2	D69H	Cardiovascular phenotype|RASopathy	VCV002728999	19	4117515	19	4117517	2728999	2883025		NC_000019.10:4117516:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.198A>T (p.Glu66Asp)	MAP2K2	E66D	not provided	VCV000561356	19	4117522	19	4117524	561356	553043	rs1568263766	NC_000019.10:4117523:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.195C>T (p.Gly65=)	MAP2K2		RASopathy	VCV000647352	19	4117525	19	4117527	647352	648138	rs765755630	NC_000019.10:4117526:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.193G>A (p.Gly65Ser)	MAP2K2	G65S	RASopathy	VCV002202271	19	4117527	19	4117529	2202271	1931394		NC_000019.10:4117528:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.187_192del (p.Lys63_Val64del)	MAP2K2		Cardio-facio-cutaneous syndrome	VCV000666424	19	4117528 - 4117533	19	4117530 - 4117535	666424	653984	rs1599307313	NC_000019.10:4117529:GACCTTG:G	Deletion	inframe_deletion	Likely pathogenic		no assertion criteria provided							
NM_030662.4(MAP2K2):c.191_192delinsCT (p.Val64Ala)	MAP2K2	V64A	Cardiovascular phenotype|RASopathy	VCV000543986	19	4117528 - 4117529	19	4117530 - 4117531	543986	533117	rs1555698682	NC_000019.10:4117529:GA:AG	Indel	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.192C>T (p.Val64=)	MAP2K2		RASopathy	VCV000040770	19	4117528	19	4117530	40770	49240	rs8157	NC_000019.10:4117529:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.191T>C (p.Val64Ala)	MAP2K2	V64A	Cardiovascular phenotype	VCV002233543	19	4117529	19	4117531	2233543	2224284		NC_000019.10:4117530:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.191T>G (p.Val64Gly)	MAP2K2	V64G	Cardiofaciocutaneous syndrome 4	VCV000431174	19	4117529	19	4117531	431174	424697	rs1135401787	NC_000019.10:4117530:A:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 3, 2017	no assertion criteria provided							
NM_030662.4(MAP2K2):c.190G>T (p.Val64Phe)	MAP2K2	V64F	not provided|RASopathy	VCV000180912	19	4117530	19	4117532	180912	179827	rs730880518	NC_000019.10:4117531:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.188A>C (p.Lys63Thr)	MAP2K2	K63T	RASopathy	VCV002750793	19	4117532	19	4117534	2750793	2915856		NC_000019.10:4117533:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.186C>T (p.Ala62=)	MAP2K2		RASopathy	VCV001107901	19	4117534	19	4117536	1107901	1106530	rs2145080416	NC_000019.10:4117535:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.185C>T (p.Ala62Val)	MAP2K2	A62V	RASopathy	VCV002981896	19	4117535	19	4117537	2981896	3152551		NC_000019.10:4117536:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.183A>G (p.Lys61=)	MAP2K2		RASopathy	VCV003016784	19	4117537	19	4117539	3016784	3178302		NC_000019.10:4117538:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.183A>T (p.Lys61Asn)	MAP2K2	K61N	not specified|not provided	VCV000505022	19	4117537	19	4117539	505022	497522	rs886041310	NC_000019.10:4117538:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2023	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.183A>C (p.Lys61Asn)	MAP2K2	K61N	Cardiofaciocutaneous syndrome 4|RASopathy|not provided	VCV000279998	19	4117537	19	4117539	279998	264851	rs886041310	NC_000019.10:4117538:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	K61E	RASopathy|Cardiofaciocutaneous syndrome 1|not provided|Cardiofaciocutaneous syndrome 4	VCV000040769	19	4117539	19	4117541	40769	49239	rs730880517	NC_000019.10:4117540:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.178C>T (p.Gln60Ter)	MAP2K2	Q60*	RASopathy	VCV001927322	19	4117542	19	4117544	1927322	1987503		NC_000019.10:4117543:G:A	single nucleotide variant	nonsense	Uncertain significance	Aug 29, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.176C>G (p.Thr59Ser)	MAP2K2	T59S	Cardiofaciocutaneous syndrome 4	VCV003583910	19	4117544	19	4117546	3583910	3709760		NC_000019.10:4117545:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.174C>T (p.Leu58=)	MAP2K2		RASopathy|not specified	VCV000227538	19	4117546	19	4117548	227538	231027	rs876657504	NC_000019.10:4117547:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.171T>C (p.Phe57=)	MAP2K2		Cardiovascular phenotype	VCV001778739	19	4117549	19	4117551	1778739	1831323		NC_000019.10:4117550:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.171T>A (p.Phe57Leu)	MAP2K2	F57L	RASopathy	VCV000578970	19	4117549	19	4117551	578970	574980	rs1057519910	NC_000019.10:4117550:A:T	single nucleotide variant	missense variant	Pathogenic	Dec 6, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.170T>A (p.Phe57Tyr)	MAP2K2	F57Y	not provided	VCV000496473	19	4117550	19	4117552	496473	487815	rs121434497	NC_000019.10:4117551:A:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys)	MAP2K2		Cardio-facio-cutaneous syndrome	VCV000008272	19	4117550	19	4117552	8272	23311	rs121434497	NC_000019.10:4117551:A:C	single nucleotide variant	missense variant	Pathogenic	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.169T>C (p.Phe57Leu)	MAP2K2	F57L	RASopathy|not provided|Cardiofaciocutaneous syndrome 4	VCV000180911	19	4117551	19	4117553	180911	179828	rs121434498	NC_000019.10:4117552:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.169T>A (p.Phe57Ile)	MAP2K2	F57I	not specified	VCV000163960	19	4117551	19	4117553	163960	176174	rs121434498	NC_000019.10:4117552:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2014	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val)	MAP2K2	F57V	Cardio-facio-cutaneous syndrome	VCV000008273	19	4117551	19	4117553	8273	23312	rs121434498	NC_000019.10:4117552:A:C	single nucleotide variant	missense variant	Pathogenic	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.168C>G (p.Ala56=)	MAP2K2		RASopathy	VCV002414194	19	4117552	19	4117554	2414194	1936824		NC_000019.10:4117553:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 13, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.168C>T (p.Ala56=)	MAP2K2		RASopathy|not specified	VCV000513563	19	4117552	19	4117554	513563	506834	rs147814905	NC_000019.10:4117553:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.167C>A (p.Ala56Asp)	MAP2K2	A56D	Cardiofaciocutaneous syndrome 4	VCV002444198	19	4117553	19	4117555	2444198	2417931		NC_000019.10:4117554:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.166G>A (p.Ala56Thr)	MAP2K2	A56T	RASopathy	VCV002815389	19	4117554	19	4117556	2815389	2970060		NC_000019.10:4117555:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.165A>G (p.Glu55=)	MAP2K2		RASopathy	VCV002883627	19	4117555	19	4117557	2883627	3046382		NC_000019.10:4117556:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.162G>A (p.Leu54=)	MAP2K2		RASopathy	VCV002858992	19	4117558	19	4117560	2858992	3025207		NC_000019.10:4117559:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.160C>T (p.Leu54=)	MAP2K2		RASopathy	VCV001591513	19	4117560	19	4117562	1591513	1577629	rs201581427	NC_000019.10:4117561:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.159del (p.Leu54fs)	MAP2K2	L54fs	not provided|RASopathy|not specified|Cardiofaciocutaneous syndrome 4	VCV000372639	19	4117561	19	4117563	372639	360561	rs777549760	NC_000019.10:4117562:CC:C	Deletion	frameshift variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.158G>A (p.Arg53Gln)	MAP2K2	R53Q	RASopathy|not provided	VCV002048201	19	4117562	19	4117564	2048201	2107387		NC_000019.10:4117563:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.157C>T (p.Arg53Trp)	MAP2K2	R53W	RASopathy	VCV002778156	19	4117563	19	4117565	2778156	2946649		NC_000019.10:4117564:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.151AAG[1] (p.Lys52del)	MAP2K2	K52del	RASopathy	VCV001968422	19	4117564 - 4117566	19	4117566 - 4117568	1968422	2028430		NC_000019.10:4117565:CTTCTTCT:CTTCT	Microsatellite	inframe_deletion	Uncertain significance	Mar 12, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.154A>C (p.Lys52Gln)	MAP2K2	K52Q	not specified|RASopathy	VCV001009146	19	4117566	19	4117568	1009146	998617	rs374336702	NC_000019.10:4117567:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.151A>C (p.Lys51Gln)	MAP2K2	K51Q	not specified	VCV003629611	19	4117569	19	4117571	3629611	3762290		NC_000019.10:4117570:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.150G>A (p.Gln50=)	MAP2K2		RASopathy	VCV002054838	19	4117570	19	4117572	2054838	2108839		NC_000019.10:4117571:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.149A>G (p.Gln50Arg)	MAP2K2	Q50R	Noonan syndrome	VCV000666423	19	4117571	19	4117573	666423	653985	rs1599307416	NC_000019.10:4117572:T:C	single nucleotide variant	missense variant	Likely benign		no assertion criteria provided							
NM_030662.4(MAP2K2):c.143A>G (p.Glu48Gly)	MAP2K2	E48G	not provided	VCV000418571	19	4117577	19	4117579	418571	410619	rs1064793306	NC_000019.10:4117578:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.141C>T (p.Asp47=)	MAP2K2		RASopathy	VCV000448953	19	4117579	19	4117581	448953	442541	rs201526172	NC_000019.10:4117580:G:A	single nucleotide variant	synonymous variant	Benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.118A>C (p.Lys40Gln)	MAP2K2	K40Q	Cardiovascular phenotype	VCV001744400	19	4117602	19	4117604	1744400	1809182		NC_000019.10:4117603:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_030662.3(MAP2K2):c.93_114del	MAP2K2		not provided	VCV003371939	19	4117606 - 4117627	19	4117608 - 4117629	3371939	3531129		NC_000019.10:4117607:CTGCAGGTCCACCAGGTTTGCCCTGCAG:CTGCAG	Deletion		Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.110T>A (p.Leu37Gln)	MAP2K2	L37Q	RASopathy|Cardiovascular phenotype	VCV002761891	19	4117610	19	4117612	2761891	2911420		NC_000019.10:4117611:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.102G>C (p.Leu34=)	MAP2K2		Noonan syndrome and Noonan-related syndrome	VCV001334263	19	4117618	19	4117620	1334263	1325122	rs549772449	NC_000019.10:4117619:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Dec 12, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.97A>C (p.Asn33His)	MAP2K2	N33H	RASopathy	VCV003001257	19	4117623	19	4117625	3001257	3164085		NC_000019.10:4117624:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.96A>G (p.Ala32=)	MAP2K2		RASopathy	VCV000544009	19	4117624	19	4117626	544009	533121	rs1555698705	NC_000019.10:4117625:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-4G>T	MAP2K2		RASopathy	VCV001578387	19	4117631	19	4117633	1578387	1587855	rs751599552	NC_000019.10:4117632:C:A	single nucleotide variant	intron variant	Likely benign	Oct 12, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-6C>T	MAP2K2		RASopathy|Noonan syndrome and Noonan-related syndrome|not specified|not provided	VCV000179389	19	4117633	19	4117635	179389	176033	rs727504836	NC_000019.10:4117634:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 11, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.93-8C>T	MAP2K2		RASopathy	VCV002167492	19	4117635	19	4117637	2167492	1902735		NC_000019.10:4117636:G:A	single nucleotide variant	intron variant	Likely benign	May 26, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-15dup	MAP2K2		Noonan syndrome and Noonan-related syndrome|RASopathy	VCV001165042	19	4117636 - 4117637	19	4117638 - 4117639	1165042	1158549	rs751442889	NC_000019.10:4117638:CCCCCC:CCCCCCC	Duplication	intron variant	Conflicting classifications of pathogenicity	Dec 18, 2022	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.93-10G>T	MAP2K2		RASopathy	VCV002072741	19	4117637	19	4117639	2072741	2130669		NC_000019.10:4117638:C:A	single nucleotide variant	intron variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-10G>C	MAP2K2		RASopathy	VCV002028431	19	4117637	19	4117639	2028431	2088906		NC_000019.10:4117638:C:G	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-11G>T	MAP2K2		RASopathy	VCV001642672	19	4117638	19	4117640	1642672	1552770	rs2145081006	NC_000019.10:4117639:C:A	single nucleotide variant	intron variant	Likely benign	Mar 26, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-20del	MAP2K2		RASopathy	VCV002710973	19	4117647	19	4117649	2710973	2868114		NC_000019.10:4117648:T:	Deletion	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-20A>C	MAP2K2		not specified|RASopathy|not provided	VCV000138165	19	4117647	19	4117649	138165	141868	rs189388604	NC_000019.10:4117648:T:G	single nucleotide variant	intron variant	Benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.93-31A>G	MAP2K2		not provided	VCV001251377	19	4117658	19	4117660	1251377	1241723	rs200867451	NC_000019.10:4117659:T:C	single nucleotide variant	intron variant	Benign	Jan 11, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.93-78A>G	MAP2K2		not provided	VCV001291295	19	4117705	19	4117707	1291295	1281110	rs350890	NC_000019.10:4117706:T:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.93-242C>A	MAP2K2		not provided	VCV001252370	19	4117869	19	4117871	1252370	1242316	rs77017960	NC_000019.10:4117870:G:T	single nucleotide variant	intron variant	Benign	Jul 6, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+266G>A	MAP2K2		not provided	VCV000561881	19	4123515	19	4123518	561881	553044	rs192871074	NC_000019.10:4123517:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+212_92+237del	MAP2K2		not provided	VCV000561462	19	4123544 - 4123569	19	4123547 - 4123572	561462	553045	rs757105280	NC_000019.10:4123546:CCGAGGGCCCCCTGCCCCGTCCTCCCCCGAGGGCCCCCTGCCCCGTCCTCCCCCGAGGG:CCGAGGGCCCCCTGCCCCGTCCTCCCCCGAGGG	Microsatellite	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+229_92+230insCCCTCGGGGGAGGACGGGGCAGGGGA	MAP2K2		not provided	VCV001257721	19	4123551 - 4123552	19	4123554 - 4123555	1257721	1249770	rs71166962	NC_000019.10:4123554:CCCCTGCCCCGTCCTCCCCCGAGGG:CCCCTGCCCCGTCCTCCCCCGAGGGTCCCCTGCCCCGTCCTCCCCCGAGGG	Microsatellite	intron variant	Benign	Jun 11, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+204G>A	MAP2K2		not provided	VCV001291482	19	4123577	19	4123580	1291482	1281296	rs186641228	NC_000019.10:4123579:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.92+152_92+178del	MAP2K2		not provided	VCV001236738	19	4123603 - 4123629	19	4123606 - 4123632	1236738	1227155	rs557240931	NC_000019.10:4123605:TCCCCTGCCCTGTCCTCCCCTCGAGAA:	Deletion	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+168A>G	MAP2K2		not provided	VCV001288093	19	4123613	19	4123616	1288093	1277925	rs147939848	NC_000019.10:4123615:T:C	single nucleotide variant	intron variant	Benign	Aug 10, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.92+46G>C	LOC130063193|MAP2K2		not provided	VCV001275251	19	4123735	19	4123738	1275251	49238	rs200190981	NC_000019.10:4123737:C:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+42G>T	LOC130063193|MAP2K2		not provided	VCV001229954	19	4123739	19	4123742	1229954	49237	rs371373956	NC_000019.10:4123741:C:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+27C>G	LOC130063193|MAP2K2		not provided	VCV001250330	19	4123754	19	4123757	1250330	1239417	rs374346282	NC_000019.10:4123756:G:C	single nucleotide variant	intron variant	Benign	Jan 13, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+18A>T	LOC130063193|MAP2K2		RASopathy	VCV002779329	19	4123763	19	4123766	2779329	2940480		NC_000019.10:4123765:T:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+15G>A	LOC130063193|MAP2K2		RASopathy	VCV003006138	19	4123766	19	4123769	3006138	3169010		NC_000019.10:4123768:C:T	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+12G>T	LOC130063193|MAP2K2		RASopathy	VCV001532895	19	4123769	19	4123772	1532895	1605450	rs2145089682	NC_000019.10:4123771:C:A	single nucleotide variant	intron variant	Likely benign	Aug 11, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.92+11A>C	LOC130063193|MAP2K2		RASopathy|not specified	VCV000510782	19	4123770	19	4123773	510782	507049	rs1228838756	NC_000019.10:4123772:T:G	single nucleotide variant	intron variant	Likely benign	Oct 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.91G>A (p.Glu31Lys)	LOC130063193|MAP2K2	E31K	Cardiovascular phenotype	VCV003228058	19	4123782	19	4123785	3228058	3387827		NC_000019.10:4123784:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.85G>T (p.Ala29Ser)	LOC130063193|MAP2K2	A29S	Noonan syndrome and Noonan-related syndrome	VCV001334264	19	4123788	19	4123791	1334264	1325123	rs770134564	NC_000019.10:4123790:C:A	single nucleotide variant	missense variant	Uncertain significance	May 1, 2020	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.84C>A (p.Gly28=)	MAP2K2|LOC130063193		not provided	VCV003388683	19	4123789	19	4123792	3388683	3547809		NC_000019.10:4123791:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.83_84delinsAA (p.Gly28Glu)	LOC130063193|MAP2K2	G28E	RASopathy|not provided	VCV000040766	19	4123789 - 4123790	19	4123792 - 4123793	40766	49236	rs730880520	NC_000019.10:4123791:GC:TT	Indel	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.83G>A (p.Gly28Asp)	LOC130063193|MAP2K2	G28D	RASopathy	VCV001965821	19	4123790	19	4123793	1965821	2024541		NC_000019.10:4123792:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.79G>A (p.Glu27Lys)	LOC130063193|MAP2K2	E27K	RASopathy	VCV002051603	19	4123794	19	4123797	2051603	2108193		NC_000019.10:4123796:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.77G>A (p.Ser26Asn)	LOC130063193|MAP2K2	S26N	RASopathy	VCV003608839	19	4123796	19	4123799	3608839	3737665		NC_000019.10:4123798:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.74C>A (p.Thr25Asn)	LOC130063193|MAP2K2	T25N	not provided	VCV001310007	19	4123799	19	4123802	1310007	1299382	rs2145089782	NC_000019.10:4123801:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2019	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.73A>G (p.Thr25Ala)	LOC130063193|MAP2K2	T25A	RASopathy	VCV001896867	19	4123800	19	4123803	1896867	1952802		NC_000019.10:4123802:T:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.71del (p.Pro24fs)	LOC130063193|MAP2K2	P24fs	RASopathy	VCV000180916	19	4123802	19	4123805	180916	179829	rs730880525	NC_000019.10:4123804:GGGG:GGG	Deletion	frameshift variant	Uncertain significance	Aug 7, 2013	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.70C>G (p.Pro24Ala)	LOC130063193|MAP2K2	P24A	not provided	VCV002649029	19	4123803	19	4123806	2649029	2815196		NC_000019.10:4123805:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.69C>T (p.Ser23=)	LOC130063193|MAP2K2		Cardiovascular phenotype	VCV001756563	19	4123804	19	4123807	1756563	1822376		NC_000019.10:4123806:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 14, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.66A>G (p.Pro22=)	LOC130063193|MAP2K2		RASopathy|Cardiovascular phenotype	VCV001642321	19	4123807	19	4123810	1642321	1552419	rs1297461977	NC_000019.10:4123809:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.61G>C (p.Gly21Arg)	LOC130063193|MAP2K2	G21R	RASopathy	VCV002838666	19	4123812	19	4123815	2838666	2999768		NC_000019.10:4123814:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.58G>A (p.Glu20Lys)	LOC130063193|MAP2K2	E20K	RASopathy	VCV003020163	19	4123815	19	4123818	3020163	3183030		NC_000019.10:4123817:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.55G>T (p.Ala19Ser)	LOC130063193|MAP2K2	A19S	RASopathy	VCV002699491	19	4123818	19	4123821	2699491	2861765		NC_000019.10:4123820:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.54C>T (p.Ile18=)	LOC130063193|MAP2K2		Cardiovascular phenotype	VCV003228056	19	4123819	19	4123822	3228056	3387825		NC_000019.10:4123821:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 10, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.52A>T (p.Ile18Phe)	LOC130063193|MAP2K2	I18F	not provided	VCV001050111	19	4123821	19	4123824	1050111	1038721	rs774968670	NC_000019.10:4123823:T:A	single nucleotide variant	missense variant	Uncertain significance		no assertion criteria provided							
NM_030662.4(MAP2K2):c.49A>G (p.Thr17Ala)	LOC130063193|MAP2K2	T17A	not specified|not provided	VCV000046238	19	4123824	19	4123827	46238	55403	rs397517415	NC_000019.10:4123826:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2022	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.48T>C (p.Pro16=)	LOC130063193|MAP2K2		Cardiovascular phenotype	VCV003542707	19	4123825	19	4123828	3542707	3699989		NC_000019.10:4123827:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.47C>G (p.Pro16Arg)	LOC130063193|MAP2K2	P16R	not provided|Cardiofaciocutaneous syndrome 4	VCV003375926	19	4123826	19	4123829	3375926	3535106		NC_000019.10:4123828:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.46C>A (p.Pro16Thr)	LOC130063193|MAP2K2	P16T	RASopathy|Cardiofaciocutaneous syndrome 4|Noonan syndrome	VCV000620595	19	4123827	19	4123830	620595	612027	rs904859028	NC_000019.10:4123829:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.45C>T (p.Asn15=)	LOC130063193|MAP2K2		RASopathy	VCV000448954	19	4123828	19	4123831	448954	442542	rs767770776	NC_000019.10:4123830:G:A	single nucleotide variant	synonymous variant	Likely benign	May 9, 2017	reviewed by expert panel							
NM_030662.4(MAP2K2):c.44A>C (p.Asn15Thr)	LOC130063193|MAP2K2	N15T	Cardiovascular phenotype	VCV002450615	19	4123829	19	4123832	2450615	2423101		NC_000019.10:4123831:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.42C>T (p.Ile14=)	LOC130063193|MAP2K2		not provided|not specified	VCV000386639	19	4123831	19	4123834	386639	377537	rs1057522557	NC_000019.10:4123833:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2019	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.39C>T (p.Thr13=)	LOC130063193|MAP2K2		not specified|Cardiovascular phenotype|RASopathy|not provided	VCV000416254	19	4123834	19	4123837	416254	403730	rs752951050	NC_000019.10:4123836:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.34C>A (p.Leu12Ile)	LOC130063193|MAP2K2	L12I	RASopathy	VCV001009902	19	4123839	19	4123842	1009902	998618	rs2041335933	NC_000019.10:4123841:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.33G>A (p.Ala11=)	LOC130063193|MAP2K2		Cardiovascular phenotype|not specified|RASopathy	VCV000050935	19	4123840	19	4123843	50935	65596	rs368233443	NC_000019.10:4123842:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.32C>G (p.Ala11Gly)	LOC130063193|MAP2K2	A11G	not specified	VCV000503542	19	4123841	19	4123844	503542	494978	rs1555699410	NC_000019.10:4123843:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2018	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.30G>C (p.Pro10=)	LOC130063193|MAP2K2		RASopathy	VCV002844347	19	4123843	19	4123846	2844347	3007988		NC_000019.10:4123845:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.30G>A (p.Pro10=)	LOC130063193|MAP2K2		RASopathy	VCV001584915	19	4123843	19	4123846	1584915	1561066	rs2145089952	NC_000019.10:4123845:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.26T>C (p.Leu9Pro)	LOC130063193|MAP2K2	L9P	RASopathy|not specified|Cardiovascular phenotype	VCV000040765	19	4123847	19	4123850	40765	49235	rs758307267	NC_000019.10:4123849:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.22del (p.Val8fs)	LOC130063193|MAP2K2	V8fs	RASopathy	VCV000040764	19	4123851	19	4123854	40764	49234	rs730880519	NC_000019.10:4123853:CC:C	Deletion	frameshift variant	Uncertain significance	Apr 2, 2012	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.21G>A (p.Pro7=)	LOC130063193|MAP2K2		RASopathy	VCV002757237	19	4123852	19	4123855	2757237	2921008		NC_000019.10:4123854:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.17A>G (p.Lys6Arg)	LOC130063193|MAP2K2	K6R	RASopathy	VCV002011390	19	4123856	19	4123859	2011390	2070619		NC_000019.10:4123858:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.10C>T (p.Arg4Trp)	LOC130063193|MAP2K2	R4W	not provided	VCV000180915	19	4123863	19	4123866	180915	179830	rs730880524	NC_000019.10:4123865:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2014	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.7G>T (p.Ala3Ser)	LOC130063193|MAP2K2	A3S	not provided|Cardiofaciocutaneous syndrome 4	VCV000636574	19	4123866	19	4123869	636574	624658	rs1399102007	NC_000019.10:4123868:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.4C>T (p.Leu2=)	LOC130063193|MAP2K2		RASopathy	VCV001936808	19	4123869	19	4123872	1936808	1993532		NC_000019.10:4123871:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2022	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-4C>G	LOC130063193|MAP2K2		not specified|not provided|Cardiovascular phenotype	VCV000516377	19	4123876	19	4123879	516377	506841	rs747742961	NC_000019.10:4123878:G:C	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.-9G>A	LOC130063193|MAP2K2		not provided|not specified	VCV000389641	19	4123881	19	4123884	389641	377543	rs1057523493	NC_000019.10:4123883:C:T	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications							
NM_030662.4(MAP2K2):c.-27CCG[6]	LOC130063193|MAP2K2		not specified	VCV000046225	19	4123887 - 4123888	19	4123890 - 4123891	46225	55390	rs397517411	NC_000019.10:4123890:CGGCGGCGGCGGCG:CGGCGGCGGCGGCGGCGGCG	Microsatellite	5 prime UTR variant	Benign/Likely benign	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.-16G>A	LOC130063193|MAP2K2		not specified	VCV001722463	19	4123888	19	4123891	1722463	1779973		NC_000019.10:4123890:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-27CCG[3]	LOC130063193|MAP2K2		RASopathy	VCV000180904	19	4123888 - 4123890	19	4123891 - 4123893	180904	179831	rs397517411	NC_000019.10:4123890:CGGCGGCGGCGGCG:CGGCGGCGGCG	Microsatellite	5 prime UTR variant	Benign	Oct 13, 2014	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-23C>A	LOC130063193|MAP2K2		not provided	VCV000387212	19	4123895	19	4123898	387212	377714	rs1057522728	NC_000019.10:4123897:G:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jun 27, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-42C>T	LOC130063193|MAP2K2		not provided	VCV000279926	19	4123914	19	4123917	279926	264853	rs886041258	NC_000019.10:4123916:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 18, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-47A>G	LOC130063193|MAP2K2		not provided	VCV000378939	19	4123919	19	4123922	378939	377716	rs1057520422	NC_000019.10:4123921:T:C	single nucleotide variant	5 prime UTR variant	Likely benign	Oct 7, 2016	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-50C>A	LOC130063193|MAP2K2		not specified	VCV000516187	19	4123922	19	4123925	516187	507414	rs760176331	NC_000019.10:4123924:G:T	single nucleotide variant	5 prime UTR variant	Likely benign	Aug 17, 2017	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.-206G>T	MAP2K2		not provided	VCV000561378	19	4124078	19	4124081	561378	553046	rs115202186	NC_000019.10:4124080:C:A	single nucleotide variant	5 prime UTR variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.4(MAP2K2):c.-243C>T	MAP2K2		Noonan syndrome and Noonan-related syndrome	VCV001334206	19	4124115	19	4124118	1334206	1325066	rs181533374	NC_000019.10:4124117:G:A	single nucleotide variant	5 prime UTR variant	Benign	Jan 17, 2017	criteria provided, single submitter							
NM_030662.3(MAP2K2):c.-269G>A	MAP2K2		not provided	VCV000561360	19	4124141	19	4124144	561360	553047	rs112548538	NC_000019.10:4124143:C:T	single nucleotide variant		Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.3(MAP2K2):c.-285G>T	LOC130063194|MAP2K2		not provided	VCV000561377	19	4124157	19	4124160	561377	553048	rs150016208	NC_000019.10:4124159:C:A	single nucleotide variant		Benign	Jun 19, 2018	criteria provided, single submitter							
NM_030662.3(MAP2K2):c.-366G>A	LOC130063194|MAP2K2		not provided	VCV000561429	19	4124238	19	4124241	561429	553049	rs114504037	NC_000019.10:4124240:C:T	single nucleotide variant		Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_030662.3(MAP2K2):c.-406C>A	MAP2K2		not provided	VCV000561937	19	4124278	19	4124281	561937	553050	rs149141097	NC_000019.10:4124280:G:T	single nucleotide variant		Likely benign	Jun 19, 2018	criteria provided, single submitter							
NM_030662.3(MAP2K2):c.-419C>A	MAP2K2		not provided	VCV000561936	19	4124291	19	4124294	561936	553051	rs144939535	NC_000019.10:4124293:G:T	single nucleotide variant		Likely benign	Jun 19, 2018	criteria provided, single submitter							
NC_000019.10:g.4124295C>T	MAP2K2		not provided	VCV001206725	19	4124292	19	4124295	1206725	1199130	rs567625341	NC_000019.10:4124294:C:T	single nucleotide variant		Likely benign	Aug 14, 2018	criteria provided, single submitter							
NC_000019.10:g.4124364del	MAP2K2		not provided	VCV001289274	19	4124361	19	4124364	1289274	1279105	rs148753612	NC_000019.10:4124363:G:	Deletion		Benign	Jun 14, 2018	criteria provided, single submitter							
NC_000019.9:g.(4099413_4101016)_(4102452_4110506)del	MAP2K2		not specified	VCV003384817	19	4099413 - 4110506			3384817	3543963			Deletion		Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NC_000019.9:g.(?_4110487)_(4171966_?)dup	CREB3L3|MAP2K2		RASopathy	VCV003248518	19	4110487 - 4171966			3248518	3407322			Duplication		Uncertain significance	Dec 17, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_4090596)_(4171966_?)dup	CREB3L3|MAP2K2		RASopathy	VCV003248517	19	4090596 - 4171966			3248517	3407321			Duplication		Uncertain significance	Mar 14, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_2430909)_(4171966_?)del	APBA3|ATCAY|CACTIN|CELF5|CREB3L3|DAPK3|DIRAS1|DOHH|EEF2|FZR1|GADD45B|GIPC3|GNA11|GNA15|GNG7|HMG20B|LMNB2|MAP2K2|MATK|MFSD12|MRPL54|NCLN|NFIC|NMRK2|PIAS4|PIP5K1C|RAX2|S1PR4|SGTA|SLC39A3|SMIM24|TBXA2R|TEKTIP1|THOP1|TJP3|TLE2|TLE5|TLE6|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF77		RASopathy	VCV003248515	19	2430909 - 4171966			3248515	3407319			Deletion		Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_3917720)_(4818389_?)dup	ANKRD24|ATCAY|CHAF1A|CREB3L3|DAPK3|DPP9|EBI3|EEF2|FEM1A|FSD1|LRG1|MAP2K2|MPND|MYDGF|NMRK2|PIAS4|PLIN4|PLIN5|SEMA6B|SH3GL1|SHD|SIRT6|STAP2|TICAM1|TMIGD2|TNFAIP8L1|UBXN6|YJU2|ZBTB7A		not provided	VCV003242666	19	3917720 - 4818389			3242666	3404385			Duplication		Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
GRCh37/hg19 19p13.3(chr19:3788725-4881494)x1	EBI3|EEF2|ANKRD24|ATCAY|DAPK3|DPP9|FEM1A|FSD1|CHAF1A|CREB3L3|LRG1|MAP2K2|MATK|MPND|MYDGF|NMRK2|PIAS4|PLIN3|PLIN4|PLIN5|SEMA6B|SH3GL1|SHD|SIRT6|STAP2|TICAM1|TMIGD2|TNFAIP8L1|UBXN6|YJU2|ZBTB7A|ZFR2		not specified	VCV003062389	19	3788725 - 4881494			3062389	3222614			copy number loss		Uncertain significance		criteria provided, single submitter							
GRCh37/hg19 19p13.3-13.2(chr19:260912-7246777)x3	ABCA7|ABHD17A|ACER1|ACSBG2|ADAMTSL5|ADAT3|ADGRE1|ALKBH7|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ARRDC5|ATCAY|ATP5F1D|ATP8B3|AZU1|BSG|BTBD2|C19orf25|C2CD4C|C3|CACTIN|CAPS|CATSPERD|CBARP|CD70|CDC34|CELF5|CFD|CHAF1A|CIMAP1D|CIRBP|CLPP|CNN2|CRB3|CREB3L3|CSNK1G2|DAPK3|DAZAP1|DENND1C|DIRAS1|DOHH|DOT1L|DPP9|DUS3L|EBI3|EEF2|EFNA2|ELANE|FAM174C|FEM1A|FGF22|FSD1|FSTL3|FUT3|FUT5|FUT6|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNG7|GPR108|GPX4|GRIN3B|GTF2F1|GZMM|HCN2|HMG20B|HSD11B1L|INSR|IZUMO4|JSRP1|KDM4B|KHSRP|KISS1R|KLF16|LINGO3|LMNB2|LONP1|LRG1|LSM7|MADCAM1|MAP2K2|MATK|MBD3|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MED16|MEX3D|MFSD12|MICOS13|MIDN|MIER2|MIR1909|MISP|MKNK2|MLLT1|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFA11|NDUFS7|NFIC|NMRK2|NRTN|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|POLR2E|POLRMT|PRR22|PRSS57|PRTN3|PSPN|PTBP1|PTPRS|PWWP3A|R3HDM4|RANBP3|RAX2|REEP6|REXO1|RFX2|RNF126|RPL36|RPS15|S1PR4|SAFB|SAFB2|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH2D3A|SH3GL1|SHC2|SHD|SIRT6|SLC25A23|SLC25A41|SLC39A3|SMIM24|SPMAP2|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TICAM1|TIMM13|TINCR|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TPGS1|TRIP10|TUBB4A|UBXN6|UHRF1|UQCR11|VAV1|VMAC|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF557|ZNF77|ZNRF4		not provided	VCV002684882	19	260912 - 7246777			2684882	2845917			copy number gain		Pathogenic	Oct 10, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_4077097)_(4123872_?)dup	MAP2K2		RASopathy	VCV002426940	19	4077097 - 4123872			2426940	1950478			Duplication		Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_4094110)_(4102471_?)dup	MAP2K2		RASopathy	VCV002426939	19	4094110 - 4102471			2426939	1950477			Duplication		Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_4090596)_(4090726_?)dup	MAP2K2		RASopathy	VCV002426938	19	4090596 - 4090726			2426938	1950476			Duplication		Uncertain significance	May 16, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_4123761)_(4123872_?)del	MAP2K2		RASopathy	VCV002426937	19	4123761 - 4123872			2426937	1950475			Deletion		Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_589946)_(5696788_?)dup	TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|UQCR11|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF77|ZNRF4|TNFAIP8L1|UBXN6|UHRF1|ABCA7|ABHD17A|ADAMTSL5|ADAT3|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ARRDC5|ATCAY|ATP5F1D|ATP8B3|AZU1|BTBD2|C19orf25|CACTIN|CBARP|CELF5|CFD|CHAF1A|CIRBP|CNN2|CREB3L3|CSNK1G2|DAPK3|DAZAP1|DIRAS1|DOHH|DOT1L|DPP9|EBI3|EEF2|EFNA2|ELANE|FAM174C|FEM1A|FGF22|FSD1|FSTL3|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNG7|GPX4|GRIN3B|HCN2|HMG20B|HSD11B1L|IZUMO4|JSRP1|KDM4B|KISS1R|KLF16|LINGO3|LMNB2|LONP1|LRG1|LSM7|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MICOS13|MIDN|MIR1909|MISP|MKNK2|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFS7|NFIC|NMRK2|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPPR3|POLR2E|POLRMT|PRSS57|PRTN3|PTBP1|PTPRS|PWWP3A|R3HDM4|RAX2|REEP6|REXO1|RNF126|RPL36|RPS15|S1PR4|SAFB|SAFB2|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH3GL1|SHD|SIRT6|SLC39A3|SMIM24|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TICAM1|TIMM13|TINCR|TJP3|TLE2		not provided	VCV002425228	19	589946 - 5696788			2425228	1942957			Duplication		Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_589946)_(4818389_?)dup	ABCA7|ABHD17A|ADAMTSL5|ADAT3|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ATCAY|ATP5F1D|ATP8B3|AZU1|BTBD2|C19orf25|CACTIN|CBARP|CELF5|CFD|CHAF1A|CIRBP|CNN2|CREB3L3|CSNK1G2|DAPK3|DAZAP1|DIRAS1|DOHH|DOT1L|DPP9|EBI3|EEF2|EFNA2|ELANE|FAM174C|FEM1A|FGF22|FSD1|FSTL3|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNG7|GPX4|GRIN3B|HCN2|HMG20B|IZUMO4|JSRP1|KISS1R|KLF16|LINGO3|LMNB2|LRG1|LSM7|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MIDN|MIR1909|MISP|MKNK2|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFS7|NFIC|NMRK2|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN4|PLIN5|PLK5|PLPPR3|POLR2E|POLRMT|PRSS57|PRTN3|PTBP1|PWWP3A|R3HDM4|RAX2|REEP6|REXO1|RNF126|RPS15|S1PR4|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH3GL1|SHD|SIRT6|SLC39A3|SMIM24|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TICAM1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TNFAIP8L1|UBXN6|UQCR11|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF77		not provided	VCV002423454	19	589946 - 4818389			2423454	1945673			Duplication		Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NC_000019.9:g.(?_4090596)_(4090726_?)del	MAP2K2		RASopathy	VCV001476500	19	4090596 - 4090726			1476500	1339273			Deletion		Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NC_000019.9:g.(?_4090596)_(4102471_?)del	MAP2K2		RASopathy	VCV001448682	19	4090596 - 4102471			1448682	1423381			Deletion		Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_4094431)_(4123872_?)del	MAP2K2		RASopathy	VCV001448681	19	4094431 - 4123872			1448681	1423380			Deletion		Uncertain significance	Sep 19, 2021	criteria provided, single submitter							
NC_000019.9:g.(?_4102354)_(4102471_?)del	MAP2K2		RASopathy	VCV001441467	19	4102354 - 4102471			1441467	1358735			Deletion		Uncertain significance	Dec 22, 2022	criteria provided, single submitter							
GRCh37/hg19 19p13.3(chr19:3501624-5357124)x1	ANKRD24|APBA3|ARRDC5|ATCAY|CACTIN|CHAF1A|CREB3L3|DAPK3|DPP9|EBI3|EEF2|FEM1A|FSD1|FZR1|GIPC3|HMG20B|KDM4B|LRG1|MAP2K2|MATK|MFSD12|MPND|MRPL54|MYDGF|NMRK2|PIAS4|PIP5K1C|PLIN3|PLIN4|PLIN5|PTPRS|RAX2|SEMA6B|SH3GL1|SHD|SIRT6|STAP2|TBXA2R|TEKTIP1|TICAM1|TJP3|TMIGD2|TNFAIP8L1|UBXN6|UHRF1|YJU2|ZBTB7A|ZFR2		not provided	VCV001340547	19	3501624 - 5357124			1340547	1331755			copy number loss		Pathogenic	Jan 20, 2021	no assertion criteria provided							
GRCh37/hg19 19p13.3(chr19:3788725-4225547)x1	ANKRD24|ATCAY|CREB3L3|DAPK3|EEF2|MAP2K2|MATK|NMRK2|PIAS4|SIRT6|ZBTB7A|ZFR2		not provided	VCV001340292	19	3788725 - 4225547			1340292	1331500			copy number loss		Uncertain significance	Jan 18, 2021	no assertion criteria provided							
GRCh37/hg19 19p13.3(chr19:3976203-4345430)	PIAS4|SHD|SIRT6|TMIGD2|YJU2|ZBTB7A|STAP2|ANKRD24|CREB3L3|EBI3|EEF2|FSD1|MAP2K2|MPND		Global developmental delay|Obesity	VCV001047892	19	3976203 - 4345430			1047892	1035725			copy number loss		Pathogenic	Mar 15, 2021	criteria provided, single submitter							
NC_000019.9:g.(?_4077097)_(4123882_?)dup	MAP2K2		RASopathy	VCV001011850	19	4077097 - 4123882			1011850	986648			Duplication		Uncertain significance	Jul 7, 2020	criteria provided, single submitter							
NC_000019.10:g.(?_4077099)_(4102463_?)del	MAP2K2		RASopathy	VCV000833444	19	4077097 - 4102461			833444	821256			Deletion		Uncertain significance	Mar 8, 2019	criteria provided, single submitter							
GRCh37/hg19 19p13.3(chr19:260912-4384674)x3	ABCA7|ABHD17A|ADAMTSL5|ADAT3|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ATCAY|ATP5F1D|ATP8B3|AZU1|BSG|BTBD2|C19orf25|C2CD4C|CACTIN|CBARP|CDC34|CELF5|CFD|CIMAP1D|CIRBP|CNN2|CREB3L3|CSNK1G2|DAPK3|DAZAP1|DIRAS1|DOHH|DOT1L|EBI3|EEF2|EFNA2|ELANE|FAM174C|FGF22|FSD1|FSTL3|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNG7|GPX4|GRIN3B|GZMM|HCN2|HMG20B|IZUMO4|JSRP1|KISS1R|KLF16|LINGO3|LMNB2|LSM7|MADCAM1|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MIDN|MIER2|MIR1909|MISP|MKNK2|MOB3A|MPND|MRPL54|NCLN|NDUFS7|NFIC|NMRK2|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLK5|PLPP2|PLPPR3|POLR2E|POLRMT|PRSS57|PRTN3|PTBP1|PWWP3A|R3HDM4|RAX2|REEP6|REXO1|RNF126|RPS15|S1PR4|SBNO2|SCAMP4|SF3A2|SGTA|SH3GL1|SHC2|SHD|SIRT6|SLC39A3|SMIM24|SPMAP2|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TPGS1|UQCR11|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF77		See cases	VCV000816518	19	260912 - 4384674			816518	804723			copy number gain		Pathogenic	Jun 1, 2018	criteria provided, single submitter							
GRCh37/hg19 19p13.3(chr19:260911-4788357)x3	ABCA7|ABHD17A|ADAMTSL5|ADAT3|AMH|ANKRD24|AP3D1|APBA3|APC2|ARHGAP45|ARID3A|ATCAY|ATP5F1D|ATP8B3|AZU1|BSG|BTBD2|C19orf25|C2CD4C|CACTIN|CBARP|CDC34|CELF5|CFD|CHAF1A|CIMAP1D|CIRBP|CNN2|CREB3L3|CSNK1G2|DAPK3|DAZAP1|DIRAS1|DOHH|DOT1L|DPP9|EBI3|EEF2|EFNA2|ELANE|FAM174C|FGF22|FSD1|FSTL3|FZR1|GADD45B|GAMT|GIPC3|GNA11|GNA15|GNG7|GPX4|GRIN3B|GZMM|HCN2|HMG20B|IZUMO4|JSRP1|KISS1R|KLF16|LINGO3|LMNB2|LRG1|LSM7|MADCAM1|MAP2K2|MATK|MBD3|MED16|MEX3D|MFSD12|MIDN|MIER2|MIR1909|MISP|MKNK2|MOB3A|MPND|MRPL54|MYDGF|NCLN|NDUFS7|NFIC|NMRK2|OAZ1|ONECUT3|PALM|PCSK4|PEAK3|PIAS4|PIP5K1C|PLEKHJ1|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|POLR2E|POLRMT|PRSS57|PRTN3|PTBP1|PWWP3A|R3HDM4|RAX2|REEP6|REXO1|RNF126|RPS15|S1PR4|SBNO2|SCAMP4|SEMA6B|SF3A2|SGTA|SH3GL1|SHC2|SHD|SIRT6|SLC39A3|SMIM24|SPMAP2|SPPL2B|STAP2|STK11|TBXA2R|TCF3|TEKTIP1|THOP1|TIMM13|TJP3|TLE2|TLE5|TLE6|TMEM259|TMIGD2|TMPRSS9|TNFAIP8L1|TPGS1|UBXN6|UQCR11|WDR18|YJU2|ZBTB7A|ZFR2|ZNF554|ZNF555|ZNF556|ZNF77		not provided	VCV000686280	19	260911 - 4788357			686280	673872			copy number gain		Pathogenic	May 21, 2018	no assertion criteria provided							
GRCh37/hg19 19p13.3(chr19:3076808-4796782)	ANKRD24|APBA3|ATCAY|CACTIN|CELF5|CHAF1A|CREB3L3|DAPK3|DOHH|DPP9|EBI3|EEF2|FEM1A|FSD1|FZR1|GIPC3|GNA11|GNA15|HMG20B|LRG1|MAP2K2|MATK|MFSD12|MPND|MRPL54|MYDGF|NCLN|NFIC|NMRK2|PIAS4|PIP5K1C|PLIN4|PLIN5|RAX2|S1PR4|SEMA6B|SH3GL1|SHD|SIRT6|SMIM24|STAP2|TBXA2R|TEKTIP1|TJP3|TMIGD2|TNFAIP8L1|UBXN6|YJU2|ZBTB7A|ZFR2		not provided	VCV000625734	19	3076808 - 4796782			625734	614038			copy number loss		Pathogenic	Nov 1, 2018	criteria provided, single submitter							
GRCh37/hg19 19p13.3-13.2(chr19:3120160-9732820)x3	ACER1|ACSBG2|ACTL9|ADAMTS10|ADGRE1|ALKBH7|ANGPTL4|ANKRD24|APBA3|ARHGEF18|ARRDC5|ATCAY|C3|CACTIN|CAMSAP3|CAPS|CATSPERD|CCL25|CD209|CD320|CD70|CELF5|CERS4|CHAF1A|CLEC4G|CLEC4M|CLPP|CRB3|CREB3L3|CTXN1|DAPK3|DENND1C|DOHH|DPP9|DUS3L|EBI3|EEF2|ELAVL1|EVI5L|FBN3|FCER2|FEM1A|FSD1|FUT3|FUT5|FUT6|FZR1|GIPC3|GNA11|GNA15|GPR108|GTF2F1|HMG20B|HNRNPM|HSD11B1L|INSR|KANK3|KDM4B|KHSRP|LONP1|LRG1|LRRC8E|MAP2K2|MAP2K7|MARCHF2|MATK|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MCEMP1|MCOLN1|MFSD12|MICOS13|MLLT1|MPND|MRPL54|MUC16|MYDGF|MYO1F|NCLN|NDUFA11|NDUFA7|NFIC|NMRK2|NRTN|OR1M1|OR2Z1|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|PCP2|PET100|PEX11G|PIAS4|PIP5K1C|PLIN3|PLIN4|PLIN5|PNPLA6|PRAM1|PRR22|PSPN|PTPRS|RAB11B|RANBP3|RAX2|RETN|RFX2|RPL36|RPS28|S1PR4|SAFB|SAFB2|SEMA6B|SH2D3A|SH3GL1|SHD|SIRT6|SLC25A23|SLC25A41|SMIM24|SNAPC2|STAP2|STXBP2|TBXA2R|TEKTIP1|TEX45|TGFBR3L|TICAM1|TIMM44|TINCR|TJP3|TMIGD2|TNFAIP8L1|TNFSF14|TNFSF9|TRAPPC5|TRIP10|TUBB4A|UBXN6|UHRF1|VAV1|VMAC|XAB2|YJU2|ZBTB7A|ZFR2|ZNF121|ZNF177|ZNF266|ZNF317|ZNF358|ZNF414|ZNF426|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF699|ZNRF4		not provided	VCV000564607	19	3120160 - 9732820			564607	555791			copy number gain		Pathogenic	Apr 17, 2018	no assertion criteria provided							
Single allele	CREB3L3|SHD|TJP3|RAX2|SIRT6|PLIN4|MATK|SEMA6B|ZFR2|DAPK3|APBA3|PLIN5|ATCAY|MPND|CHAF1A|EEF2|PIAS4|ANKRD24|EBI3|YJU2|UBXN6|FSD1|STAP2|MRPL54|LRG1|NMRK2|SH3GL1|ZBTB7A|MAP2K2|TMIGD2		Primary amenorrhea	VCV000549647	19	3718839 - 4604407			549647	540127			Duplication		Uncertain significance	Jun 1, 2018	criteria provided, single submitter							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)	PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRSS57|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|REX1BD|RDH13|RDH8|REEP6|RELB|RETN|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMC4|TMED1|TMEM143|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|UBA2|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR83OS|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|EMC10|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|ILVBL|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KISS1R|KLC3|KLF1|KLF16|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LIM2|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NFIC|NFIX|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOSIP|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9		See cases	VCV000443499	19	260912 - 58956888			443499	437161			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3	TMC4|TMED1|TMEM143|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LIM2|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NFIC|NFIX|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOSIP|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRSS57|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|RDH13|RDH8|REEP6|RELB|RETN|REX1BD|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EMC10|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|ILVBL|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KISS1R|KLC3|KLF1|KLF16|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR83OS|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9		See cases	VCV000443498	19	260912 - 58956888			443498	437160			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
NM_030662.4(MAP2K2):c.146A>C (p.Gln49Pro)	MAP2K2	Q49P	not provided	VCV003360048					3360048	3519259			single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2023	criteria provided, single submitter							
NM_030662.4(MAP2K2):c.528+5G>T	MAP2K2		not provided	VCV003359576					3359576	3518788			single nucleotide variant	intron variant	Uncertain significance	Jun 16, 2023	criteria provided, single submitter							
